<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">103728</article-id><article-id pub-id-type="doi">10.7554/eLife.103728</article-id><article-version article-version-type="publication-state">version of record</article-version><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group></article-categories><title-group><article-title>A systematic review and embryological perspective of pluripotent stem cell-derived autonomic postganglionic neuron differentiation for human disease modeling</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Bos</surname><given-names>Thomas A</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2837-7355</contrib-id><email>t.a.bos@lumc.nl</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Polyakova</surname><given-names>Elizaveta</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9615-2871</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>van Gils</surname><given-names>Janine Maria</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>de Vries</surname><given-names>Antoine AF</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Goumans</surname><given-names>Marie-José</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Freund</surname><given-names>Christian</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>DeRuiter</surname><given-names>Marco C</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Jongbloed</surname><given-names>Monique RM</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9132-0418</contrib-id><email>m.r.m.jongbloed@lumc.nl</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05xvt9f17</institution-id><institution>Department of Anatomy and Embryology, Leiden University Medical Centre</institution></institution-wrap><addr-line><named-content content-type="city">Leiden</named-content></addr-line><country>Netherlands</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05xvt9f17</institution-id><institution>Department of Cardiology, Leiden University Medical Centre</institution></institution-wrap><addr-line><named-content content-type="city">Leiden</named-content></addr-line><country>Netherlands</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05xvt9f17</institution-id><institution>Department of Cell and Chemical Biology, Leiden University Medical Centre</institution></institution-wrap><addr-line><named-content content-type="city">Leiden</named-content></addr-line><country>Netherlands</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05xvt9f17</institution-id><institution>Leiden hiPSC Centre, Leiden University Medical Centre</institution></institution-wrap><addr-line><named-content content-type="city">Leiden</named-content></addr-line><country>Netherlands</country></aff><aff id="aff5"><label>5</label><institution>Centre for Congenital Heart Disease Amsterdam-Leiden (CAHAL)</institution><addr-line><named-content content-type="city">Leiden</named-content></addr-line><country>Netherlands</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Scherschel</surname><given-names>Katharina</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/024z2rq82</institution-id><institution>Heinrich Heine University Düsseldorf</institution></institution-wrap><country>Germany</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Ajijola</surname><given-names>Olujimi A</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/046rm7j60</institution-id><institution>University of California, Los Angeles</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>12</day><month>03</month><year>2025</year></pub-date><volume>14</volume><elocation-id>e103728</elocation-id><history><date date-type="received" iso-8601-date="2024-10-01"><day>01</day><month>10</month><year>2024</year></date><date date-type="accepted" iso-8601-date="2025-02-13"><day>13</day><month>02</month><year>2025</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at .</event-desc><date date-type="preprint" iso-8601-date="2022-08-22"><day>22</day><month>08</month><year>2022</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2022.08.19.504404"/></event></pub-history><permissions><copyright-statement>© 2025, Bos et al</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Bos et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-103728-v2.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-103728-figures-v2.pdf"/><abstract><p>Human autonomic neuronal cell models are emerging as tools for modeling diseases such as cardiac arrhythmias. In this systematic review, we compared 33 articles applying 14 different protocols to generate sympathetic neurons and 3 different procedures to produce parasympathetic neurons. All methods involved the differentiation of human pluripotent stem cells, and none employed permanent or reversible cell immortalization. Almost all protocols were reproduced in multiple pluripotent stem cell lines, and over half showed evidence of neural firing capacity. Common limitations in the field are a lack of three-dimensional models and models that include multiple cell types. Sympathetic neuron differentiation protocols largely mirrored embryonic development, with the notable absence of migration, axon extension, and target-specificity cues. Parasympathetic neuron differentiation protocols may be improved by including several embryonic cues promoting cell survival, cell maturation, or ion channel expression. Moreover, additional markers to define parasympathetic neurons in vitro may support the validity of these protocols. Nonetheless, four sympathetic neuron differentiation protocols and one parasympathetic neuron differentiation protocol reported more than two-thirds of cells expressing autonomic neuron markers. Altogether, these protocols promise to open new research avenues of human autonomic neuron development and disease modeling.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>sympathetic neurons</kwd><kwd>parasympathetic neurons</kwd><kwd>pluripotent stem cells</kwd><kwd>embryology</kwd><kwd>human</kwd><kwd>systematic review</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Mouse</kwd><kwd>Chicken</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003246</institution-id><institution>Nederlandse Organisatie voor Wetenschappelijk Onderzoek</institution></institution-wrap></funding-source><award-id>91719346</award-id><principal-award-recipient><name><surname>Jongbloed</surname><given-names>Monique RM</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Although methods to efficiently generate functional autonomic postganglionic neurons from human pluripotent stem cells largely mirror signaling cues during embryonic development, several in vivo signaling cues remain to be explored in vitro.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>The sympathetic and parasympathetic nervous systems, collectively the autonomic nervous system (ANS), typically have peripheral pathways consisting of two serially connected neurons (<xref ref-type="bibr" rid="bib161">Wehrwein et al., 2016</xref>). <italic>Preganglionic</italic> neurons, with somata located in the central nervous system (CNS), form synapses with <italic>postganglionic</italic> neurons with somata located in autonomic ganglia. Sympathetic and parasympathetic postganglionic neurons (henceforth designated ‘sympathetic neurons’ and ‘parasympathetic neurons’) communicate directly with effector cells throughout the body to coordinate physiological homeostasis (<xref ref-type="bibr" rid="bib161">Wehrwein et al., 2016</xref>). The widespread distribution of both subdivisions of the ANS in the body is reflected by the myriad of diseases exacerbated or complicated by autonomic dysfunction, including life-threatening cardiac arrhythmias, ventricular remodeling in heart failure, diabetes mellitus, and Parkinson’s disease (<xref ref-type="bibr" rid="bib135">Shen and Zipes, 2014</xref>; <xref ref-type="bibr" rid="bib159">Vinik et al., 2003</xref>; <xref ref-type="bibr" rid="bib25">Chen et al., 2020</xref>; <xref ref-type="bibr" rid="bib47">Florea and Cohn, 2014</xref>).</p><p>Past ANS research has largely relied on animal models, which are often limited by functional differences with humans (<xref ref-type="bibr" rid="bib181">Zwanenburg et al., 2025</xref>). For instance, under standard laboratory conditions, mice exhibit a predominant sympathetic tone, in contrast to the predominant parasympathetic tone usually observed in humans (<xref ref-type="bibr" rid="bib144">Swoap et al., 2008</xref>). This, combined with ethical concerns and the poor translatability of findings in animal studies to human contexts (<xref ref-type="bibr" rid="bib120">Robinson et al., 2019</xref>), shows the need for valid human ANS models. However, primary human autonomic neurons are difficult to obtain and maintain in culture.</p><p>As an alternative, a number of promising sympathetic nervous system models derived from human pluripotent stem cells (hPSCs) have been published (last reviewed in 2019) (<xref ref-type="bibr" rid="bib166">Wu and Zeltner, 2019</xref>). Patient-derived hPSCs have the advantage of offering patient-specific research opportunities. Another approach, conditional immortalization, has previously been used to reversibly induce the proliferation of primary cells with otherwise limited mitotic capacities, such as human epicardium-derived cells and atrial myocytes (<xref ref-type="bibr" rid="bib63">Harlaar et al., 2022</xref>; <xref ref-type="bibr" rid="bib53">Ge et al., 2021</xref>). Cells generated in this manner can regain the functional characteristics of the source cells upon exiting the state of proliferation. In particular, cells derived from the conditional immortalization of autonomic neurons could be especially well-suited for high-throughput applications like drug screening.</p><p>However, a number of challenges remain to be addressed in this relatively young field of research. Generally, hPSC-derived cells do not fully recapitulate adult phenotypes, which may limit validity for modeling of adult-onset diseases (<xref ref-type="bibr" rid="bib98">Mateos-Aparicio et al., 2020</xref>; <xref ref-type="bibr" rid="bib75">Karbassi et al., 2020</xref>). Validity for modeling in vivo autonomic neurons may also be increased by incorporating important embryonic signaling cues in autonomic neuron differentiation methods. Another challenge is the considerable proportions of cells other than autonomic neurons generated by many current methods, which may obscure or skew measurements. Additionally, care must be taken to confirm autonomic neuron identities in vitro, outside of the anatomical and physiological context. This is particularly the case for autonomic neurons originating from hPSCs, which can theoretically differentiate towards every cell type of the body, including central cholinergic or noradrenergic neurons (<xref ref-type="bibr" rid="bib151">Thomson et al., 1998</xref>; <xref ref-type="bibr" rid="bib145">Takahashi et al., 2007</xref>).</p><p>The aim of this systematic review is to summarize and discuss the currently available methods to derive autonomic neurons. Therefore, the following questions were asked:</p><list list-type="order"><list-item><p>How do in vitro autonomic neuron differentiation strategies compare to in vivo signaling cues during the embryonic development of the ANS?</p></list-item><list-item><p>Which molecular definitions of autonomic neurons are applied in vitro?</p></list-item><list-item><p>How efficient are the current differentiation strategies to generate autonomic neurons?</p></list-item><list-item><p>Which functional characteristics are shown by autonomic neurons generated in vitro?</p></list-item><list-item><p>Which current challenges should future studies address?</p></list-item></list></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Study selection</title><p>In total, 1440 records were retrieved. After excluding duplicates, and screening titles, abstracts, and full texts, 33 articles were retained (<xref ref-type="fig" rid="fig1">Figure 1</xref>). Each excluded article during full-text screening is listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>. The included articles described a total of 14 different protocols to generate sympathetic neurons (‘sympathetic protocols’, in brief) and 3 different procedures to produce parasympathetic neurons (‘parasympathetic protocols’, in brief) (<xref ref-type="table" rid="table1">Table 1</xref>; <xref ref-type="bibr" rid="bib69">Huang et al., 2016</xref>; <xref ref-type="bibr" rid="bib26">Cheng et al., 2024</xref>; <xref ref-type="bibr" rid="bib178">Zhang et al., 2016</xref>; <xref ref-type="bibr" rid="bib108">Oh et al., 2016</xref>; <xref ref-type="bibr" rid="bib177">Zeltner et al., 2016</xref>; <xref ref-type="bibr" rid="bib124">Saito-Diaz et al., 2019</xref>; <xref ref-type="bibr" rid="bib48">Frith et al., 2018</xref>; <xref ref-type="bibr" rid="bib49">Frith and Tsakiridis, 2019</xref>; <xref ref-type="bibr" rid="bib125">Saldana-Guerrero et al., 2024</xref>; <xref ref-type="bibr" rid="bib80">Kirino et al., 2018</xref>; <xref ref-type="bibr" rid="bib7">Amer-Sarsour et al., 2024</xref>; <xref ref-type="bibr" rid="bib126">Saleh et al., 2024</xref>; <xref ref-type="bibr" rid="bib21">Carr-Wilkinson et al., 2018</xref>; <xref ref-type="bibr" rid="bib61">Hackland et al., 2019</xref>; <xref ref-type="bibr" rid="bib57">Gomez et al., 2019</xref>; <xref ref-type="bibr" rid="bib167">Wu and Zeltner, 2020</xref>; <xref ref-type="bibr" rid="bib168">Wu et al., 2022a</xref>; <xref ref-type="bibr" rid="bib169">Wu et al., 2022b</xref>; <xref ref-type="bibr" rid="bib170">Wu et al., 2023</xref>; <xref ref-type="bibr" rid="bib171">Wu et al., 2024a</xref>; <xref ref-type="bibr" rid="bib164">Winbo et al., 2020</xref>; <xref ref-type="bibr" rid="bib165">Winbo et al., 2021</xref>; <xref ref-type="bibr" rid="bib13">Bernardin et al., 2022</xref>; <xref ref-type="bibr" rid="bib90">Li et al., 2023</xref>; <xref ref-type="bibr" rid="bib156">Van Haver et al., 2024</xref>; <xref ref-type="bibr" rid="bib42">Fan et al., 2024a</xref>; <xref ref-type="bibr" rid="bib43">Fan et al., 2024b</xref>; <xref ref-type="bibr" rid="bib147">Takayama et al., 2020</xref>; <xref ref-type="bibr" rid="bib148">Takayama et al., 2023</xref>; <xref ref-type="bibr" rid="bib3">Akagi et al., 2024a</xref>; <xref ref-type="bibr" rid="bib4">Akagi et al., 2024b</xref>; <xref ref-type="bibr" rid="bib56">Goldsteen et al., 2022</xref>; <xref ref-type="bibr" rid="bib172">Wu et al., 2024b</xref>). All articles derived neurons from hPSCs, and none applied immortalization techniques. Most articles described protocol development or methods (20/33). The remainder focused exclusively on protocol applications.</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Study selection.</title><p>MEDLINE, Medical Literature Analysis and Retrieval System Online; PMC, PubMed Central; PRISMA, Preferred Reporting Items for Systematic reviews and Meta Analyses; PSCs, pluripotent stem cells.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-103728-fig1-v2.tif"/></fig><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Characteristics of the included articles.</title><p>Articles are grouped per protocol and neuron type, in chronological order. Rows in bold indicate the earliest article per protocol.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reference</th><th align="left" valign="bottom">Journal (ISO 4)</th><th align="left" valign="bottom">Neuron type</th><th align="left" valign="bottom">Article type</th><th align="left" valign="bottom">Source cells</th></tr></thead><tbody><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib69">Huang et al., 2016</xref></td><td align="left" valign="bottom"><italic><bold>Sci Rep</bold></italic></td><td align="left" valign="bottom"><bold>Sympathetic</bold></td><td align="left" valign="bottom"><bold>Protocol development</bold></td><td align="left" valign="bottom">PSCs</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib26">Cheng et al., 2024</xref><sup><xref ref-type="table-fn" rid="table1fn2">*</xref></sup></td><td align="left" valign="bottom"><italic>Sci Rep</italic></td><td align="left" valign="bottom">Sympathetic</td><td align="left" valign="bottom">Protocol application</td><td align="left" valign="bottom">iPSCs</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib178">Zhang et al., 2016</xref></td><td align="left" valign="bottom"><italic><bold>PLoS One</bold></italic></td><td align="left" valign="bottom"><bold>Sympathetic</bold></td><td align="left" valign="bottom"><bold>Protocol development/application</bold></td><td align="left" valign="bottom"><bold>ESCs</bold></td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib108">Oh et al., 2016</xref></td><td align="left" valign="bottom"><italic><bold>Cell Stem Cell</bold></italic></td><td align="left" valign="bottom"><bold>Sympathetic</bold></td><td align="left" valign="bottom"><bold>Protocol development</bold></td><td align="left" valign="bottom"><bold>PSCs</bold></td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib177">Zeltner et al., 2016</xref></td><td align="left" valign="bottom"><italic><bold>Nat Med</bold></italic></td><td align="left" valign="bottom"><bold>Sympathetic</bold></td><td align="left" valign="bottom"><bold>Protocol development/application</bold></td><td align="left" valign="bottom"><bold>PSCs</bold></td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib124">Saito-Diaz et al., 2019</xref></td><td align="left" valign="bottom"><italic>Curr Protoc Stem Cell Biol</italic></td><td align="left" valign="bottom">Sympathetic</td><td align="left" valign="bottom">Methodological</td><td align="left" valign="bottom">PSCs</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib48">Frith et al., 2018</xref></td><td align="left" valign="bottom"><italic><bold>eLife</bold></italic></td><td align="left" valign="bottom"><bold>Sympathetic</bold></td><td align="left" valign="bottom"><bold>Protocol development</bold></td><td align="left" valign="bottom"><bold>PSCs</bold></td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib49">Frith and Tsakiridis, 2019</xref></td><td align="left" valign="bottom"><italic>Curr Protoc Stem Cell Biol</italic></td><td align="left" valign="bottom">Sympathetic</td><td align="left" valign="bottom">Methodological</td><td align="left" valign="bottom">PSCs</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib125">Saldana-Guerrero et al., 2024</xref></td><td align="left" valign="bottom"><italic>Nat Commun</italic></td><td align="left" valign="bottom">Sympathetic</td><td align="left" valign="bottom">Protocol application</td><td align="left" valign="bottom">ESCs</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib80">Kirino et al., 2018</xref></td><td align="left" valign="bottom"><italic><bold>Sci Rep</bold></italic></td><td align="left" valign="bottom"><bold>Sympathetic</bold></td><td align="left" valign="bottom"><bold>Protocol development</bold></td><td align="left" valign="bottom"><bold>PSCs</bold></td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib7">Amer-Sarsour et al., 2024</xref></td><td align="left" valign="bottom"><italic>Embo J</italic></td><td align="left" valign="bottom">Sympathetic</td><td align="left" valign="bottom">Protocol application</td><td align="left" valign="bottom">iPSCs</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib126">Saleh et al., 2024</xref></td><td align="left" valign="bottom"><italic>Free Radic Biol Med</italic></td><td align="left" valign="bottom">Sympathetic</td><td align="left" valign="bottom">Protocol application</td><td align="left" valign="bottom">iPSCs</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib21">Carr-Wilkinson et al., 2018</xref></td><td align="left" valign="bottom"><italic><bold>Stem Cells Int</bold></italic></td><td align="left" valign="bottom"><bold>Sympathetic</bold></td><td align="left" valign="bottom"><bold>Protocol development</bold></td><td align="left" valign="bottom"><bold>ESCs</bold></td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib61">Hackland et al., 2019</xref></td><td align="left" valign="bottom"><italic><bold>Stem Cell Reports</bold></italic></td><td align="left" valign="bottom"><bold>Sympathetic</bold></td><td align="left" valign="bottom"><bold>Protocol development/application</bold></td><td align="left" valign="bottom"><bold>PSCs</bold></td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib57">Gomez et al., 2019</xref></td><td align="left" valign="bottom"><italic><bold>Development</bold></italic></td><td align="left" valign="bottom"><bold>Sympathetic</bold></td><td align="left" valign="bottom"><bold>Protocol development/application</bold></td><td align="left" valign="bottom"><bold>PSCs</bold></td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib167">Wu and Zeltner, 2020</xref></td><td align="left" valign="bottom"><italic><bold>J Vis Exp</bold></italic></td><td align="left" valign="bottom"><bold>Sympathetic</bold></td><td align="left" valign="bottom"><bold>Methodological</bold></td><td align="left" valign="bottom"><bold>ESCs</bold></td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib168">Wu et al., 2022a</xref></td><td align="left" valign="bottom"><italic>Clin Auton Res</italic></td><td align="left" valign="bottom">Sympathetic</td><td align="left" valign="bottom">Protocol application</td><td align="left" valign="bottom">PSCs</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib169">Wu et al., 2022b</xref></td><td align="left" valign="bottom"><italic>Nat Commun</italic></td><td align="left" valign="bottom">Sympathetic</td><td align="left" valign="bottom">Protocol development/application</td><td align="left" valign="bottom">PSCs</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib170">Wu et al., 2023</xref></td><td align="left" valign="bottom"><italic>Front Neurosci</italic></td><td align="left" valign="bottom">Sympathetic</td><td align="left" valign="bottom">Protocol application</td><td align="left" valign="bottom">ESCs</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib171">Wu et al., 2024a</xref></td><td align="left" valign="bottom"><italic>STAR Protoc</italic></td><td align="left" valign="bottom">Sympathetic</td><td align="left" valign="bottom">Methodological</td><td align="left" valign="bottom">ESCs</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib164">Winbo et al., 2020</xref></td><td align="left" valign="bottom"><italic><bold>Am J Physiol Heart Circ Physiol</bold></italic></td><td align="left" valign="bottom"><bold>Sympathetic</bold></td><td align="left" valign="bottom"><bold>Protocol development</bold></td><td align="left" valign="bottom"><bold>iPSCs</bold></td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib165">Winbo et al., 2021</xref></td><td align="left" valign="bottom"><italic>Am J Physiol Heart Circ Physiol</italic></td><td align="left" valign="bottom">Sympathetic</td><td align="left" valign="bottom">Protocol application</td><td align="left" valign="bottom">iPSCs</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib13">Bernardin et al., 2022</xref></td><td align="left" valign="bottom"><italic>Cells</italic></td><td align="left" valign="bottom">Sympathetic</td><td align="left" valign="bottom">Protocol application</td><td align="left" valign="bottom">iPSCs</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib90">Li et al., 2023</xref></td><td align="left" valign="bottom"><italic>Philos Trans R Soc Lond B Biol Sci</italic></td><td align="left" valign="bottom">Sympathetic</td><td align="left" valign="bottom">Protocol application</td><td align="left" valign="bottom">iPSCs</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib156">Van Haver et al., 2024</xref></td><td align="left" valign="bottom"><italic><bold>iScience</bold></italic></td><td align="left" valign="bottom"><bold>Sympathetic</bold></td><td align="left" valign="bottom"><bold>Protocol development/application</bold></td><td align="left" valign="bottom"><bold>PSCs</bold></td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib42">Fan et al., 2024a</xref></td><td align="left" valign="bottom"><italic>J Mol Neurosci</italic></td><td align="left" valign="bottom">Sympathetic</td><td align="left" valign="bottom">Protocol development</td><td align="left" valign="bottom">PSCs</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib43">Fan et al., 2024b</xref></td><td align="left" valign="bottom"><italic>Cell Rep Med</italic></td><td align="left" valign="bottom">Sympathetic</td><td align="left" valign="bottom">Protocol application</td><td align="left" valign="bottom">PSCs</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib147">Takayama et al., 2020</xref></td><td align="left" valign="bottom"><italic><bold>Sci Rep</bold></italic></td><td align="left" valign="bottom"><bold>Sympathetic or parasympathetic</bold></td><td align="left" valign="bottom"><bold>Protocol development</bold></td><td align="left" valign="bottom"><bold>PSCs</bold></td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib148">Takayama et al., 2023</xref></td><td align="left" valign="bottom"><italic>Int J Mol Sci</italic></td><td align="left" valign="bottom">Sympathetic or parasympathetic</td><td align="left" valign="bottom">Protocol application</td><td align="left" valign="bottom">PSCs</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib3">Akagi et al., 2024a</xref></td><td align="left" valign="bottom"><italic>FEBS Open Bio</italic></td><td align="left" valign="bottom">Parasympathetic</td><td align="left" valign="bottom">Protocol application</td><td align="left" valign="bottom">iPSCs</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib4">Akagi et al., 2024b</xref></td><td align="left" valign="bottom"><italic>Molecules</italic></td><td align="left" valign="bottom">Sympathetic or parasympathetic</td><td align="left" valign="bottom">Protocol application</td><td align="left" valign="bottom">iPSCs</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib56">Goldsteen et al., 2022</xref></td><td align="left" valign="bottom"><italic><bold>Front Pharmacol</bold></italic></td><td align="left" valign="bottom"><bold>Parasympathetic</bold></td><td align="left" valign="bottom"><bold>Protocol development</bold></td><td align="left" valign="bottom"><bold>ESCs</bold></td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib172">Wu et al., 2024b</xref></td><td align="left" valign="bottom"><italic><bold>Cell Stem Cell</bold></italic></td><td align="left" valign="bottom"><bold>Parasympathetic</bold></td><td align="left" valign="bottom"><bold>Protocol development/application</bold></td><td align="left" valign="bottom"><bold>PSCs</bold></td></tr></tbody></table><table-wrap-foot><fn><p>ESCs, embryonic stem cells; iPSCs, induced pluripotent stem cells; ISO, International Organization for Standardization; PSCs, pluripotent stem cells (iPSCs or ESCs).</p></fn><fn id="table1fn2"><label>*</label><p><xref ref-type="bibr" rid="bib26">Cheng et al., 2024</xref> applied three of the protocols included in this review, by <xref ref-type="bibr" rid="bib69">Huang et al., 2016</xref>, <xref ref-type="bibr" rid="bib48">Frith et al., 2018</xref>, and <xref ref-type="bibr" rid="bib80">Kirino et al., 2018</xref>.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s2-2"><title>Quality assessment</title><p>Next, articles were judged by two independent reviewers based on the criteria formulated in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>. Interrater reliability was high (Cohen’s kappa=0.914). Generally, articles performed well on reporting and rationale items, whereas information about PSC-related items, such as induction methods, pluripotency markers, and karyotype validation, was often incomplete or absent (<xref ref-type="fig" rid="fig2">Figure 2</xref>). When pooling articles per protocol, all protocols were reproduced in multiple PSC lines, except for the protocols by <xref ref-type="bibr" rid="bib178">Zhang et al., 2016</xref>; <xref ref-type="bibr" rid="bib21">Carr-Wilkinson et al., 2018</xref>; and <xref ref-type="bibr" rid="bib56">Goldsteen et al., 2022</xref>. Furthermore, nearly all articles investigated neuronal identity markers via gene or protein expression (32/33). However, functional outcomes such as neurotransmitter secretion (15/33), electrophysiology (18/33), and co-culture with other cell types (10/33) were reported markedly less frequently. Almost a third of articles (10/33) reported no functional outcomes (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). Additionally, only half of the articles reported identities of contaminating cell types (i.e., cells other than autonomic neurons) (16/33).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Quality assessment.</title><p>Quality assessment results per criterion. Criteria topics are indicated to the left of the criteria. See <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref> for results per article, and <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref> for detailed criteria. iPSCs, Induced pluripotent stem cells; n/a, not applicable; PSCs, pluripotent stem cells.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-103728-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Quality assessment results per article.</title><p>Quality assessment results per article, grouped by protocol and neuron type, and listed chronologically. The earliest article per protocol is printed in bold. Reference numbers are indicated following the article authors and year. The quality criteria in <xref ref-type="fig" rid="fig2">Figure 2</xref> have been indicated diagonally above each column. Topic categories have been indicated below the table. Please see <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref> for detailed criteria. * Methodological articles were assessed using the same criteria as other articles. iPSCs, induced pluripotent stem cells; n/a, not applicable; PSCs, pluripotent stem cells.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-103728-fig2-figsupp1-v2.tif"/></fig></fig-group></sec><sec id="s2-3"><title>How do in vitro autonomic neuron differentiation strategies compare to in vivo signaling cues during the embryonic development of the autonomic nervous system?</title><p>During embryonic development, autonomic neurons arise from neural crest cells (NCCs), a multipotent migratory cell population, which, in turn, is derived from the neural plate border. The neural plate border emerges between the neural plate and non-neural ectoderm, which respectively form the CNS and epidermis (<xref ref-type="bibr" rid="bib150">Thawani and Groves, 2020</xref>). Distinct neural crest and preplacodal regions then form at the neural plate border (<xref ref-type="bibr" rid="bib150">Thawani and Groves, 2020</xref>). Next, NCCs migrate throughout the embryo in a rostrocaudal sequence as the neural plate folds to form the neural tube. Depending on their point of origin, NCCs generate different cell types (<xref ref-type="bibr" rid="bib97">Martik and Bronner, 2017</xref>). Postganglionic sympathetic neurons mainly originate from trunk NCCs (<xref ref-type="bibr" rid="bib97">Martik and Bronner, 2017</xref>), whereas postganglionic parasympathetic neurons arise mostly from more rostrally situated vagal NCCs (<xref ref-type="bibr" rid="bib40">Espinosa-Medina et al., 2014</xref>).</p><p>A portion of the trunk NCCs migrate ventrally to arrive at the dorsal aorta, where they coalesce to form the sympathetic ganglia (<xref ref-type="bibr" rid="bib119">Rickmann et al., 1985</xref>; <xref ref-type="bibr" rid="bib76">Kasemeier-Kulesa et al., 2006</xref>). Sympathetic neurons project to target organs from this paravertebral position, in contrast to parasympathetic somata, which are situated in close proximity to their target organs. Reflecting this, vagal NCCs fated to generate parasympathetic ganglia migrate along the course of preganglionic cranial nerves towards their target organs as Schwann cell precursors (SCPs) (<xref ref-type="bibr" rid="bib40">Espinosa-Medina et al., 2014</xref>; <xref ref-type="bibr" rid="bib157">Verberne et al., 1998</xref>; <xref ref-type="bibr" rid="bib66">Hildreth et al., 2008</xref>; <xref ref-type="bibr" rid="bib34">Dyachuk et al., 2014</xref>). As autonomic ganglia mature, mitotic precursor cells differentiate to postmitotic neurons, which rely on target-derived factors for survival (<xref ref-type="bibr" rid="bib58">Gonsalvez et al., 2013</xref>; <xref ref-type="bibr" rid="bib82">Koszinowski et al., 2015</xref>).</p><p>In the following section, the different in vitro strategies have been compared to each stage of the autonomic neuronal development outlined above. Most knowledge on signaling requirements during embryonic development is based on a variety of non-human vertebrate models. To most closely approach the human situation, we based our representation of in vivo signaling on studies performed in amniote models, namely mammals and birds.</p></sec><sec id="s2-4"><title>Neural crest cell induction</title><p>Most protocols initiated differentiation by inducing NCCs. Based on common signaling cues during NCC induction, we grouped protocols into four categories (<xref ref-type="fig" rid="fig3">Figure 3</xref>). One of the earliest approaches, applied in two sympathetic protocols (<xref ref-type="bibr" rid="bib178">Zhang et al., 2016</xref>; <xref ref-type="bibr" rid="bib21">Carr-Wilkinson et al., 2018</xref>), utilized the stromal cell-derived inducing activity (SDIA) of PA6 cells, a mouse preadipocyte cell line (<xref ref-type="bibr" rid="bib78">Kawasaki et al., 2000</xref>). Although both protocols reported the expression of catecholaminergic markers, sympathetic neuron yields were low, despite the use of fluorescence-activated cell sorting (FACS) to select for NCC markers during differentiation. Moreover, the signaling cues involved in SDIA have not been fully defined and can also induce dopaminergic neuron differentiation (<xref ref-type="bibr" rid="bib129">Schwartz et al., 2012</xref>). Together, this suggests SDIA does not specifically recapitulate the embryonic development of sympathetic neurons.</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Neural crest cell induction.</title><p>Timings and signaling cues used during the first phase of differentiation until neural crest induction per unique protocol. Duration of this phase per protocol is indicated by the horizontal black bars. Categories of similar approaches are indicated to the right of the figure. Molecules targeting similar pathways have been grouped by color. Colors also match the signaling cues in <xref ref-type="fig" rid="fig4">Figures 4</xref>—<xref ref-type="fig" rid="fig6">6</xref>. * Selection step yields optimal cell purity, but this is not required. † <xref ref-type="bibr" rid="bib57">Gomez et al., 2019</xref> identified two optimal CHIR concentrations for neural crest induction, 3 µM and 10 µM. 10 µM was used for sympathetic neuron differentiation. BMP, bone morphogenetic protein; CD49d, Integrin subunit α4; CHIR, CHIR99021; DMH, dorsomorphin; eGFP, enhanced green fluorescent protein; FGF, fibroblast growth factor; GD2, disialoganglioside; HNK1, human natural killer-1; LDN, LDN193189; m3i, Modified three inhibitor approach (CHIR99021, DAPT, and PD173074); NGF, nerve growth factor; NGFR, nerve growth factor receptor; PHOX2B, paired-like homeobox 2b; PMP, purmorphamine; RA, retinoic acid; SB, SB431542; SDIA, stromal cell-derived inducing activity; SHH, Sonic hedgehog; TGFβ, transforming growth factor beta.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-103728-fig3-v2.tif"/></fig><p>All other approaches applied activation of Wnt signaling via CHIR99021 (CHIR)-based glycogen synthesis kinase 3 inhibition to generate NCCs (<xref ref-type="fig" rid="fig3">Figure 3</xref>, for additional culture details, see <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>). The modes of action for all small molecules used in the included protocols are provided in <xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>. Activation of Wnt signaling via CHIR in these protocols is in line with avian NCC development, which also depends on Wnt signaling (<xref ref-type="fig" rid="fig4">Figure 4A</xref>; <xref ref-type="bibr" rid="bib113">Patthey et al., 2009</xref>). Of protocols applying CHIR, two parasympathetic protocols (<xref ref-type="bibr" rid="bib147">Takayama et al., 2020</xref>; <xref ref-type="bibr" rid="bib56">Goldsteen et al., 2022</xref>) and four sympathetic protocols (<xref ref-type="bibr" rid="bib108">Oh et al., 2016</xref>; <xref ref-type="bibr" rid="bib177">Zeltner et al., 2016</xref>; <xref ref-type="bibr" rid="bib164">Winbo et al., 2020</xref>; <xref ref-type="bibr" rid="bib147">Takayama et al., 2020</xref>) applied a technique coined ‘dual SMAD inhibition’. These protocols combined SMAD2/3 inhibition and SMAD1/5/8 inhibition from the start of differentiation, and added CHIR from day 2 of differentiation. Transforming growth factor beta (TGFβ)-, Activin-, and Nodal-specific SMAD2/3 signaling was always inhibited via anaplastic lymphoma kinase (ALK)4/5/7 receptor inhibitor SB431542 (SB) (<xref ref-type="bibr" rid="bib72">Inman et al., 2002</xref>), and bone morphogenetic protein (BMP)-specific SMAD1/5/8 signaling was inhibited by small molecule inhibitors LDN193189 (LDN) or dorsomorphin (DMH) (<xref ref-type="bibr" rid="bib23">Chambers et al., 2009</xref>; <xref ref-type="bibr" rid="bib24">Chambers et al., 2012</xref>). Although little seems to be known about SMAD2/3 signaling requirements for NCC induction in vivo, SMAD1/5/8 signaling is inhibited at the start of neural crest specification, followed by activation as neural crest development progresses (<xref ref-type="bibr" rid="bib113">Patthey et al., 2009</xref>; <xref ref-type="bibr" rid="bib45">Faure et al., 2002</xref>). This may parallel the use of LDN or DMH. Furthermore, in the absence of CHIR, dual SMAD inhibition instead results in high proportions of neural plate marker expression in vitro (<xref ref-type="bibr" rid="bib23">Chambers et al., 2009</xref>). This resembles the way inhibition of Wnt induces neural plate expression in avian ectodermal explants, which would otherwise express neural crest markers (<xref ref-type="fig" rid="fig4">Figure 4A</xref>; <xref ref-type="bibr" rid="bib113">Patthey et al., 2009</xref>).</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>In vivo neural crest induction signaling requirements.</title><p>(<bold>A</bold>) General signaling requirements for distinct populations at the neural plate border. Left, a dorsal schematic view of the embryo and signaling cues (indicated in colored text) present near the neural plate border during early gastrulation are shown. Right, the temporal sequence of signaling cues required for distinct populations near the neural plate border in amniotes between gastrulation and neurulation is shown (based on <xref ref-type="bibr" rid="bib150">Thawani and Groves, 2020</xref>). (<bold>B</bold>) Neuromesodermal progenitors arise in the tailbud during axial elongation under conditions of high Wnt and FGF signaling activation. Wnt and FGF concentrations form a rostrocaudal gradient, with highest concentrations in the tailbud. Right, neuromesodermal progenitors possibly contribute to posterior neural crest cell populations. BMP, bone morphogenetic protein; BMP-i, BMP signaling inhibition; FGF, fibroblast growth factor; SOX2, SRY-box transcription factor 2; TBXT, T-box transcription factor T; Wnt-i, Wnt signaling inhibition.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-103728-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Rostrocaudal boundaries of vagal and trunk neural crest.</title><p>Lateral view of an embryo around the time of neural crest delamination. The rostrocaudal boundaries of vagal neural crest, which gives rise to parasympathetic neurons (<xref ref-type="fig" rid="fig6">Figure 6</xref>), are indicated by the light purple line adjacent to the embryo. The darker purple line indicates the rostrocaudal boundaries of trunk neural crest, which gives rise to sympathetic neurons (<xref ref-type="fig" rid="fig5">Figure 5</xref>). In later developmental stages, as axial elongation progresses, (sacral) neural crest continues to be formed caudally from trunk neural crest.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-103728-fig4-figsupp1-v2.tif"/></fig></fig-group><p>The addition of CHIR to dual SMAD inhibition results in ~70% of cells expressing neural crest marker SRY-box transcription factor 10 (SOX10) by day 12 of differentiation (<xref ref-type="bibr" rid="bib24">Chambers et al., 2012</xref>). Addition of two other small molecules (DAPT, an indirect Notch signaling inhibitor; <xref ref-type="bibr" rid="bib54">Geling et al., 2002</xref>), and SU5402, an inhibitor of fibroblast growth factor receptor 1 (FGFR1) and vascular endothelial growth factor receptor 2 (VEGFR2) (<xref ref-type="bibr" rid="bib101">Mohammadi et al., 1997</xref>), slightly increases the proportion of cells expressing SOX10 by day 12 of differentiation to ~80% (<xref ref-type="bibr" rid="bib24">Chambers et al., 2012</xref>). Oh et al. later modified this approach (i.e., modified three inhibitor approach) by substituting SU5402 for PD173074 (<xref ref-type="bibr" rid="bib108">Oh et al., 2016</xref>), another FGFR inhibitor. The mechanisms by which SU5402 or PD173074, and DAPT contribute to NCC induction are still unknown. Although Notch signaling influences fate decisions after NCC induction, any direct role of Notch during NCC induction is unclear in chicken and mice (<xref ref-type="bibr" rid="bib142">Stuhlmiller and García-Castro, 2012a</xref>). Furthermore, fibroblast growth factor (FGF) signaling inhibition by SU5402 or PD173074 seems to contradict the FGF requirement for NCC formation in vivo (<xref ref-type="bibr" rid="bib143">Stuhlmiller and García-Castro, 2012b</xref>; <xref ref-type="fig" rid="fig4">Figure 4A</xref>). On the other hand, the concentration of PD173074 used, 0.2 µM, may not entirely suppress endogenous cellular FGF signaling (<xref ref-type="bibr" rid="bib57">Gomez et al., 2019</xref>).</p><p>CHIR-mediated Wnt signaling activation from day 0 of differentiation instead of day 2 of differentiation dramatically reduces SOX10-positive NCC induction under dual SMAD inhibition conditions (<xref ref-type="bibr" rid="bib100">Mica et al., 2013</xref>). Therefore, we consider protocols employing CHIR from the start of differentiation (i.e., ‘early Wnt activation’) to be distinct from dual SMAD inhibition protocols. Protocols in the ‘early Wnt activation’ category often inhibited SMAD1/5/8 signaling via SB (<xref ref-type="bibr" rid="bib69">Huang et al., 2016</xref>; <xref ref-type="bibr" rid="bib80">Kirino et al., 2018</xref>; <xref ref-type="bibr" rid="bib61">Hackland et al., 2019</xref>; <xref ref-type="bibr" rid="bib167">Wu and Zeltner, 2020</xref>; <xref ref-type="bibr" rid="bib156">Van Haver et al., 2024</xref>; <xref ref-type="bibr" rid="bib42">Fan et al., 2024a</xref>; <xref ref-type="bibr" rid="bib172">Wu et al., 2024b</xref>), but did not inhibit BMP-specific SMAD2/3 signaling. The lack of BMP modulation in most early Wnt activation protocols seemingly contradicts evidence from embryonic development (<xref ref-type="bibr" rid="bib113">Patthey et al., 2009</xref>; <xref ref-type="bibr" rid="bib45">Faure et al., 2002</xref>). Moreover, similar to dual SMAD inhibition protocols, almost no early Wnt activation protocols actively stimulate FGF signaling simultaneously with Wnt signaling stimulation, both of which are required for avian NCC development (<xref ref-type="bibr" rid="bib143">Stuhlmiller and García-Castro, 2012b</xref>). Nonetheless, three of the four protocols retrieved by our query, which reported high sympathetic neuron differentiation purities (≥67% of cells expressing tyrosine hydroxylase (TH)), relied on a form of early Wnt activation without active FGF stimulation for NCC induction (<xref ref-type="bibr" rid="bib80">Kirino et al., 2018</xref>; <xref ref-type="bibr" rid="bib167">Wu and Zeltner, 2020</xref>; <xref ref-type="bibr" rid="bib42">Fan et al., 2024a</xref>). Information on endogenous cellular Wnt, BMP, and FGF signaling in these protocols would help clarify this apparent discrepancy.</p><p>A final induction strategy applied by <xref ref-type="bibr" rid="bib48">Frith et al., 2018</xref> is based on neuromesodermal progenitor (NMP) induction. Although the evidence is not conclusive, NMPs may contribute to posterior NCCs in vivo (<xref ref-type="fig" rid="fig4">Figure 4B</xref>), as suggested by various grafting and lineage-tracing studies (<xref ref-type="bibr" rid="bib133">Shaker et al., 2021</xref>; <xref ref-type="bibr" rid="bib121">Rodrigo Albors et al., 2018</xref>; <xref ref-type="bibr" rid="bib179">Zhao et al., 2007</xref>; <xref ref-type="bibr" rid="bib74">Javali et al., 2017</xref>). Most relevant to sympathetic neurons, NMPs are located in the tail bud during axial elongation (<xref ref-type="bibr" rid="bib109">Olivera-Martinez et al., 2012</xref>; <xref ref-type="bibr" rid="bib173">Wymeersch et al., 2016</xref>). As the name implies, NMPs express the pro-mesodermal marker, T-box transcription factor T (TBXT), and the neuroepithelial marker, SRY-box transcription factor 2 (SOX2). In the protocol developed by <xref ref-type="bibr" rid="bib48">Frith et al., 2018</xref>, &gt;80% of cells co-expressed these markers after 3 days of concomitant Wnt and FGF2 signaling activation. Indeed, both these signaling pathways are also upregulated in vivo in the primitive streak where NMPs can be found (<xref ref-type="bibr" rid="bib174">Wymeersch et al., 2019</xref>; <xref ref-type="fig" rid="fig4">Figure 4B</xref>). The involvement of FGF and Wnt signaling in NMP induction is also supported by transcriptome analyses (<xref ref-type="bibr" rid="bib8">Amin et al., 2016</xref>; <xref ref-type="bibr" rid="bib59">Gouti et al., 2017</xref>). After generating NMPs, Frith et al. induced NCCs via ‘top-down BMP inhibition’ (<xref ref-type="bibr" rid="bib60">Hackland et al., 2017</xref>), resulting in around 60% SOX10-positive cells.</p></sec><sec id="s2-5"><title>Caudalization</title><p>NMP induction, as described above, reflects broader efforts to achieve posterior or trunk NCC identity (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). However, early protocols for NCC induction mostly generated NCCs of anterior identity (<xref ref-type="bibr" rid="bib69">Huang et al., 2016</xref>). On the other hand, the majority of SOX10-positive NCCs generated via NMP induction expressed homeobox C9 (HOXC9) (<xref ref-type="bibr" rid="bib48">Frith et al., 2018</xref>), which indicates the trunk position (<xref ref-type="bibr" rid="bib30">Dasen et al., 2003</xref>). HOXC9 expression can also depend on CHIR concentration, as shown by <xref ref-type="bibr" rid="bib57">Gomez et al., 2019</xref>. By comparing 2-day CHIR exposures of different concentrations between 0 and 12 µM, CHIR concentrations of 3 µM and 10 µM were found to most efficiently induce SOX10 and paired box 7 (PAX7) expression. Strikingly, cells treated with 10 µM CHIR showed vastly higher <italic>HOXC9</italic> expression than cells treated with 3 µM CHIR. Further investigation is warranted to explore whether this relatively simple approach to generate posterior NCCs can be used to efficiently generate mature sympathetic neurons.</p><p>Another tactic to induce posterior gene expression, often referred to as caudalization, utilizes retinoic acid (RA), sometimes combined with activation of Wnt signaling (<xref ref-type="bibr" rid="bib162">Wichterle et al., 2002</xref>; <xref ref-type="bibr" rid="bib73">Irioka et al., 2005</xref>; <xref ref-type="bibr" rid="bib91">Lippmann et al., 2015</xref>). Three autonomic protocols applied this technique to stimulate <italic>HOX</italic> gene expression as far posterior as <italic>HOXC9</italic> and homeobox B9 (<italic>HOXB9</italic>) at the population level (<xref ref-type="bibr" rid="bib69">Huang et al., 2016</xref>; <xref ref-type="bibr" rid="bib80">Kirino et al., 2018</xref>; <xref ref-type="bibr" rid="bib56">Goldsteen et al., 2022</xref>). However, there is controversy about the efficiency by which RA can induce posterior markers. In one experiment, RA-based caudalization induced posterior <italic>HOX</italic> gene expression much less efficiently than NMP induction (<xref ref-type="bibr" rid="bib48">Frith et al., 2018</xref>). Additionally, in the work by Gomez et al., RA mainly induced the anterior marker homeobox B4 (<italic>HOXB4</italic>), but not <italic>HOXC9</italic> (<xref ref-type="bibr" rid="bib57">Gomez et al., 2019</xref>). Altogether, considering the instructive role <italic>HOX</italic> genes have during development (<xref ref-type="bibr" rid="bib94">Mallo et al., 2010</xref>), we recommend demonstrating posterior <italic>HOX</italic> gene expression when establishing new sympathetic protocols.</p></sec><sec id="s2-6"><title>Sympathetic neurogenesis</title><p>After NCC induction, many sympathetic protocols (11/14) (<xref ref-type="bibr" rid="bib69">Huang et al., 2016</xref>; <xref ref-type="bibr" rid="bib108">Oh et al., 2016</xref>; <xref ref-type="bibr" rid="bib48">Frith et al., 2018</xref>; <xref ref-type="bibr" rid="bib80">Kirino et al., 2018</xref>; <xref ref-type="bibr" rid="bib21">Carr-Wilkinson et al., 2018</xref>; <xref ref-type="bibr" rid="bib61">Hackland et al., 2019</xref>; <xref ref-type="bibr" rid="bib57">Gomez et al., 2019</xref>; <xref ref-type="bibr" rid="bib164">Winbo et al., 2020</xref>; <xref ref-type="bibr" rid="bib156">Van Haver et al., 2024</xref>; <xref ref-type="bibr" rid="bib42">Fan et al., 2024a</xref>; <xref ref-type="bibr" rid="bib147">Takayama et al., 2020</xref>) employed signaling cues encountered by migratory NCCs en route to the dorsal aorta, such as BMPs (10/14) (<xref ref-type="bibr" rid="bib69">Huang et al., 2016</xref>; <xref ref-type="bibr" rid="bib108">Oh et al., 2016</xref>; <xref ref-type="bibr" rid="bib48">Frith et al., 2018</xref>; <xref ref-type="bibr" rid="bib80">Kirino et al., 2018</xref>; <xref ref-type="bibr" rid="bib21">Carr-Wilkinson et al., 2018</xref>; <xref ref-type="bibr" rid="bib61">Hackland et al., 2019</xref>; <xref ref-type="bibr" rid="bib164">Winbo et al., 2020</xref>; <xref ref-type="bibr" rid="bib156">Van Haver et al., 2024</xref>; <xref ref-type="bibr" rid="bib42">Fan et al., 2024a</xref>; <xref ref-type="bibr" rid="bib147">Takayama et al., 2020</xref>), and sonic hedgehog (SHH) (6/14) (<xref ref-type="bibr" rid="bib108">Oh et al., 2016</xref>; <xref ref-type="bibr" rid="bib48">Frith et al., 2018</xref>; <xref ref-type="bibr" rid="bib61">Hackland et al., 2019</xref>; <xref ref-type="bibr" rid="bib57">Gomez et al., 2019</xref>; <xref ref-type="bibr" rid="bib164">Winbo et al., 2020</xref>; <xref ref-type="bibr" rid="bib156">Van Haver et al., 2024</xref>; <xref ref-type="fig" rid="fig5">Figure 5A</xref>, full-length sympathetic protocol overviews are shown in <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>). This mostly involved the use of BMP4, and a combination of recombinant SHH and the SHH agonist purmorphamine (PMP). In vivo, NCCs migrate ventrally towards the dorsal aorta (<xref ref-type="bibr" rid="bib110">O’Rahilly and Müller, 2007</xref>; <xref ref-type="bibr" rid="bib14">Betters et al., 2010</xref>; <xref ref-type="bibr" rid="bib17">Bronner-Fraser, 1986</xref>; <xref ref-type="bibr" rid="bib131">Serbedzija et al., 1990</xref>; <xref ref-type="fig" rid="fig5">Figure 5B</xref>), attracted by neuregulin 1 (NRG1) and C-X-C motif chemokine ligand 12 (CXCL12) (<xref ref-type="bibr" rid="bib123">Saito et al., 2012</xref>), and repelled by semaphorin 3A (SEMA3A) (<xref ref-type="bibr" rid="bib79">Kawasaki et al., 2002</xref>). Upon arrival, NCCs differentiate into sympathetic precursors under the influence of BMP4 and BMP7 emitted by the dorsal aorta (<xref ref-type="bibr" rid="bib123">Saito et al., 2012</xref>; <xref ref-type="bibr" rid="bib118">Reissmann et al., 1996</xref>; <xref ref-type="bibr" rid="bib132">Shah et al., 1996</xref>; <xref ref-type="bibr" rid="bib127">Schneider et al., 1999</xref>; <xref ref-type="fig" rid="fig5">Figure 5B</xref>). In vitro, the only sympathetic protocol to investigate the sympathetic neuron differentiation efficiency of different BMPs did not conclusively show any of BMP2, BMP4, and BMP7 to be superior to the others (<xref ref-type="bibr" rid="bib69">Huang et al., 2016</xref>). In any case, three of the four sympathetic protocols reporting high differentiation efficiencies (≥67% of cells expressing TH) actively stimulated BMP signaling (<xref ref-type="bibr" rid="bib80">Kirino et al., 2018</xref>; <xref ref-type="bibr" rid="bib164">Winbo et al., 2020</xref>; <xref ref-type="bibr" rid="bib42">Fan et al., 2024a</xref>), suggesting this is also an important component of sympathetic neuron differentiation in vitro.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Sympathetic neurogenesis.</title><p>(<bold>A</bold>) Timings and signaling cues used from neural crest induction until the end of sympathetic neuron differentiation. Duration of this phase per protocol is indicated by the horizontal black bars. Total durations of this phase exceeding the width of the graph are indicated to the right of the graph. Molecules targeting similar pathways have been grouped by color. (<bold>B</bold>) Transverse cross section of the trunk of an embryo during neural crest migration. Signaling requirements for ventral neural crest migration and sympathetic specification are indicated by bold text. Signaling cues targeted by the protocols in (<bold>A</bold>) are indicated with colored text matching those in the figure legend. (<bold>C</bold>) Schematic view of the signaling requirements for sympathetic precursor proliferation and target innervation. The discontinuous axon and blood vessel represent the large distance from the sympathetic ganglia to their peripheral targets. * Aphidicolin selection yields optimal cell purity. However, this is not required. AA, ascorbic acid; BDNF, brain-derived neurotrophic factor; BMP, bone morphogenetic protein; CHIR, CHIR99021; CXCL12, C-X-C motif chemokine ligand 12; dbcAMP, dibutyryl cyclic adenosine monophosphate; EGF, epidermal growth factor; eGFP, enhanced green fluorescent protein; FGF, fibroblast growth factor; FSK, forskolin; GDNF, glial cell line derived neurotrophic factor; IGF, insulin-like growth factor; MYCN, MYCN proto-oncogene; NGF, nerve growth factor; NRG1, neuregulin 1; NRTN, neurturin; NTF3, neurotrophin 3; PHOX2B, paired-like homeobox 2b; PMP, purmorphamine; RA, retinoic acid; SEMA3A, semaphorin 3A; SB, SB431542; SDIA, stromal cell-derived-inducing activity; SHH, Sonic hedgehog; TGFβ, transforming growth factor beta.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-103728-fig5-v2.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Total overview of all sympathetic protocols.</title><p>Overview of all unique sympathetic protocols. Protocol durations are indicated by the horizontal black bars. Total protocol durations exceeding the width of the graph are indicated to the right of the graph. Molecules targeting similar pathways have been grouped by color. AA, ascorbic acid; BDNF, brain-derived neurotrophic factor; BMP, bone morphogenetic protein; CD49d, integrin subunit α4; CHIR, CHIR99021; dbcAMP, dibutyryl cyclic adenosine monophosphate; DMH, dorsomorphin; EGF, epidermal growth factor; eGFP, enhanced green fluorescent protein; FGF, fibroblast growth factor; FSK, forskolin; GD2, disialoganglioside; GDNF, glial cell line-derived neurotrophic factor; HNK1, human natural killer-1; IGF1, insulin-like growth factor 1; LDN, LDN193189; m3i, modified three inhibitor approach (CHIR99021, DAPT, and PD173074); MYCN, MYCN proto-oncogene; NGF, nerve growth factor; NGFR, nerve growth factor receptor; NTF3, neurotrophin 3; PHOX2B, paired-like homeobox 2B; PMP, purmorphamine; RA, retinoic acid; SB, SB431542; SDIA, stromal cell-derived inducing activity; SHH, Sonic hedgehog; TGFβ, transforming growth factor.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-103728-fig5-figsupp1-v2.tif"/></fig></fig-group><p>SHH may also participate in sympathetic differentiation, as suggested by its emission along the NCC migratory path at the notochord and floorplate of the neural tube (<xref ref-type="bibr" rid="bib35">Echelard et al., 1993</xref>; <xref ref-type="bibr" rid="bib29">Danesin and Soula, 2017</xref>). In vitro, exposure to SHH increases the proportion of cells expressing TH in populations of primary NCCs or sympathetic neurons (<xref ref-type="bibr" rid="bib118">Reissmann et al., 1996</xref>; <xref ref-type="bibr" rid="bib163">Williams et al., 2000</xref>). Further supporting this notion, <italic>Shh</italic>-null mice show dysmorphic hypoplastic sympathetic ganglia with delayed neuronal development (<xref ref-type="bibr" rid="bib103">Morikawa et al., 2009</xref>). Additionally, proximity of the notochord and floorplate to the dorsal aorta is required for normal sympathetic neuronal development (<xref ref-type="bibr" rid="bib140">Stern et al., 1991</xref>). However, direct stimulation of SHH signaling is only included in one of the four sympathetic protocols reporting high efficiencies (≥67% TH-positive) (<xref ref-type="bibr" rid="bib164">Winbo et al., 2020</xref>). At most, this suggests that active stimulation of SHH signaling plays an accessory role in vitro.</p><p>Upon formation at the dorsal aorta, the primordial sympathetic ganglia consist mainly of proliferative cells (<xref ref-type="bibr" rid="bib58">Gonsalvez et al., 2013</xref>). In vitro, eight autonomic protocols stimulated the proliferation of NCCs by expansion in low-adherence conditions via FGF2 and/or epidermal growth factor (EGF) (<xref ref-type="bibr" rid="bib178">Zhang et al., 2016</xref>; <xref ref-type="bibr" rid="bib177">Zeltner et al., 2016</xref>; <xref ref-type="bibr" rid="bib80">Kirino et al., 2018</xref>; <xref ref-type="bibr" rid="bib167">Wu and Zeltner, 2020</xref>; <xref ref-type="bibr" rid="bib156">Van Haver et al., 2024</xref>; <xref ref-type="bibr" rid="bib42">Fan et al., 2024a</xref>; <xref ref-type="bibr" rid="bib56">Goldsteen et al., 2022</xref>; <xref ref-type="bibr" rid="bib172">Wu et al., 2024b</xref>; <xref ref-type="fig" rid="fig5">Figure 5A</xref>). Four protocols in this review combined these factors with activation of Wnt signaling (<xref ref-type="bibr" rid="bib177">Zeltner et al., 2016</xref>; <xref ref-type="bibr" rid="bib167">Wu and Zeltner, 2020</xref>; <xref ref-type="bibr" rid="bib156">Van Haver et al., 2024</xref>; <xref ref-type="bibr" rid="bib56">Goldsteen et al., 2022</xref>). This may be analogous to the requirement of canonical Wnt signaling for mitotic sympathetic precursor cell maintenance (<xref ref-type="bibr" rid="bib9">Armstrong et al., 2011</xref>; <xref ref-type="fig" rid="fig5">Figure 5C</xref>). Additionally, Zhang et al. applied IGF1 in this phase (<xref ref-type="bibr" rid="bib178">Zhang et al., 2016</xref>), which supports sympathetic precursor proliferation and neurite outgrowth (<xref ref-type="bibr" rid="bib176">Zackenfels et al., 1995</xref>). At this stage, sympathetic precursors differentiate into glial and neuronal cells depending on the stimulation or inhibition of Notch signaling, respectively (<xref ref-type="bibr" rid="bib155">Tsarovina et al., 2008</xref>; <xref ref-type="bibr" rid="bib137">Shtukmaster and Huber, 2023</xref>). Yet, no sympathetic protocol included inhibition of Notch signaling after NCC induction. In order to fully recapitulate sympathetic embryonic development, we believe a protocol should be capable of generating both glial cells and neurons from the same progenitor population, depending on Notch signaling. However, generally, the presence of glial cells was not investigated in current protocols.</p><p>During the maturation of sympathetic neurons in vivo, neurite development and target innervation depend on various autocrine and target-derived growth factors (<xref ref-type="fig" rid="fig5">Figure 5C</xref>, and reviewed thoroughly elsewhere; <xref ref-type="bibr" rid="bib130">Scott-Solomon et al., 2021</xref>). Of all sympathetic protocols, four did not proceed past the precursor phase (<xref ref-type="bibr" rid="bib69">Huang et al., 2016</xref>; <xref ref-type="bibr" rid="bib178">Zhang et al., 2016</xref>; <xref ref-type="bibr" rid="bib57">Gomez et al., 2019</xref>; <xref ref-type="bibr" rid="bib156">Van Haver et al., 2024</xref>). Nearly all others employed nerve growth factor (NGF) (9/10) (<xref ref-type="bibr" rid="bib108">Oh et al., 2016</xref>; <xref ref-type="bibr" rid="bib48">Frith et al., 2018</xref>; <xref ref-type="bibr" rid="bib80">Kirino et al., 2018</xref>; <xref ref-type="bibr" rid="bib21">Carr-Wilkinson et al., 2018</xref>; <xref ref-type="bibr" rid="bib61">Hackland et al., 2019</xref>; <xref ref-type="bibr" rid="bib167">Wu and Zeltner, 2020</xref>; <xref ref-type="bibr" rid="bib164">Winbo et al., 2020</xref>; <xref ref-type="bibr" rid="bib147">Takayama et al., 2020</xref>) for neuronal maturation, which stimulates neurite outgrowth and sympathetic neuron survival upon axonal contact with target tissue (<xref ref-type="bibr" rid="bib84">Kuruvilla et al., 2004</xref>; <xref ref-type="bibr" rid="bib28">Crowley et al., 1994</xref>; <xref ref-type="bibr" rid="bib134">Shelton and Reichardt, 1984</xref>). Before this, neurite outgrowth is promoted by the vasculature-derived factors artemin and neurotrophin 3 (NTF3), of which the latter also supports survival (<xref ref-type="bibr" rid="bib84">Kuruvilla et al., 2004</xref>; <xref ref-type="bibr" rid="bib36">Enomoto et al., 1998</xref>; <xref ref-type="bibr" rid="bib68">Honma et al., 2002</xref>; <xref ref-type="bibr" rid="bib158">Verdi and Anderson, 1994</xref>). Artemin, as well as factors like neurturin (NRTN), endothelins, and netrin 1, coordinate differential pathfinding and target-specific sympathetic innervation (<xref ref-type="bibr" rid="bib51">Furlan et al., 2016</xref>; <xref ref-type="bibr" rid="bib95">Manousiouthakis et al., 2014</xref>; <xref ref-type="bibr" rid="bib93">Makita et al., 2008</xref>; <xref ref-type="bibr" rid="bib18">Brunet et al., 2014</xref>). Of all these factors, only NTF3 featured in two sympathetic protocols (<xref ref-type="bibr" rid="bib42">Fan et al., 2024a</xref>; <xref ref-type="bibr" rid="bib147">Takayama et al., 2020</xref>). However, simultaneous NGF application in these protocols likely reduced the effect of NTF3 (<xref ref-type="bibr" rid="bib158">Verdi and Anderson, 1994</xref>).</p><p>Instead, most sympathetic protocols which proceeded past the precursor phase (8/10) (<xref ref-type="bibr" rid="bib108">Oh et al., 2016</xref>; <xref ref-type="bibr" rid="bib48">Frith et al., 2018</xref>; <xref ref-type="bibr" rid="bib80">Kirino et al., 2018</xref>; <xref ref-type="bibr" rid="bib61">Hackland et al., 2019</xref>; <xref ref-type="bibr" rid="bib167">Wu and Zeltner, 2020</xref>; <xref ref-type="bibr" rid="bib164">Winbo et al., 2020</xref>; <xref ref-type="bibr" rid="bib156">Van Haver et al., 2024</xref>; <xref ref-type="bibr" rid="bib42">Fan et al., 2024a</xref>) combined NGF with brain-derived neurotrophic factor (BDNF) and glial cell line-derived neurotrophic factor (GDNF) to promote further neurogenic differentiation (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). The exact contributions of the latter two factors in these protocols were not reported. In vivo, BDNF secreted by preganglionic axons likely guides primary sympathetic ganglia to their secondary paravertebral position (<xref ref-type="bibr" rid="bib77">Kasemeier-Kulesa et al., 2015</xref>), although differential growth also plays a role (<xref ref-type="bibr" rid="bib83">Kruepunga et al., 2021</xref>). Secondly, BDNF secreted by more mature sympathetic neurons induces axon pruning and cell death in adjacent neurons (<xref ref-type="bibr" rid="bib138">Singh et al., 2008</xref>; <xref ref-type="bibr" rid="bib39">Escudero et al., 2019</xref>; <xref ref-type="fig" rid="fig5">Figure 5C</xref>). Conversely, GDNF may promote cell proliferation or survival, as suggested by reduced numbers of sympathetic neurons in <italic>Gdnf</italic>-knockout mice (<xref ref-type="bibr" rid="bib102">Moore et al., 1996</xref>). However, the mechanism remains unclear, as knockout of receptor tyrosine kinase <italic>Ret,</italic> required for GDNF family ligand signaling, or co-receptor GDNF family receptor α1, required for preferential GDNF signaling (<xref ref-type="bibr" rid="bib11">Baloh et al., 2000</xref>), do not fully replicate this phenotype (<xref ref-type="bibr" rid="bib36">Enomoto et al., 1998</xref>; <xref ref-type="bibr" rid="bib33">Durbec et al., 1996</xref>).</p></sec><sec id="s2-7"><title>Parasympathetic neurogenesis</title><p>After generating NCCs, each parasympathetic protocol employed divergent tactics to generate parasympathetic precursors (<xref ref-type="fig" rid="fig6">Figure 6A</xref>, full-length parasympathetic protocol overviews are shown in <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>). In vivo, vagal NCCs migrate along preganglionic axons to the site of the prospective parasympathetic ganglia in the form of SCPs, which depend on axonal signals like NRG1 for survival (<xref ref-type="bibr" rid="bib139">Solovieva and Bronner, 2021</xref>; <xref ref-type="bibr" rid="bib32">Dong et al., 1995</xref>; <xref ref-type="bibr" rid="bib107">Newbern and Birchmeier, 2010</xref>; <xref ref-type="fig" rid="fig6">Figure 6B</xref>). Goldsteen et al. and Wu et al. showed increased expression of axial markers of vagal NCCs (<xref ref-type="bibr" rid="bib56">Goldsteen et al., 2022</xref>; <xref ref-type="bibr" rid="bib172">Wu et al., 2024b</xref>), homeobox B3 (<italic>HOXB3</italic>) and homeobox B5 (<italic>HOXB5</italic>). However, only Wu et al. explicitly targeted SCP generation via NRG1 in combination with CHIR and FGF2 (<xref ref-type="bibr" rid="bib172">Wu et al., 2024b</xref>). In strong support of the recapitulation of embryonic development in this protocol, Wu et al. showed that the resulting SOX10-positive SCPs were also capable of Schwann cell generation.</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Parasympathetic neurogenesis.</title><p>(<bold>A</bold>) Timings and signaling cues used from neural crest induction until the end of parasympathetic neuron differentiation. Duration of this phase per protocol is indicated by the horizontal black bars. Total duration of this phase per protocol is indicated to the right of the graph. Molecules targeting similar pathways have been grouped by color. (<bold>B</bold>) Migration of vagal neural crest-derived Schwann cell precursors along a cranial nerve. (<bold>C</bold>) Schematic view of the signaling requirements for parasympathetic precursor proliferation and target innervation. Signaling requirements are indicated by bold text. Signaling cues targeted by the protocols in (<bold>A</bold>) are indicated with colored text matching those in the figure legend. * Cytosine arabinoside selection yields optimal cell purity. However, this is not required. AA, ascorbic acid; AraC, cytosine arabinoside; BDNF, brain-derived neurotrophic factor; BMP, bone morphogenetic protein; CHIR, CHIR99021; CNTF, ciliary neurotrophic factor; dbcAMP, dibutyryl cyclic adenosine monophosphate; FGF, fibroblast growth factor; FSK, forskolin; GDNF, glial cell line-derived neurotrophic factor; NGF, nerve growth factor; NRG1, neuregulin 1; NRTN, neurturin; NTF3, neurotrophin 3; RA, retinoic acid; SHH, Sonic hedgehog; TGFβ, transforming growth factor beta.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-103728-fig6-v2.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Total overview of all parasympathetic protocols.</title><p>Overview of all unique parasympathetic protocols. Protocol durations are indicated by the horizontal black bars. Total protocol durations are indicated to the right of the graph. Molecules targeting similar pathways have been grouped by color. AA, ascorbic acid; AraC, cytosine arabinoside; BDNF, brain-derived neurotrophic factor; BMP, bone morphogenetic protein; CHIR, CHIR99021; CNTF, ciliary neurotrophic factor; dbcAMP, dibutyryl cyclic adenosine monophosphate; DMH, dorsomorphin; FGF, fibroblast growth factor; FSK, forskolin; GDNF, glial cell line-derived neurotrophic factor; LDN, LDN193189; NGF, nerve growth factor; NRG1, neuregulin 1; NTF3, neurotrophin 3; RA, retinoic acid; SB, SB431542; SHH, Sonic hedgehog; TGFβ, transforming growth factor.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-103728-fig6-figsupp1-v2.tif"/></fig></fig-group><p>In vivo, the development of ciliary ganglion neurons, a parasympathetic neuron subtype, depends on local BMPs, possibly BMP4, BMP5, and/or BMP7 (<xref ref-type="bibr" rid="bib105">Müller and Rohrer, 2002</xref>). The only parasympathetic protocol to actively stimulate BMP signaling after NCC induction was the protocol by <xref ref-type="bibr" rid="bib147">Takayama et al., 2020</xref>. As mentioned before, sympathetic ganglia also rely on BMPs during development (<xref ref-type="bibr" rid="bib123">Saito et al., 2012</xref>; <xref ref-type="bibr" rid="bib118">Reissmann et al., 1996</xref>; <xref ref-type="bibr" rid="bib132">Shah et al., 1996</xref>; <xref ref-type="bibr" rid="bib127">Schneider et al., 1999</xref>). Instead of SCP generation, this protocol inhibited alternative NCC fates to retain progenitor populations capable of both sympathetic and parasympathetic differentiation. SHH signaling stimulates enteric neuron-fated NCC proliferation (<xref ref-type="bibr" rid="bib50">Fu et al., 2004</xref>), and constitutively active Wnt signaling abolishes autonomic neuron differentiation in favor of sensory neuron differentiation (<xref ref-type="bibr" rid="bib88">Lee et al., 2004</xref>). Therefore, the inhibition of alternative NCC fates was implemented by SHH and Wnt inhibition, via SANT1 and IWR1, respectively (<xref ref-type="bibr" rid="bib147">Takayama et al., 2020</xref>). This strategy contrasts strikingly with the majority of other autonomic protocols (9/12) (<xref ref-type="bibr" rid="bib69">Huang et al., 2016</xref>; <xref ref-type="bibr" rid="bib108">Oh et al., 2016</xref>; <xref ref-type="bibr" rid="bib177">Zeltner et al., 2016</xref>; <xref ref-type="bibr" rid="bib48">Frith et al., 2018</xref>; <xref ref-type="bibr" rid="bib61">Hackland et al., 2019</xref>; <xref ref-type="bibr" rid="bib57">Gomez et al., 2019</xref>; <xref ref-type="bibr" rid="bib167">Wu and Zeltner, 2020</xref>; <xref ref-type="bibr" rid="bib164">Winbo et al., 2020</xref>; <xref ref-type="bibr" rid="bib56">Goldsteen et al., 2022</xref>), which apply activation of Wnt and/or SHH signaling. Nonetheless, neurons expressing either sympathetic or parasympathetic neuron markers were generated depending on BDNF and ciliary neurotrophic factor (CNTF) concentrations, as well as cell density. However, differentiation efficiencies of the optimized sympathetic- and parasympathetic-specific protocols were not reported and the efficiency of autonomic neuron induction in the combined autonomic protocol was &lt;10%. This suggests that this approach results in high proportions of contaminating cells.</p><p>Both Wu et al. and Takayama et al. used GDNF, among other factors, for neuronal maturation (<xref ref-type="bibr" rid="bib147">Takayama et al., 2020</xref>; <xref ref-type="bibr" rid="bib172">Wu et al., 2024b</xref>). Once established near target tissues, parasympathetic precursors of several ganglia are initially dependent on Wnt and GDNF for proliferation (<xref ref-type="bibr" rid="bib37">Enomoto et al., 2000</xref>; <xref ref-type="bibr" rid="bib106">Muñoz-Bravo et al., 2013</xref>; <xref ref-type="bibr" rid="bib81">Knosp et al., 2015</xref>; <xref ref-type="fig" rid="fig6">Figure 6C</xref>). The only protocol not to apply GDNF was developed by Goldsteen et al. Instead, they relied on BDNF for development and maturation of parasympathetic neurons, based on its requirement for the innervation of distal airway smooth muscle (<xref ref-type="bibr" rid="bib117">Radzikinas et al., 2011</xref>). However, postganglionic parasympathetic neurons barely innervate the distal airways (<xref ref-type="bibr" rid="bib10">Aven and Ai, 2013</xref>), and BDNF deletion therefore probably affects the extrinsic sympathetic, sensory, and/or vagal innervation of the lungs.</p><p>Both Takayama et al. and Wu et al. applied CNTF for neuronal maturation (<xref ref-type="bibr" rid="bib147">Takayama et al., 2020</xref>; <xref ref-type="bibr" rid="bib172">Wu et al., 2024b</xref>). Additionally, Takayama et al. applied NGF and NTF3 (<xref ref-type="bibr" rid="bib147">Takayama et al., 2020</xref>). Although CNTF and NGF promote parasympathetic neuron survival in vitro (<xref ref-type="bibr" rid="bib27">Collins and Dawson, 1983</xref>; <xref ref-type="bibr" rid="bib1">Adler et al., 1979</xref>; <xref ref-type="bibr" rid="bib153">Tom et al., 1998</xref>), it is at best unknown if these factors are required during embryonic development (<xref ref-type="bibr" rid="bib141">Stöckli et al., 1989</xref>). Finally, Wu et al. developed the only protocol to date to apply late RA exposure (<xref ref-type="bibr" rid="bib172">Wu et al., 2024b</xref>). Knockdown of RA receptor β in chicken ciliary ganglia delays mature neurotransmitter profiles and programmed cell death, characteristic of neuronal maturation (<xref ref-type="bibr" rid="bib82">Koszinowski et al., 2015</xref>).</p><p>Upon maturation, parasympathetic neurons generally switch dependency from GDNF to NRTN (<xref ref-type="bibr" rid="bib37">Enomoto et al., 2000</xref>; <xref ref-type="bibr" rid="bib87">Laurikainen et al., 2000</xref>; <xref ref-type="bibr" rid="bib65">Heuckeroth et al., 1999</xref>). Likewise, parasympathetic intrinsic airway neurons rely on GDNF family ligands for survival, one of which is likely NRTN (<xref ref-type="bibr" rid="bib86">Langsdorf et al., 2011</xref>). Nonetheless, NRTN was not included in any parasympathetic protocol, and we believe this would be a promising candidate to improve parasympathetic neuron maturity.</p></sec><sec id="s2-8"><title>Which molecular definitions of autonomic neurons are applied in vitro?</title><p>Whereas neurons can be classified on the basis of their anatomical location in vivo, the demonstration of specific protein or gene expression is required to distinguish the many different types of neurons that can be generated from hPSCs in vitro. Therefore, the various markers used to define sympathetic neurons in the articles included in this review were collected and ordered by the number of articles each marker was used in (<xref ref-type="fig" rid="fig7">Figure 7A and B</xref>). If different definitions were applied within an article per technique, priority was given to the definitions used for quantification as a proportion of cells generated (i.e., flow cytometry or quantitative immunofluorescence microscopy), followed by qualitative immunofluorescence microscopy, and quantitative reverse transcriptase polymerase chain reaction (RT-qPCR). Descriptions and expression patterns of each marker are provided in <xref ref-type="supplementary-material" rid="supp5">Supplementary file 5</xref>.</p><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Sympathetic neuron definitions and differentiation efficiency.</title><p>(<bold>A</bold>) All sympathetic neuron markers used in ≥3 articles, stratified by technique. (<bold>B</bold>) All combinations of sympathetic neuron markers used in ≥6 articles. Markers featured in multiple combinations are marked by colored text in (<bold>A</bold>) and (<bold>B</bold>). (<bold>C</bold>) Scatter plot of protocol purity and time of quantification per article. The graph shows only the latest timepoint per article %TH+ (or %GATA3 + or %DBH+, if %TH+ was not determined) was measured. Shapes indicate the markers used for quantification and protocol applied per article is indicated by color. #1 <xref ref-type="bibr" rid="bib57">Gomez et al., 2019</xref>, #2 <xref ref-type="bibr" rid="bib26">Cheng et al., 2024</xref>, #3 <xref ref-type="bibr" rid="bib48">Frith et al., 2018</xref>, #4 <xref ref-type="bibr" rid="bib108">Oh et al., 2016</xref>, #5 <xref ref-type="bibr" rid="bib169">Wu et al., 2022b</xref>, #6 <xref ref-type="bibr" rid="bib177">Zeltner et al., 2016</xref>, #7 <xref ref-type="bibr" rid="bib21">Carr-Wilkinson et al., 2018</xref>, #8 <xref ref-type="bibr" rid="bib80">Kirino et al., 2018</xref>, #9 <xref ref-type="bibr" rid="bib42">Fan et al., 2024a</xref>, #10 <xref ref-type="bibr" rid="bib90">Li et al., 2023</xref>, #11 <xref ref-type="bibr" rid="bib164">Winbo et al., 2020</xref>. Sample sizes per article can be found in <xref ref-type="supplementary-material" rid="sdata1">Source data 1</xref>. ASCL1, achaete-scute family bHLH transcription factor 1; DBH, dopamine beta-hydroxylase; GATA3, GATA binding protein 3; RT-qPCR, quantitative reverse transcriptase polymerase chain reaction; PHOX2B, paired-like homeobox 2B; PRPH, peripherin; SEM, standard error of the mean; TH, tyrosine hydroxylase; TUBB3, tubulin beta 3 class III.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-103728-fig7-v2.tif"/></fig></sec><sec id="s2-9"><title>Sympathetic neuron definitions</title><p>As expected, the catecholaminergic enzymes were popular markers; TH and/or dopamine β hydroxylase (DBH) featured in 83% (24/29) of sympathetic neuron definitions. TH is essential for the synthesis of all catecholamines, whereas DBH is only required for noradrenaline and adrenaline synthesis. The (nor)adrenergic transcription factors achaete-scute family bHLH transcription factor 1 (ASCL1), paired-like homeobox 2B (PHOX2B), or GATA binding protein 3 (GATA3) also featured in 38% (11/29) of sympathetic neuron definitions. The most frequently combined markers were TH and peripherin (PRPH) (48%, 14/29), an intermediate filament mostly expressed in the cytoskeleton of neurons with axons projecting outside the CNS (<xref ref-type="bibr" rid="bib122">Romano et al., 2022</xref>).</p><p>Considering that the combined expression of TH and PRPH is likely limited to catecholaminergic cells outside the CNS in vivo, we recommend demonstrating the expression of this combination, or a similar combination indicative of peripheral and catecholaminergic identity, to confirm sympathetic neuron identity. The expression of PRPH also likely excludes other peripheral NCC-derived catecholaminergic cells, such as chromaffin cells and small intensely fluorescent cells, although both cell types can also be distinguished from sympathetic neurons on a morphological basis (<xref ref-type="bibr" rid="bib146">Takaki et al., 2015</xref>; <xref ref-type="bibr" rid="bib31">Derer et al., 1989</xref>; <xref ref-type="bibr" rid="bib154">Troy et al., 1990</xref>; <xref ref-type="bibr" rid="bib2">Ahonen, 1991</xref>). The largest caveat to defining sympathetic neurons by expression of TH and PRPH is the potential confusion with immature parasympathetic and enteric neurons. Both neuron subtypes express PRPH from early development throughout adulthood, and express TH transiently during embryonic development (<xref ref-type="bibr" rid="bib85">Landis et al., 1987</xref>; <xref ref-type="bibr" rid="bib149">Teitelman et al., 1979</xref>; <xref ref-type="supplementary-material" rid="supp5">Supplementary file 5</xref>). Therefore, ideally new sympathetic differentiation protocols should demonstrate low expression of enteric or parasympathetic neuron markers, like choline O-acetyltransferase (CHAT), in mature sympathetic neurons.</p></sec><sec id="s2-10"><title>Parasympathetic neuron definitions</title><p>All six parasympathetic articles partly based their parasympathetic neuron definitions on the cholinergic enzyme CHAT (<xref ref-type="bibr" rid="bib147">Takayama et al., 2020</xref>; <xref ref-type="bibr" rid="bib148">Takayama et al., 2023</xref>; <xref ref-type="bibr" rid="bib3">Akagi et al., 2024a</xref>; <xref ref-type="bibr" rid="bib4">Akagi et al., 2024b</xref>; <xref ref-type="bibr" rid="bib56">Goldsteen et al., 2022</xref>; <xref ref-type="bibr" rid="bib172">Wu et al., 2024b</xref>). However, several other peripheral neurons also express CHAT, of which enteric neurons and cholinergic sympathetic neurons are derived from NCCs as well. This highlights the need for additional markers to support specific parasympathetic neuron identity. Other markers combined with CHAT in parasympathetic neuron articles included PHOX2B (<xref ref-type="bibr" rid="bib147">Takayama et al., 2020</xref>; <xref ref-type="bibr" rid="bib148">Takayama et al., 2023</xref>; <xref ref-type="bibr" rid="bib4">Akagi et al., 2024b</xref>), PRPH (<xref ref-type="bibr" rid="bib3">Akagi et al., 2024a</xref>; <xref ref-type="bibr" rid="bib4">Akagi et al., 2024b</xref>; <xref ref-type="bibr" rid="bib172">Wu et al., 2024b</xref>), and the pan-neuronal marker, tubulin β3 (TUBB3) (<xref ref-type="bibr" rid="bib56">Goldsteen et al., 2022</xref>).</p><p>However, all these markers are also expressed by cholinergic enteric and cholinergic sympathetic neurons (<xref ref-type="bibr" rid="bib40">Espinosa-Medina et al., 2014</xref>; <xref ref-type="bibr" rid="bib51">Furlan et al., 2016</xref>; <xref ref-type="bibr" rid="bib152">Tiveron et al., 1996</xref>; <xref ref-type="supplementary-material" rid="supp5">Supplementary file 5</xref>). To exclude cholinergic sympathetic neuron identity, we recommend demonstrating the expression of H6 family homeobox 2 (HMX2) or H6 family homeobox 3 (HMX3) (<xref ref-type="bibr" rid="bib38">Ernsberger et al., 2020</xref>). Although HMX2 and HMX3 were not included in their parasympathetic neuron quantification, Wu et al. demonstrated expression of both these markers in their parasympathetic neurons (<xref ref-type="bibr" rid="bib172">Wu et al., 2024b</xref>). However, at least <italic>Hmx3</italic> is also expressed in the enteric nervous system (<xref ref-type="bibr" rid="bib64">Heanue and Pachnis, 2006</xref>). Moreover, some enteric neurons also stem from vagal NCCs and SCPs, thereby overlapping the developmental path of parasympathetic neurons (<xref ref-type="bibr" rid="bib41">Espinosa-Medina et al., 2017</xref>). Until single-cell RNA sequencing data of peripheral cholinergic neurons is available to identify specific non-anatomical markers of identity, we believe it will be difficult to distinguish PSC-derived parasympathetic neurons and cholinergic enteric neurons in vitro.</p></sec><sec id="s2-11"><title>How efficient are the current differentiation strategies to generate autonomic neurons?</title><p>To assess the practical applicability of each protocol, we focused on the percentage of total cells expressing autonomic neuron markers, and differentiation time. Eleven articles, applying a total of 10 sympathetic protocols, quantified sympathetic neuron purity (<xref ref-type="bibr" rid="bib26">Cheng et al., 2024</xref>; <xref ref-type="bibr" rid="bib108">Oh et al., 2016</xref>; <xref ref-type="bibr" rid="bib177">Zeltner et al., 2016</xref>; <xref ref-type="bibr" rid="bib48">Frith et al., 2018</xref>; <xref ref-type="bibr" rid="bib80">Kirino et al., 2018</xref>; <xref ref-type="bibr" rid="bib21">Carr-Wilkinson et al., 2018</xref>; <xref ref-type="bibr" rid="bib57">Gomez et al., 2019</xref>; <xref ref-type="bibr" rid="bib169">Wu et al., 2022b</xref>; <xref ref-type="bibr" rid="bib164">Winbo et al., 2020</xref>; <xref ref-type="bibr" rid="bib90">Li et al., 2023</xref>; <xref ref-type="fig" rid="fig7">Figure 7C</xref>). If the outcome was available, we reported %TH-positive cells or %TH- and PRPH-positive cells, or if unavailable, the percentage of cells positive for DBH, or GATA3, a sympathetic neuron marker downstream to PHOX2B (<xref ref-type="bibr" rid="bib97">Martik and Bronner, 2017</xref>), was reported.</p><p>Gomez et al. were the earliest to quantify the percentage of cells expressing autonomic neuron markers, at 9 days of differentiation, and were the only ones to report GATA3 expression in 100% of the cells (<xref ref-type="bibr" rid="bib57">Gomez et al., 2019</xref>). However, this should be interpreted cautiously; only 50% of cells expressed ASCL1. In addition, GATA3 is widely expressed during development, including expression in the non-neural ectoderm (<xref ref-type="bibr" rid="bib67">Home et al., 2009</xref>; <xref ref-type="bibr" rid="bib136">Sheng and Stern, 1999</xref>). Moreover, as was the case for the cells reported by <xref ref-type="bibr" rid="bib26">Cheng et al., 2024</xref>, the cells did not show neuronal morphology at this stage.</p><p>Generally, the acceptable minimal differentiation purity will differ per research goal. However, as an arbitrary rule of thumb, we recommend that at least two-thirds of cells in culture express relevant autonomic neuron markers. The only protocols to achieve ≥67% sympathetic neuron marker expression in cultures with neuronal morphology were those described by <xref ref-type="bibr" rid="bib80">Kirino et al., 2018</xref>, <xref ref-type="bibr" rid="bib164">Winbo et al., 2020</xref>; <xref ref-type="bibr" rid="bib90">Li et al., 2023</xref>, <xref ref-type="bibr" rid="bib169">Wu et al., 2022b</xref>, and <xref ref-type="bibr" rid="bib42">Fan et al., 2024a</xref>. However, all these protocols took ≥30 days to complete, which necessitates considerable time and material costs compared to more rapid protocols. To increase the number of cells generated per round of differentiation, three of these protocols featured an optional expansion phase of precursor populations for up to 2 weeks or longer before terminal differentiation (<xref ref-type="bibr" rid="bib80">Kirino et al., 2018</xref>; <xref ref-type="bibr" rid="bib169">Wu et al., 2022b</xref>; <xref ref-type="bibr" rid="bib42">Fan et al., 2024a</xref>).</p><p>Generally, little data was available on parasympathetic differentiation efficiency. Of the two reported quantifications, only the protocol published by Wu et al. attained a ≥67% efficient parasympathetic neuron purity with 81.5 ± 2.0% CHAT-positive cells on day 30 of differentiation using cytosine arabinoside (AraC) selection (<xref ref-type="bibr" rid="bib172">Wu et al., 2024b</xref>). The other reported quantification of the protocol by Goldsteen et al. showed much less pure parasympathetic neuron populations, with a mean of 27.7 ± 3.8% CHAT- and TUBB3-positive cells on day 50 of differentiation (<xref ref-type="bibr" rid="bib56">Goldsteen et al., 2022</xref>).</p></sec><sec id="s2-12"><title>Which functional characteristics are shown by autonomic neurons generated in vitro?</title><p>Many disease modeling applications of autonomic neurons require neurons that are capable of functional neuron firing and interactions with other cell types. To model in vivo neuronal functions, autonomic neurons should synthesize appropriate neurotransmitters, generate action potentials in response to nicotinic stimuli, and form synapses capable of functionally influencing target cell types. These neuronal functions have been demonstrated by a majority of autonomic protocols (11/17) (<xref ref-type="bibr" rid="bib108">Oh et al., 2016</xref>; <xref ref-type="bibr" rid="bib177">Zeltner et al., 2016</xref>; <xref ref-type="bibr" rid="bib48">Frith et al., 2018</xref>; <xref ref-type="bibr" rid="bib80">Kirino et al., 2018</xref>; <xref ref-type="bibr" rid="bib167">Wu and Zeltner, 2020</xref>; <xref ref-type="bibr" rid="bib164">Winbo et al., 2020</xref>; <xref ref-type="bibr" rid="bib42">Fan et al., 2024a</xref>; <xref ref-type="bibr" rid="bib147">Takayama et al., 2020</xref>; <xref ref-type="bibr" rid="bib56">Goldsteen et al., 2022</xref>; <xref ref-type="bibr" rid="bib172">Wu et al., 2024b</xref>) with varying degrees of success (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>).</p></sec><sec id="s2-13"><title>Neurotransmitter synthesis</title><p>Neurotransmitter synthesis is essential to neuron function. Moreover, determining the presence of noradrenaline or acetylcholine provides specific information on neuronal identity. This was frequently measured (11/17) (<xref ref-type="bibr" rid="bib108">Oh et al., 2016</xref>; <xref ref-type="bibr" rid="bib177">Zeltner et al., 2016</xref>; <xref ref-type="bibr" rid="bib48">Frith et al., 2018</xref>; <xref ref-type="bibr" rid="bib80">Kirino et al., 2018</xref>; <xref ref-type="bibr" rid="bib167">Wu and Zeltner, 2020</xref>; <xref ref-type="bibr" rid="bib164">Winbo et al., 2020</xref>; <xref ref-type="bibr" rid="bib42">Fan et al., 2024a</xref>; <xref ref-type="bibr" rid="bib147">Takayama et al., 2020</xref>; <xref ref-type="bibr" rid="bib56">Goldsteen et al., 2022</xref>; <xref ref-type="bibr" rid="bib172">Wu et al., 2024b</xref>) either via ELISA or high-performance liquid chromatography. Eight protocols successfully demonstrated the presence of appropriate neurotransmitters in culture medium (<xref ref-type="bibr" rid="bib108">Oh et al., 2016</xref>; <xref ref-type="bibr" rid="bib48">Frith et al., 2018</xref>; <xref ref-type="bibr" rid="bib80">Kirino et al., 2018</xref>; <xref ref-type="bibr" rid="bib167">Wu and Zeltner, 2020</xref>; <xref ref-type="bibr" rid="bib164">Winbo et al., 2020</xref>; <xref ref-type="bibr" rid="bib42">Fan et al., 2024a</xref>; <xref ref-type="bibr" rid="bib56">Goldsteen et al., 2022</xref>; <xref ref-type="bibr" rid="bib172">Wu et al., 2024b</xref>). However, only three protocols measured neurotransmitter concentrations in culture medium following spontaneous release (<xref ref-type="bibr" rid="bib169">Wu et al., 2022b</xref>; <xref ref-type="bibr" rid="bib42">Fan et al., 2024a</xref>; <xref ref-type="bibr" rid="bib172">Wu et al., 2024b</xref>). All others relied on non-physiological stimulatory cues like potassium chloride or optogenetic stimulation for neurotransmitter release. By instead using nicotine as a stimulatory cue, future protocols could simultaneously provide evidence for functional nicotinic acetylcholine receptors, a feature of all autonomic neurons (<xref ref-type="bibr" rid="bib161">Wehrwein et al., 2016</xref>). Furthermore, determining the presence of additional neurotransmitters such as neuropeptide Y might further specify the identity of PSC-derived autonomic neurons (<xref ref-type="bibr" rid="bib38">Ernsberger et al., 2020</xref>).</p></sec><sec id="s2-14"><title>Electrophysiology</title><p>Crucial to neuronal function, neurons integrate and pass on signals through action potential generation. Nine autonomic protocols provided evidence of action potential generation, via multi-electrode array (MEA) recordings, cytosolic [Ca<sup>2+</sup>] imaging, or whole-cell patch clamp recordings (<xref ref-type="bibr" rid="bib108">Oh et al., 2016</xref>; <xref ref-type="bibr" rid="bib48">Frith et al., 2018</xref>; <xref ref-type="bibr" rid="bib167">Wu and Zeltner, 2020</xref>; <xref ref-type="bibr" rid="bib164">Winbo et al., 2020</xref>; <xref ref-type="bibr" rid="bib42">Fan et al., 2024a</xref>; <xref ref-type="bibr" rid="bib147">Takayama et al., 2020</xref>; <xref ref-type="bibr" rid="bib56">Goldsteen et al., 2022</xref>; <xref ref-type="bibr" rid="bib172">Wu et al., 2024b</xref>). MEAs can record neuron firing rates of large areas of neurons over time or in response to stimuli, but provide limited information on the specific electrophysiological characteristics of individual neurons. In total, MEA recordings were reported for four protocols, revealing spontaneous firing in all cases (<xref ref-type="bibr" rid="bib168">Wu et al., 2022a</xref>; <xref ref-type="bibr" rid="bib148">Takayama et al., 2023</xref>; <xref ref-type="bibr" rid="bib56">Goldsteen et al., 2022</xref>; <xref ref-type="bibr" rid="bib172">Wu et al., 2024b</xref>).</p><p>To measure electrophysiological characteristics and the associated action potential dynamics of individual neurons, cytosolic [Ca<sup>2+</sup>] imaging or patch clamp can be used. Cytosolic [Ca<sup>2+</sup>] imaging visualizes the calcium transients associated with electrical activity, but does not directly measure voltages and currents (<xref ref-type="bibr" rid="bib6">Ali and Kwan, 2020</xref>). The most direct method to measure individual neuron electrophysiology is by whole-cell patch clamp recordings, reported for four protocols (<xref ref-type="table" rid="table2">Table 2</xref>; <xref ref-type="bibr" rid="bib108">Oh et al., 2016</xref>; <xref ref-type="bibr" rid="bib48">Frith et al., 2018</xref>; <xref ref-type="bibr" rid="bib164">Winbo et al., 2020</xref>; <xref ref-type="bibr" rid="bib42">Fan et al., 2024a</xref>). For lack of any primary human sympathetic neuron patch clamp data, whole-cell patch clamp data of adult murine thoracic sympathetic neurons have been added to <xref ref-type="table" rid="table2">Table 2</xref> for reference (<xref ref-type="bibr" rid="bib99">McKinnon et al., 2019</xref>). All four protocols demonstrated in- and outward voltage-sensitive currents, and <xref ref-type="bibr" rid="bib164">Winbo et al., 2020</xref>, <xref ref-type="bibr" rid="bib165">Winbo et al., 2021</xref> and <xref ref-type="bibr" rid="bib43">Fan et al., 2024b</xref> also demonstrated spontaneous firing. Although all adult murine sympathetic neurons fire repetitively (i.e., show tonic activation) following current injection, a substantial portion of the hPSC-derived sympathetic neurons produce only single action potentials (i.e., display phasic activation) after current injection.</p><table-wrap id="table2" position="float"><label>Table 2.</label><caption><title>Patch clamp recordings of hPSC-derived sympathetic neurons.</title><p>Electrophysiological characteristics of hPSC-derived sympathetic neurons determined by whole-cell patch clamp. Data from primary adult murine thoracic sympathetic neurons is included for reference. Tabulation is in chronological order. Data is reported as mean ± SEM or range, unless indicated otherwise. AP, action potential; hPSC, human pluripotent stem cell; NR, not reported; SEM, standard error of the mean.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom"/><th align="left" valign="bottom">Adult murine thoracic sympathetic neurons (<xref ref-type="bibr" rid="bib99">McKinnon et al., 2019</xref>) (n=35)</th><th align="left" valign="bottom"><xref ref-type="bibr" rid="bib108">Oh et al., 2016</xref> (n=9)</th><th align="left" valign="bottom"><xref ref-type="bibr" rid="bib48">Frith et al., 2018</xref> (n=14)</th><th align="left" valign="bottom"><xref ref-type="bibr" rid="bib164">Winbo et al., 2020</xref> (n=30)</th><th align="left" valign="bottom"><xref ref-type="bibr" rid="bib148">Takayama et al., 2023</xref> (n=113)</th></tr></thead><tbody><tr><td align="left" valign="bottom">Age (days)</td><td align="left" valign="bottom">37–379 (postnatal)</td><td align="left" valign="bottom">28</td><td align="left" valign="bottom">&gt;20</td><td align="left" valign="bottom">48–76</td><td align="left" valign="bottom">&gt;42</td></tr><tr><td align="left" valign="bottom">Membrane capacitance (pF)</td><td align="left" valign="bottom">89 ± 4.6<break/>(n=34)</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">11 ± 0.6</td><td align="left" valign="bottom">85 ± 5.1</td><td align="left" valign="bottom">NR</td></tr><tr><td align="left" valign="bottom">Current injection range (pA)</td><td align="left" valign="bottom">0–200</td><td align="left" valign="bottom">0–800</td><td align="left" valign="bottom">–10 to 100</td><td align="left" valign="bottom">0–300</td><td align="left" valign="bottom">–100 to 300</td></tr><tr><td align="left" valign="bottom">Proportion neurons firing repetitive APs, %</td><td align="left" valign="bottom">100</td><td align="left" valign="bottom">56</td><td align="left" valign="bottom">21</td><td align="left" valign="bottom">73</td><td align="left" valign="bottom">36</td></tr><tr><td align="left" valign="bottom">Resting membrane potential (mV)</td><td align="left" valign="bottom">−60 ± 1.1</td><td align="left" valign="bottom">−46 ± 5.4</td><td align="left" valign="bottom">−54 to –60</td><td align="left" valign="bottom">−60 ± 1.9</td><td align="left" valign="bottom">NR</td></tr><tr><td align="left" valign="bottom">AP amplitude (mV)</td><td align="left" valign="bottom">54 ± 2.7</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">93 ± 3.9</td><td align="left" valign="bottom">74 ± 4.3<break/>(n=20)</td></tr><tr><td align="left" valign="bottom">AP duration, half-width (ms)</td><td align="left" valign="bottom">4.6 ± 0.2</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">NR</td><td align="left" valign="bottom">2.8 ± 0.2</td><td align="left" valign="bottom">NR</td></tr></tbody></table></table-wrap><p>Altogether, the electrophysiological characteristics measured by Winbo et al. most closely resemble those of adult murine sympathetic neurons. However, this may be due to the longer culture time of these neurons compared to the other protocols. When Winbo et al. measured sympathetic neurons after only 28–41 days of differentiation, resting membrane potentials were significantly less polarized and action potential kinetics significantly slower than at 48–76 days (<xref ref-type="bibr" rid="bib164">Winbo et al., 2020</xref>). Wu et al. also showed increased spontaneous firing rates with extended culture times (<xref ref-type="bibr" rid="bib169">Wu et al., 2022b</xref>). Together, this emphasizes the importance of prolonged differentiation time for electrophysiological maturation.</p></sec><sec id="s2-15"><title>Functional interactions with other cell types</title><p>The ultimate result of autonomic neuronal function in vivo is the establishment of functional changes in target cells. The rapid changes in cardiomyocyte beating rates following autonomic neuronal firing represent a practical way to demonstrate target cell coupling. In total, five sympathetic (<xref ref-type="bibr" rid="bib108">Oh et al., 2016</xref>; <xref ref-type="bibr" rid="bib169">Wu et al., 2022b</xref>; <xref ref-type="bibr" rid="bib164">Winbo et al., 2020</xref>; <xref ref-type="bibr" rid="bib43">Fan et al., 2024b</xref>; <xref ref-type="bibr" rid="bib147">Takayama et al., 2020</xref>) and two parasympathetic protocols (<xref ref-type="bibr" rid="bib147">Takayama et al., 2020</xref>; <xref ref-type="bibr" rid="bib172">Wu et al., 2024b</xref>) showed altered beating rates of cardiomyocytes in co-culture with autonomic neurons following nicotinic stimulation. Although both studies applying parasympathetic neurons adequately accounted for this, readers should note that nicotine administration can cause subtle decreases of hPSC-derived cardiomyocyte spontaneous beating rates, even in the absence of co-cultured autonomic neurons (<xref ref-type="bibr" rid="bib164">Winbo et al., 2020</xref>; <xref ref-type="bibr" rid="bib43">Fan et al., 2024b</xref>; <xref ref-type="bibr" rid="bib147">Takayama et al., 2020</xref>). Therefore, we recommend including a cardiomyocyte monoculture control for nicotine reactivity experiments.</p><p>Besides cardiomyocytes, other cell types have also successfully formed functional interactions with hPSC-derived autonomic neurons. Wu et al. also showed hPSC-derived parasympathetic neurons could increase calcium flux in salivary acinar cells upon nicotine administration (<xref ref-type="bibr" rid="bib172">Wu et al., 2024b</xref>). Finally, autonomic neurons generated by Wu et al. and Fan et al. demonstrated specific interactions with adipocyte-like cells (<xref ref-type="bibr" rid="bib42">Fan et al., 2024a</xref>; <xref ref-type="bibr" rid="bib172">Wu et al., 2024b</xref>). Co-culture with hPSC-derived sympathetic neurons caused human adipose-derived stem cells to increase lipid hydrolysis and adopt brown-like adipocyte identities (<xref ref-type="bibr" rid="bib42">Fan et al., 2024a</xref>). Conversely, co-culture with hPSC-derived parasympathetic neurons caused 3T3-L1-derived mouse adipocytes to adopt mature morphology and increase adipogenesis (<xref ref-type="bibr" rid="bib172">Wu et al., 2024b</xref>).</p><p>All-in-all, we recommend that new autonomic protocols show nicotine-dependent neuron firing or nicotine-dependent functional interactions with target cells to prove neuron functionality. Both these approaches demonstrate neuronal function from the activation of postsynaptic nicotinic receptors to the generation of an action potential. Ideally, action potential kinetics should also be measured to provide information on neuron identity and maturity.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>In this systematic review, we have shown that most current methods to generate human autonomic neurons are hPSC-based and aimed at sympathetic neuronal differentiation. In contrast to their parasympathetic counterparts, hPSC-derived sympathetic neurons have already been applied in multiple studies modeling the sympathetic contribution to diseases including familial dysautonomia (<xref ref-type="bibr" rid="bib177">Zeltner et al., 2016</xref>; <xref ref-type="bibr" rid="bib169">Wu et al., 2022b</xref>), congenital central hypoventilation syndrome (<xref ref-type="bibr" rid="bib7">Amer-Sarsour et al., 2024</xref>), long QT syndrome (<xref ref-type="bibr" rid="bib165">Winbo et al., 2021</xref>), Parkinson’s disease (<xref ref-type="bibr" rid="bib126">Saleh et al., 2024</xref>), and diabetic autonomic neuropathy (<xref ref-type="bibr" rid="bib170">Wu et al., 2023</xref>). Our comparison between hPSC-derived autonomic neuronal differentiation protocols and the embryonic development of the ANS has highlighted a number of unexplored in vitro signaling cues for parasympathetic, but also for sympathetic neuronal differentiation. Additionally, we provided an overview and outlined the challenges of molecular strategies to define hPSC-derived autonomic neurons in vitro.</p><sec id="s3-1"><title>Comparison to embryonic development</title><p>Most sympathetic protocols had a firm basis in embryology. Nonetheless, a number of signals vital to sympathetic neuron development in vivo were absent from all protocols, such as SEMA3A, required for the patterning of the sympathetic trunk and target innervation (<xref ref-type="bibr" rid="bib79">Kawasaki et al., 2002</xref>; <xref ref-type="bibr" rid="bib71">Ieda et al., 2007</xref>). Other factors involved in the development of sympathetic neurons, such as NRG1, CXCL12, and artemin, were omitted from all sympathetic protocols. The common denominator for these factors is that they primarily regulate cell migration or axon extension. These functions are probably less crucial in vitro, where cells do not require migration or axon extension to encounter signaling cues. However, factors like artemin, NRTN, endothelins, and netrin 1 may be required to recapitulate the target-specific phenotypical sympathetic neuron diversity observed in vivo (<xref ref-type="bibr" rid="bib51">Furlan et al., 2016</xref>). For parasympathetic neurons, besides NRTN, TGFβ1 is another promising candidate to improve neuron maturation. In vivo, TGFβ1 regulates the expression of Ca<sup>2+</sup>-activated K<sup>+</sup>-channels together with NRG1 (<xref ref-type="bibr" rid="bib20">Cameron et al., 2001</xref>; <xref ref-type="bibr" rid="bib19">Cameron et al., 1998</xref>).</p><p>Embryological studies often provide inspiration for in vitro differentiation strategies, but the reverse can also be true. Although few experiments were specifically designed to answer embryological questions via the differentiation of hPSCs, the ability to induce sympathetic neuron markers in hPSCs with signaling cues observed in murine and avian models suggests that human sympathetic developmental signaling cues in vivo have not diverged notably from other amniotes. From this perspective, only the prominent role of SB-mediated SMAD2/3 inhibition in hPSC-derived NCC induction in this review raises questions about the role of this pathway in vivo. Other outcomes of embryological interest are the other cell types generated by autonomic neuron differentiation protocols. Animal models have shown that glial cells, sensory neurons, enteric neurons, and chromaffin cells, among others, are closely related to autonomic neurons (<xref ref-type="bibr" rid="bib97">Martik and Bronner, 2017</xref>). The other cell types generated by the protocols in this review support the idea that these cell types and autonomic neurons are also derived from common progenitors in humans. In the protocol developed by Zeltner et al., which is one of the few protocols without BMP, contaminating cell types were shown to express α-smooth muscle actin (myofibroblast marker), or brain-specific homeobox/POU domain protein 3A (<italic>POU4F1</italic>, also known as <italic>BRN3A</italic>; sensory neuron marker) (<xref ref-type="bibr" rid="bib177">Zeltner et al., 2016</xref>).</p></sec><sec id="s3-2"><title>In vitro autonomic neuron definitions</title><p>Besides markers expressed by the mature neurons, autonomic neuron identity was usually supported during differentiation by demonstrating the intermediate presence of NCC markers NGFR, HNK1, and/or SOX10 (or CD49d, which correlates with SOX10 expression; <xref ref-type="bibr" rid="bib44">Fattahi et al., 2016</xref>). Of these, SOX10 seems most robustly expressed in both human premigratory and migratory human NCCs (<xref ref-type="bibr" rid="bib14">Betters et al., 2010</xref>), but all markers are also expressed in parts of the neural tube, underscoring the need for multiple NCC markers in vitro.</p><p>After NCC induction, SCP formation is another specific feature of parasympathetic neuron development. However, only one article demonstrated the intermediate presence of SCPs by SOX10 expression and Schwann cell differentiation potential (<xref ref-type="bibr" rid="bib172">Wu et al., 2024b</xref>). Considering that NCCs also express SOX10 (<xref ref-type="bibr" rid="bib14">Betters et al., 2010</xref>), markers such as myelin protein 0 and cadherin 19 should be used to distinguish SCPs from NCCs (<xref ref-type="bibr" rid="bib139">Solovieva and Bronner, 2021</xref>).</p><p>Even after establishing intermediate SCP identity, parasympathetic neurons and cholinergic enteric neurons cannot be distinguished from one another. The field currently lacks a comprehensive transcriptomic characterization of parasympathetic neurons (<xref ref-type="bibr" rid="bib38">Ernsberger et al., 2020</xref>), as exists for sympathetic neurons (<xref ref-type="bibr" rid="bib51">Furlan et al., 2016</xref>), to address this issue. A recent investigation of the right atrial ganglionic plexus, which contains parasympathetic neurons, may provide some clues (<xref ref-type="bibr" rid="bib104">Moss et al., 2021</xref>). However, the neurons of the intrinsic cardiac ganglia are diverse (<xref ref-type="bibr" rid="bib46">Fedele and Brand, 2020</xref>). Ideally, single-cell RNA sequencing of peripheral cholinergic neurons would reveal specific molecular parasympathetic markers for future PSC-derived parasympathetic protocols.</p></sec><sec id="s3-3"><title>Protocol efficiency</title><p>Quantitative efficiency parameters largely determine the practical applicability of a particular differentiation protocol. Several sympathetic protocols have reported ≥67% TH-positive cells, but only one parasympathetic protocol achieved ≥67% CHAT-positive cells. Furthermore, although outpacing the in vivo rate of differentiation (<xref ref-type="bibr" rid="bib83">Kruepunga et al., 2021</xref>), differentiation durations of protocols with high purity (≥30 days) remain a significant barrier to widespread protocol implementation. A final important metric in this category, especially for industrial applications, is cost-effectiveness. In this regard, future protocol development should include attempts to replace growth factors with less expensive small molecules (<xref ref-type="bibr" rid="bib180">Zhu et al., 2010</xref>). Forced expression of lineage-specifying transcription factors like neurogenin 2 may be another way to reduce costs by decreasing differentiation time (<xref ref-type="bibr" rid="bib70">Hulme et al., 2022</xref>). The same is likely to be true for autonomic neuronal cell lines derived by conditional immortalization.</p></sec><sec id="s3-4"><title>Neuronal maturation</title><p>From a functional point of view, a major challenge for hPSC-derived neurons is to develop from electrically passive hPSCs to mature neurons within a short time span. Besides prolonged time in culture, other strategies to improve autonomic neuronal maturity include the generation of microtissues containing multiple cell types. As an example, addition of hPSC-derived cardiac fibroblasts to three-dimensional (3D) microtissues consisting of hPSC-CMs and cardiac endothelial cells has been shown to improve hPSC-CM maturity (<xref ref-type="bibr" rid="bib55">Giacomelli et al., 2020</xref>). Co-culture with epicardium-derived cells has also been shown to improve cardiomyocyte maturation and to stimulate sympathetic ganglion neurite outgrowth (<xref ref-type="bibr" rid="bib160">Weeke-Klimp et al., 2010</xref>; <xref ref-type="bibr" rid="bib52">Ge et al., 2020</xref>). Satellite glial cells, which support neuronal survival and firing in vivo (<xref ref-type="bibr" rid="bib62">Hanani and Spray, 2020</xref>), are other interesting candidates to assist autonomic neuronal maturation.</p></sec><sec id="s3-5"><title>Three-dimensional autonomic neuronal models</title><p>In addition to glial cells, autonomic neurons neighbor several other cell types in vivo, such as pericytes and endoneurial fibroblasts (<xref ref-type="bibr" rid="bib96">Mapps et al., 2022</xref>). Exposure to the signals and extracellular matrix deposited by these cells can influence culture stability, as well as gene and protein expression levels (<xref ref-type="bibr" rid="bib22">Chaicharoenaudomrung et al., 2019</xref>). Ultimately, 3D cultures composed of multiple cell types could potentially capture disease phenotypes that two-dimensional (2D) cultures consisting mainly of neurons may not be accurate or sensitive enough for. However, although several articles report the self-assembly of autonomic neurons into ganglia-like clusters (<xref ref-type="bibr" rid="bib48">Frith et al., 2018</xref>; <xref ref-type="bibr" rid="bib167">Wu and Zeltner, 2020</xref>; <xref ref-type="bibr" rid="bib147">Takayama et al., 2020</xref>), all current protocols have been developed for 2D culture. Considering the variety of cells that is likely to impact autonomic neuron function, and the 3D anatomy of autonomic ganglia in vivo, the field would benefit from the availability of 3D models of autonomic ganglia with multiple cell types.</p></sec><sec id="s3-6"><title>Conditional immortalization</title><p>A final lacuna revealed by our search was a complete lack of lines of immortalized human autonomic neurons. Immortalization strategies promise low proportions of contaminating cell types and fast neuron generation. The cell line probably closest to fitting our definitions would be the catecholaminergic SH-SY5Y cell line. Not strictly sympathetic, this line was derived from a human neuroblastoma metastasis. Despite its ability to express DBH in addition to TH, SH-SY5Y has widely been used to model dopaminergic neurons (which do not express DBH) to research Parkinson’s disease (<xref ref-type="bibr" rid="bib175">Xicoy et al., 2017</xref>). However, among other drawbacks, expression profiles of terminally differentiated SH-SY5Y-derived neurons appear inconsistent between different studies (<xref ref-type="bibr" rid="bib12">Bell and Zempel, 2022</xref>), limiting their ability to model specific neuronal subtypes. This limitation could be circumvented by direct immortalization of specific neuronal subtypes. Moreover, the possibility of switching proliferation off after immortalization (i.e., conditional immortalization) could aid the recovery of mature features upon differentiation, as has been shown for human atrial myocytes (<xref ref-type="bibr" rid="bib63">Harlaar et al., 2022</xref>), another cell type with limited mitotic capacity.</p></sec><sec id="s3-7"><title>Limitations</title><p>Our comparison of in vitro differentiation methods to embryonic development has a few limitations. Although we focused mainly on the signaling molecules authors explicitly reported, as these are likely to have been selected based on experimental evidence, other growth factors were also often present (<xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>). For instance, although at first glance only Frith et al. include FGF2 from the start of differentiation (<xref ref-type="bibr" rid="bib48">Frith et al., 2018</xref>), other protocols initiate differentiation in the PSC maintenance media StemPro, which contains FGF2 and IGF1, among others (<xref ref-type="bibr" rid="bib5">Akopian et al., 2010</xref>), or StemFlex, which likely also contains FGF2. Other media contained proprietary supplements, like knockout serum replacement, of which the exact composition is not provided (<xref ref-type="bibr" rid="bib116">Price and Tilkins, 1998</xref>). Moreover, multiple protocols contained undefined components like the factors secreted by PA6 cells, or fetal bovine serum, bovine serum albumin, and Matrigel, which contain varying quantities of undetermined growth factors. Finally, no studies measured or defined the levels of endogenous signaling molecules secreted by cells during differentiation. For example, spontaneously differentiating human embryonic stem cells (hESCs) produce endogenous BMP2 (<xref ref-type="bibr" rid="bib114">Pera et al., 2004</xref>) and endogenous Wnt signaling varies between hESC clones (<xref ref-type="bibr" rid="bib15">Blauwkamp et al., 2012</xref>). The approach closest to addressing endogenous variation was the 'top-down BMP inhibition’ (<xref ref-type="bibr" rid="bib60">Hackland et al., 2017</xref>) applied by two protocols (<xref ref-type="bibr" rid="bib49">Frith and Tsakiridis, 2019</xref>; <xref ref-type="bibr" rid="bib61">Hackland et al., 2019</xref>), which combines BMP inhibition with BMP stimulation to limit the influence of endogenous signals. Together, these factors obscure a total overview of active signaling cues in autonomic neuron protocols.</p><p>Furthermore, the scope of this review was limited to human autonomic neurons derived from hPSCs or via immortalization of primary human cells. However, alternative strategies could not be retrieved by our search strategy, such as direct reprogramming. For example, although murine, noradrenergic neurons and ganglion organoids containing multiple autonomic neuron types have been generated by overexpression of combinations of catecholaminergic transcription factors in astrocytes or mouse embryonic fibroblasts (<xref ref-type="bibr" rid="bib89">Li et al., 2019</xref>; <xref ref-type="bibr" rid="bib92">Liu et al., 2023</xref>). This may present another feasible route to generate human sympathetic-like neurons.</p></sec><sec id="s3-8"><title>Conclusions</title><p>The derivation of sympathetic neurons from hPSCs has progressed tremendously since the first attempts in 2016, mostly mirroring signaling cues observed in vivo. These protocols have now reached a phase in which they can be applied to human disease modeling, as evidenced by various articles included in this review. Future sympathetic protocols should consider the generation of subtypes of sympathetic neurons by incorporating target-specific factors. By comparison, the generation and application of hPSC-derived parasympathetic neurons lag behind, with few available approaches and a lack of extensive electrophysiological characterization. A significant hurdle to generating parasympathetic neurons in vitro is a lack of established specific markers. Finally, attempts to generate human autonomic neurons through conditional immortalization have not yet been reported, but will likely complement the existing hPSC-based approaches to produce these valuable but otherwise near unobtainable cells.</p></sec></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><p>This systematic review was conducted following the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) 2020 guidelines (checklist is provided as <xref ref-type="supplementary-material" rid="supp6">Supplementary file 6</xref>; <xref ref-type="bibr" rid="bib112">Page et al., 2021</xref>). Accordingly, a systematic review protocol was registered with Open Science Framework prior to data collection (doi:<ext-link ext-link-type="uri" xlink:href="http://doi.org/10.17605/OSF.IO/E9VGU">10.17605/OSF.IO/E9VGU</ext-link>). The protocol was amended before data collection by widening article eligibility from cardiac or unspecified sympathetic or parasympathetic neurons, to all postganglionic sympathetic or parasympathetic neurons, after it became apparent that most protocols did not aim to generate organ-specific neuronal subpopulations. This led to the inclusion of one additional article, that is, <xref ref-type="bibr" rid="bib56">Goldsteen et al., 2022</xref>.</p><sec id="s4-1"><title>Search strategy and article selection</title><p>The search strategy (see Appendix 1) was compiled with support from a medical information specialist. Queries were designed to retrieve all articles including in vitro research with hPSCs or immortalization, and human autonomic neurons or autonomic precursors. No additional limits or filters were applied. The PubMed (databases: Medical Literature Analysis and Retrieval System Online, PubMed Central, and Bookshelf), Ovid (database: Embase), and Web of Science (database: Web of Science Core Collection) interfaces were last searched on November 13, 2024. During full-text screening, the reference list of each article was screened for further eligible articles.</p><p>All articles were deduplicated in EndNote 20 as previously described (<xref ref-type="bibr" rid="bib16">Bramer et al., 2016</xref>). Next, two reviewers (EP and TAB) independently screened titles and abstracts for potential eligibility using Rayyan (<ext-link ext-link-type="uri" xlink:href="https://www.rayyan.ai/">https://www.rayyan.ai/</ext-link>; <xref ref-type="bibr" rid="bib111">Ouzzani et al., 2016</xref>). After resolving all discrepancies via discussion, a single reviewer (TAB) assessed the selected full-text records for eligibility. In cases of uncertain eligibility, eligibility was verified by discussion with two other reviewers (MCDR and MRMJ). Finally, articles that met each of the following criteria were selected:</p><list list-type="order"><list-item><p>An English peer-reviewed full-text record was available.</p></list-item><list-item><p>The article described original experiments and/or methods.</p></list-item><list-item><p>Techniques involving hPSCs or immortalized cells were applied.</p></list-item><list-item><p>The authors aimed to produce sympathetic or parasympathetic postganglionic neurons, or neurons that strongly resemble these cell types.</p></list-item><list-item><p>The neurons were human.</p></list-item><list-item><p>The authors aimed to induce homogenous populations of sympathetic or parasympathetic neurons.</p></list-item><list-item><p>The article provided, or referred to, methodological details and any characterization outcomes.</p></list-item></list></sec><sec id="s4-2"><title>Quality assessment</title><p>At the time of publication, no widely applied guidelines to assess methodology and reporting of in vitro studies existed. Therefore, we developed criteria based on the Consolidated Standards of Reporting Trials (CONSORT) and Animal Research: Reporting of In Vivo Experiments (ARRIVE) guidelines (<xref ref-type="bibr" rid="bib128">Schulz et al., 2010</xref>; <xref ref-type="bibr" rid="bib115">Percie du Sert et al., 2020</xref>), supplemented with self-devised criteria specific for studies involving hPSCs and neuronal cell culture (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>). Using these criteria, two reviewers (EP and TAB) independently judged each eligible record, resolving discrepancies via discussion.</p></sec><sec id="s4-3"><title>Data collection</title><p>All data was extracted manually from eligible records by a single reviewer (TAB) in Microsoft Excel and validated by a second reviewer (EP). Publication metadata, and information about materials, conditions, timepoints, and methods for deriving neurons were collected from all eligible articles. Additionally, data on gene and protein expression, neurotransmitter secretion, electrophysiology, morphology, and co-culture outcomes were collected. If multiple iterations of a protocol were reported, data was collected from the version yielding the highest purity of sympathetic or parasympathetic neurons, or if this was not determined, the most mature markers. Differentiation duration was defined as the time between the first day conditions deviated from hPSC maintenance conditions and the first day at which end-stage cells were analyzed by any means. Markers used to define neuronal identities were collected depending on outcome availability. If quantitative data was only provided graphically, values were derived from images.</p></sec><sec id="s4-4"><title>Statistics</title><p>All statistics were performed in R (version 4.4.2). Interrater reliability was calculated via Cohen’s kappa using the irr package (<ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/package=irr">https://cran.r-project.org/package=irr</ext-link>). The heterogeneity in applied methods and measured outcomes between articles precluded any meta-analyses. Individual study averages were reported as mean ± standard error of the mean (SEM). If not reported, SEM was derived by dividing the standard deviation by the square root of the number of observations.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Investigation, Visualization, Methodology, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Validation, Investigation, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Supervision, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con4"><p>Writing – review and editing</p></fn><fn fn-type="con" id="con5"><p>Writing – review and editing</p></fn><fn fn-type="con" id="con6"><p>Writing – review and editing</p></fn><fn fn-type="con" id="con7"><p>Conceptualization, Supervision, Writing – review and editing</p></fn><fn fn-type="con" id="con8"><p>Conceptualization, Supervision, Funding acquisition, Writing – original draft, Writing – review and editing</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>List of excluded articles.</title><p>A list of all articles that were excluded during full-text screening, including the reason of exclusion. PSCs, pluripotent stem cells.</p></caption><media xlink:href="elife-103728-supp1-v2.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>Quality assessment criteria and definitions.</title><p>Detailed criteria and definitions per judgement per criterion.</p></caption><media xlink:href="elife-103728-supp2-v2.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="supp3"><label>Supplementary file 3.</label><caption><title>Methodological details of included protocols.</title><p>Additional culture details per original protocol, relating to <xref ref-type="fig" rid="fig3">Figures 3</xref>, <xref ref-type="fig" rid="fig5">5</xref> and <xref ref-type="fig" rid="fig6">6</xref>.</p></caption><media xlink:href="elife-103728-supp3-v2.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="supp4"><label>Supplementary file 4.</label><caption><title>Small molecules used in autonomic neuron protocols.</title><p>Modes of actions for all small molecules featured in this article.</p></caption><media xlink:href="elife-103728-supp4-v2.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="supp5"><label>Supplementary file 5.</label><caption><title>Molecular autonomic neuron markers.</title><p>Function and expression profiles of molecular autonomic neuron markers.</p></caption><media xlink:href="elife-103728-supp5-v2.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="supp6"><label>Supplementary file 6.</label><caption><title>Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 Main Checklist.</title><p>Locations of all Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 Main Checklist items.</p></caption><media xlink:href="elife-103728-supp6-v2.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-103728-mdarchecklist1-v2.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="sdata1"><label>Source data 1.</label><caption><title>Dataset relating to <xref ref-type="fig" rid="fig1">Figure 1</xref>.</title><p>All title-abstract exclusion reasons per record. Please see <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref> for exclusion reasons during full-text screening. n/a, not available. Dataset relating to <xref ref-type="fig" rid="fig7">Figure 7A and B</xref>. Definitions of sympathetic neurons per article. Only one of quantification, immunofluorescence or RT-qPCR data was collected per article. Quantification data was preferentially collected over immunofluorescence or RT-qPCR. Immunofluorescence data was collected preferentially over RT-qPCR. n/a, not available; RT-qPCR, quantitative reverse transcriptase polymerase chain reaction. Dataset relating to <xref ref-type="fig" rid="fig7">Figure 7C</xref>: sympathetic neuron efficiency quantification per article. Only one efficiency marker was collected per article. %TH+ was collected preferentially over the other markers. %TH+ PRPH+ was collected preferentially over %GATA3+ and %DBH+. DBH, dopamine beta-hydroxylase; GATA3, GATA binding protein 3; n/a, not available; NR, not reported; PRPH, peripherin; TH, tyrosine hydroxylase.</p></caption><media xlink:href="elife-103728-data1-v2.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>All supporting data is provided in the tables, figures and supplementary files.</p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank José Plevier for her assistance in compiling the search strategy. Additionally, we are thankful to Ronald Slagter for drawing the illustrations in <xref ref-type="fig" rid="fig4">Figures 4</xref>—<xref ref-type="fig" rid="fig6">6</xref>.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adler</surname><given-names>R</given-names></name><name><surname>Landa</surname><given-names>KB</given-names></name><name><surname>Manthorpe</surname><given-names>M</given-names></name><name><surname>Varon</surname><given-names>S</given-names></name></person-group><year iso-8601-date="1979">1979</year><article-title>Cholinergic neuronotrophic factors: intraocular distribution of trophic activity for ciliary neurons</article-title><source>Science</source><volume>204</volume><fpage>1434</fpage><lpage>1436</lpage><pub-id pub-id-type="doi">10.1126/science.451576</pub-id><pub-id pub-id-type="pmid">451576</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahonen</surname><given-names>M</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Neurofilament immunoreactivity and acetylcholinesterase activity in the developing sympathetic tissues of the rat</article-title><source>Histochemistry</source><volume>96</volume><fpage>467</fpage><lpage>478</lpage><pub-id pub-id-type="doi">10.1007/BF00267072</pub-id><pub-id pub-id-type="pmid">1685155</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akagi</surname><given-names>Y</given-names></name><name><surname>Takayama</surname><given-names>Y</given-names></name><name><surname>Nihashi</surname><given-names>Y</given-names></name><name><surname>Yamashita</surname><given-names>A</given-names></name><name><surname>Yoshida</surname><given-names>R</given-names></name><name><surname>Miyamoto</surname><given-names>Y</given-names></name><name><surname>Kida</surname><given-names>YS</given-names></name></person-group><year iso-8601-date="2024">2024a</year><article-title>Functional engineering of human iPSC-derived parasympathetic neurons enhances responsiveness to gastrointestinal hormones</article-title><source>FEBS Open Bio</source><volume>14</volume><fpage>63</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1002/2211-5463.13741</pub-id><pub-id pub-id-type="pmid">38013211</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akagi</surname><given-names>Y</given-names></name><name><surname>Norimoto</surname><given-names>A</given-names></name><name><surname>Kawamura</surname><given-names>T</given-names></name><name><surname>Kida</surname><given-names>YS</given-names></name></person-group><year iso-8601-date="2024">2024b</year><article-title>Label-free assessment of neuronal activity using raman micro-spectroscopy</article-title><source>Molecules</source><volume>29</volume><elocation-id>3174</elocation-id><pub-id pub-id-type="doi">10.3390/molecules29133174</pub-id><pub-id pub-id-type="pmid">38999126</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akopian</surname><given-names>V</given-names></name><name><surname>Andrews</surname><given-names>PW</given-names></name><name><surname>Beil</surname><given-names>S</given-names></name><name><surname>Benvenisty</surname><given-names>N</given-names></name><name><surname>Brehm</surname><given-names>J</given-names></name><name><surname>Christie</surname><given-names>M</given-names></name><name><surname>Ford</surname><given-names>A</given-names></name><name><surname>Fox</surname><given-names>V</given-names></name><name><surname>Gokhale</surname><given-names>PJ</given-names></name><name><surname>Healy</surname><given-names>L</given-names></name><name><surname>Holm</surname><given-names>F</given-names></name><name><surname>Hovatta</surname><given-names>O</given-names></name><name><surname>Knowles</surname><given-names>BB</given-names></name><name><surname>Ludwig</surname><given-names>TE</given-names></name><name><surname>McKay</surname><given-names>RDG</given-names></name><name><surname>Miyazaki</surname><given-names>T</given-names></name><name><surname>Nakatsuji</surname><given-names>N</given-names></name><name><surname>Oh</surname><given-names>SKW</given-names></name><name><surname>Pera</surname><given-names>MF</given-names></name><name><surname>Rossant</surname><given-names>J</given-names></name><name><surname>Stacey</surname><given-names>GN</given-names></name><name><surname>Suemori</surname><given-names>H</given-names></name><collab>International Stem Cell Initiative Consortium</collab></person-group><year iso-8601-date="2010">2010</year><article-title>Comparison of defined culture systems for feeder cell free propagation of human embryonic stem cells</article-title><source>In Vitro Cellular &amp; Developmental Biology. Animal</source><volume>46</volume><fpage>247</fpage><lpage>258</lpage><pub-id pub-id-type="doi">10.1007/s11626-010-9297-z</pub-id><pub-id pub-id-type="pmid">20186512</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ali</surname><given-names>F</given-names></name><name><surname>Kwan</surname><given-names>AC</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Interpreting <italic>in vivo</italic> calcium signals from neuronal cell bodies, axons, and dendrites: a review</article-title><source>Neurophotonics</source><volume>7</volume><elocation-id>011402</elocation-id><pub-id pub-id-type="doi">10.1117/1.NPh.7.1.011402</pub-id><pub-id pub-id-type="pmid">31372367</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amer-Sarsour</surname><given-names>F</given-names></name><name><surname>Falik</surname><given-names>D</given-names></name><name><surname>Berdichevsky</surname><given-names>Y</given-names></name><name><surname>Kordonsky</surname><given-names>A</given-names></name><name><surname>Eid</surname><given-names>S</given-names></name><name><surname>Rabinski</surname><given-names>T</given-names></name><name><surname>Ishtayeh</surname><given-names>H</given-names></name><name><surname>Cohen-Adiv</surname><given-names>S</given-names></name><name><surname>Braverman</surname><given-names>I</given-names></name><name><surname>Blumen</surname><given-names>SC</given-names></name><name><surname>Laviv</surname><given-names>T</given-names></name><name><surname>Prag</surname><given-names>G</given-names></name><name><surname>Vatine</surname><given-names>GD</given-names></name><name><surname>Ashkenazi</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Disease-associated polyalanine expansion mutations impair UBA6-dependent ubiquitination</article-title><source>The EMBO Journal</source><volume>43</volume><fpage>250</fpage><lpage>276</lpage><pub-id pub-id-type="doi">10.1038/s44318-023-00018-9</pub-id><pub-id pub-id-type="pmid">38177505</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amin</surname><given-names>S</given-names></name><name><surname>Neijts</surname><given-names>R</given-names></name><name><surname>Simmini</surname><given-names>S</given-names></name><name><surname>van Rooijen</surname><given-names>C</given-names></name><name><surname>Tan</surname><given-names>SC</given-names></name><name><surname>Kester</surname><given-names>L</given-names></name><name><surname>van Oudenaarden</surname><given-names>A</given-names></name><name><surname>Creyghton</surname><given-names>MP</given-names></name><name><surname>Deschamps</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Cdx and T brachyury co-activate growth signaling in the embryonic axial progenitor niche</article-title><source>Cell Reports</source><volume>17</volume><fpage>3165</fpage><lpage>3177</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2016.11.069</pub-id><pub-id pub-id-type="pmid">28009287</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Armstrong</surname><given-names>A</given-names></name><name><surname>Ryu</surname><given-names>YK</given-names></name><name><surname>Chieco</surname><given-names>D</given-names></name><name><surname>Kuruvilla</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Frizzled3 is required for neurogenesis and target innervation during sympathetic nervous system development</article-title><source>The Journal of Neuroscience</source><volume>31</volume><fpage>2371</fpage><lpage>2381</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4243-10.2011</pub-id><pub-id pub-id-type="pmid">21325504</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aven</surname><given-names>L</given-names></name><name><surname>Ai</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Mechanisms of respiratory innervation during embryonic development</article-title><source>Organogenesis</source><volume>9</volume><fpage>194</fpage><lpage>198</lpage><pub-id pub-id-type="doi">10.4161/org.24842</pub-id><pub-id pub-id-type="pmid">23974176</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baloh</surname><given-names>RH</given-names></name><name><surname>Enomoto</surname><given-names>H</given-names></name><name><surname>Johnson</surname><given-names>EM</given-names></name><name><surname>Milbrandt</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>The GDNF family ligands and receptors - implications for neural development</article-title><source>Current Opinion in Neurobiology</source><volume>10</volume><fpage>103</fpage><lpage>110</lpage><pub-id pub-id-type="doi">10.1016/s0959-4388(99)00048-3</pub-id><pub-id pub-id-type="pmid">10679429</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bell</surname><given-names>M</given-names></name><name><surname>Zempel</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>SH-SY5Y-derived neurons: a human neuronal model system for investigating TAU sorting and neuronal subtype-specific TAU vulnerability</article-title><source>Reviews in the Neurosciences</source><volume>33</volume><fpage>1</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1515/revneuro-2020-0152</pub-id><pub-id pub-id-type="pmid">33866701</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernardin</surname><given-names>AA</given-names></name><name><surname>Colombani</surname><given-names>S</given-names></name><name><surname>Rousselot</surname><given-names>A</given-names></name><name><surname>Andry</surname><given-names>V</given-names></name><name><surname>Goumon</surname><given-names>Y</given-names></name><name><surname>Delanoë-Ayari</surname><given-names>H</given-names></name><name><surname>Pasqualin</surname><given-names>C</given-names></name><name><surname>Brugg</surname><given-names>B</given-names></name><name><surname>Jacotot</surname><given-names>ED</given-names></name><name><surname>Pasquié</surname><given-names>JL</given-names></name><name><surname>Lacampagne</surname><given-names>A</given-names></name><name><surname>Meli</surname><given-names>AC</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Impact of neurons on patient-derived cardiomyocytes using organ-on-a-chip and IPSC biotechnologies</article-title><source>Cells</source><volume>11</volume><elocation-id>3764</elocation-id><pub-id pub-id-type="doi">10.3390/cells11233764</pub-id><pub-id pub-id-type="pmid">36497024</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Betters</surname><given-names>E</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Kjaeldgaard</surname><given-names>A</given-names></name><name><surname>Sundström</surname><given-names>E</given-names></name><name><surname>García-Castro</surname><given-names>MI</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Analysis of early human neural crest development</article-title><source>Developmental Biology</source><volume>344</volume><fpage>578</fpage><lpage>592</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2010.05.012</pub-id><pub-id pub-id-type="pmid">20478300</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blauwkamp</surname><given-names>TA</given-names></name><name><surname>Nigam</surname><given-names>S</given-names></name><name><surname>Ardehali</surname><given-names>R</given-names></name><name><surname>Weissman</surname><given-names>IL</given-names></name><name><surname>Nusse</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Endogenous Wnt signalling in human embryonic stem cells generates an equilibrium of distinct lineage-specified progenitors</article-title><source>Nature Communications</source><volume>3</volume><elocation-id>1070</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms2064</pub-id><pub-id pub-id-type="pmid">22990866</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bramer</surname><given-names>WM</given-names></name><name><surname>Giustini</surname><given-names>D</given-names></name><name><surname>de Jonge</surname><given-names>GB</given-names></name><name><surname>Holland</surname><given-names>L</given-names></name><name><surname>Bekhuis</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>De-duplication of database search results for systematic reviews in EndNote</article-title><source>Journal of the Medical Library Association</source><volume>104</volume><fpage>240</fpage><lpage>243</lpage><pub-id pub-id-type="doi">10.3163/1536-5050.104.3.014</pub-id><pub-id pub-id-type="pmid">27366130</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bronner-Fraser</surname><given-names>M</given-names></name></person-group><year iso-8601-date="1986">1986</year><article-title>Analysis of the early stages of trunk neural crest migration in avian embryos using monoclonal antibody HNK-1</article-title><source>Developmental Biology</source><volume>115</volume><fpage>44</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1016/0012-1606(86)90226-5</pub-id><pub-id pub-id-type="pmid">3516760</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brunet</surname><given-names>I</given-names></name><name><surname>Gordon</surname><given-names>E</given-names></name><name><surname>Han</surname><given-names>J</given-names></name><name><surname>Cristofaro</surname><given-names>B</given-names></name><name><surname>Broqueres-You</surname><given-names>D</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Bouvrée</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>del Toro</surname><given-names>R</given-names></name><name><surname>Mathivet</surname><given-names>T</given-names></name><name><surname>Larrivée</surname><given-names>B</given-names></name><name><surname>Jagu</surname><given-names>J</given-names></name><name><surname>Pibouin-Fragner</surname><given-names>L</given-names></name><name><surname>Pardanaud</surname><given-names>L</given-names></name><name><surname>Machado</surname><given-names>MJC</given-names></name><name><surname>Kennedy</surname><given-names>TE</given-names></name><name><surname>Zhuang</surname><given-names>Z</given-names></name><name><surname>Simons</surname><given-names>M</given-names></name><name><surname>Levy</surname><given-names>BI</given-names></name><name><surname>Tessier-Lavigne</surname><given-names>M</given-names></name><name><surname>Grenz</surname><given-names>A</given-names></name><name><surname>Eltzschig</surname><given-names>H</given-names></name><name><surname>Eichmann</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Netrin-1 controls sympathetic arterial innervation</article-title><source>The Journal of Clinical Investigation</source><volume>124</volume><fpage>3230</fpage><lpage>3240</lpage><pub-id pub-id-type="doi">10.1172/JCI75181</pub-id><pub-id pub-id-type="pmid">24937433</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cameron</surname><given-names>JS</given-names></name><name><surname>Lhuillier</surname><given-names>L</given-names></name><name><surname>Subramony</surname><given-names>P</given-names></name><name><surname>Dryer</surname><given-names>SE</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Developmental regulation of neuronal K+ channels by target-derived TGF beta in vivo and in vitro</article-title><source>Neuron</source><volume>21</volume><fpage>1045</fpage><lpage>1053</lpage><pub-id pub-id-type="doi">10.1016/s0896-6273(00)80622-4</pub-id><pub-id pub-id-type="pmid">9856460</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cameron</surname><given-names>JS</given-names></name><name><surname>Dryer</surname><given-names>L</given-names></name><name><surname>Dryer</surname><given-names>SE</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>beta -Neuregulin-1 is required for the in vivo development of functional Ca2+-activated K+ channels in parasympathetic neurons</article-title><source>PNAS</source><volume>98</volume><fpage>2832</fpage><lpage>2836</lpage><pub-id pub-id-type="doi">10.1073/pnas.041394098</pub-id><pub-id pub-id-type="pmid">11226326</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carr-Wilkinson</surname><given-names>J</given-names></name><name><surname>Prathalingam</surname><given-names>N</given-names></name><name><surname>Pal</surname><given-names>D</given-names></name><name><surname>Moad</surname><given-names>M</given-names></name><name><surname>Lee</surname><given-names>N</given-names></name><name><surname>Sundaresh</surname><given-names>A</given-names></name><name><surname>Forgham</surname><given-names>H</given-names></name><name><surname>James</surname><given-names>P</given-names></name><name><surname>Herbert</surname><given-names>M</given-names></name><name><surname>Lako</surname><given-names>M</given-names></name><name><surname>Tweddle</surname><given-names>DA</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Differentiation of human embryonic stem cells to sympathetic neurons: a potential model for understanding neuroblastoma pathogenesis</article-title><source>Stem Cells International</source><volume>2018</volume><elocation-id>4391641</elocation-id><pub-id pub-id-type="doi">10.1155/2018/4391641</pub-id><pub-id pub-id-type="pmid">30515222</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaicharoenaudomrung</surname><given-names>N</given-names></name><name><surname>Kunhorm</surname><given-names>P</given-names></name><name><surname>Noisa</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Three-dimensional cell culture systems as an <italic>in vitro</italic> platform for cancer and stem cell modeling</article-title><source>World Journal of Stem Cells</source><volume>11</volume><fpage>1065</fpage><lpage>1083</lpage><pub-id pub-id-type="doi">10.4252/wjsc.v11.i12.1065</pub-id><pub-id pub-id-type="pmid">31875869</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chambers</surname><given-names>SM</given-names></name><name><surname>Fasano</surname><given-names>CA</given-names></name><name><surname>Papapetrou</surname><given-names>EP</given-names></name><name><surname>Tomishima</surname><given-names>M</given-names></name><name><surname>Sadelain</surname><given-names>M</given-names></name><name><surname>Studer</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling</article-title><source>Nature Biotechnology</source><volume>27</volume><fpage>275</fpage><lpage>280</lpage><pub-id pub-id-type="doi">10.1038/nbt.1529</pub-id><pub-id pub-id-type="pmid">19252484</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chambers</surname><given-names>SM</given-names></name><name><surname>Qi</surname><given-names>Y</given-names></name><name><surname>Mica</surname><given-names>Y</given-names></name><name><surname>Lee</surname><given-names>G</given-names></name><name><surname>Zhang</surname><given-names>X-J</given-names></name><name><surname>Niu</surname><given-names>L</given-names></name><name><surname>Bilsland</surname><given-names>J</given-names></name><name><surname>Cao</surname><given-names>L</given-names></name><name><surname>Stevens</surname><given-names>E</given-names></name><name><surname>Whiting</surname><given-names>P</given-names></name><name><surname>Shi</surname><given-names>S-H</given-names></name><name><surname>Studer</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Combined small-molecule inhibition accelerates developmental timing and converts human pluripotent stem cells into nociceptors</article-title><source>Nature Biotechnology</source><volume>30</volume><fpage>715</fpage><lpage>720</lpage><pub-id pub-id-type="doi">10.1038/nbt.2249</pub-id><pub-id pub-id-type="pmid">22750882</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Autonomic dysfunction in Parkinson’s disease: Implications for pathophysiology, diagnosis, and treatment</article-title><source>Neurobiology of Disease</source><volume>134</volume><elocation-id>104700</elocation-id><pub-id pub-id-type="doi">10.1016/j.nbd.2019.104700</pub-id><pub-id pub-id-type="pmid">31809788</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>B</given-names></name><name><surname>Fang</surname><given-names>W</given-names></name><name><surname>Pastor</surname><given-names>S</given-names></name><name><surname>March</surname><given-names>AR</given-names></name><name><surname>Porras</surname><given-names>T</given-names></name><name><surname>Wu</surname><given-names>HW</given-names></name><name><surname>Velez</surname><given-names>M</given-names></name><name><surname>Parekh</surname><given-names>C</given-names></name><name><surname>Maris</surname><given-names>JM</given-names></name><name><surname>Asgharzadeh</surname><given-names>S</given-names></name><name><surname>Huang</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Comparison of human pluripotent stem cell differentiation protocols to generate neuroblastoma tumors</article-title><source>Scientific Reports</source><volume>14</volume><elocation-id>23050</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-024-73947-y</pub-id><pub-id pub-id-type="pmid">39367051</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collins</surname><given-names>F</given-names></name><name><surname>Dawson</surname><given-names>A</given-names></name></person-group><year iso-8601-date="1983">1983</year><article-title>An effect of nerve growth factor on parasympathetic neurite outgrowth</article-title><source>PNAS</source><volume>80</volume><fpage>2091</fpage><lpage>2094</lpage><pub-id pub-id-type="doi">10.1073/pnas.80.7.2091</pub-id><pub-id pub-id-type="pmid">6340114</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crowley</surname><given-names>C</given-names></name><name><surname>Spencer</surname><given-names>SD</given-names></name><name><surname>Nishimura</surname><given-names>MC</given-names></name><name><surname>Chen</surname><given-names>KS</given-names></name><name><surname>Pitts-Meek</surname><given-names>S</given-names></name><name><surname>Armaninl</surname><given-names>MP</given-names></name><name><surname>Ling</surname><given-names>LH</given-names></name><name><surname>McMahon</surname><given-names>SB</given-names></name><name><surname>Shelton</surname><given-names>DL</given-names></name><name><surname>Levinson</surname><given-names>AD</given-names></name><name><surname>Phillips</surname><given-names>HS</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons</article-title><source>Cell</source><volume>76</volume><fpage>1001</fpage><lpage>1011</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(94)90378-6</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Danesin</surname><given-names>C</given-names></name><name><surname>Soula</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Moving the shh source over time: what impact on neural cell diversification in the developing spinal cord?</article-title><source>Journal of Developmental Biology</source><volume>5</volume><elocation-id>4</elocation-id><pub-id pub-id-type="doi">10.3390/jdb5020004</pub-id><pub-id pub-id-type="pmid">29615562</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dasen</surname><given-names>JS</given-names></name><name><surname>Liu</surname><given-names>JP</given-names></name><name><surname>Jessell</surname><given-names>TM</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Motor neuron columnar fate imposed by sequential phases of Hox-c activity</article-title><source>Nature</source><volume>425</volume><fpage>926</fpage><lpage>933</lpage><pub-id pub-id-type="doi">10.1038/nature02051</pub-id><pub-id pub-id-type="pmid">14586461</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Derer</surname><given-names>M</given-names></name><name><surname>Grynszpan-Winograd</surname><given-names>O</given-names></name><name><surname>Portier</surname><given-names>MM</given-names></name></person-group><year iso-8601-date="1989">1989</year><article-title>Immunocytochemical localization of the intermediate filament protein peripherin in adult mouse adrenal chromaffin cells in culture</article-title><source>Neuroscience</source><volume>31</volume><fpage>471</fpage><lpage>477</lpage><pub-id pub-id-type="doi">10.1016/0306-4522(89)90389-8</pub-id><pub-id pub-id-type="pmid">2571956</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>Z</given-names></name><name><surname>Brennan</surname><given-names>A</given-names></name><name><surname>Liu</surname><given-names>N</given-names></name><name><surname>Yarden</surname><given-names>Y</given-names></name><name><surname>Lefkowitz</surname><given-names>G</given-names></name><name><surname>Mirsky</surname><given-names>R</given-names></name><name><surname>Jessen</surname><given-names>KR</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Neu differentiation factor is a neuron-glia signal and regulates survival, proliferation, and maturation of rat Schwann cell precursors</article-title><source>Neuron</source><volume>15</volume><fpage>585</fpage><lpage>596</lpage><pub-id pub-id-type="doi">10.1016/0896-6273(95)90147-7</pub-id><pub-id pub-id-type="pmid">7546738</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durbec</surname><given-names>PL</given-names></name><name><surname>Larsson-Blomberg</surname><given-names>LB</given-names></name><name><surname>Schuchardt</surname><given-names>A</given-names></name><name><surname>Costantini</surname><given-names>F</given-names></name><name><surname>Pachnis</surname><given-names>V</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Common origin and developmental dependence on c-ret of subsets of enteric and sympathetic neuroblasts</article-title><source>Development</source><volume>122</volume><fpage>349</fpage><lpage>358</lpage><pub-id pub-id-type="doi">10.1242/dev.122.1.349</pub-id><pub-id pub-id-type="pmid">8565847</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dyachuk</surname><given-names>V</given-names></name><name><surname>Furlan</surname><given-names>A</given-names></name><name><surname>Shahidi</surname><given-names>MK</given-names></name><name><surname>Giovenco</surname><given-names>M</given-names></name><name><surname>Kaukua</surname><given-names>N</given-names></name><name><surname>Konstantinidou</surname><given-names>C</given-names></name><name><surname>Pachnis</surname><given-names>V</given-names></name><name><surname>Memic</surname><given-names>F</given-names></name><name><surname>Marklund</surname><given-names>U</given-names></name><name><surname>Müller</surname><given-names>T</given-names></name><name><surname>Birchmeier</surname><given-names>C</given-names></name><name><surname>Fried</surname><given-names>K</given-names></name><name><surname>Ernfors</surname><given-names>P</given-names></name><name><surname>Adameyko</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Neurodevelopment: parasympathetic neurons originate from nerve-associated peripheral glial progenitors</article-title><source>Science</source><volume>345</volume><fpage>82</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.1126/science.1253281</pub-id><pub-id pub-id-type="pmid">24925909</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Echelard</surname><given-names>Y</given-names></name><name><surname>Epstein</surname><given-names>DJ</given-names></name><name><surname>St-Jacques</surname><given-names>B</given-names></name><name><surname>Shen</surname><given-names>L</given-names></name><name><surname>Mohler</surname><given-names>J</given-names></name><name><surname>McMahon</surname><given-names>JA</given-names></name><name><surname>McMahon</surname><given-names>AP</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Sonic hedgehog, a member of a family of putative signaling molecules, is implicated in the regulation of CNS polarity</article-title><source>Cell</source><volume>75</volume><fpage>1417</fpage><lpage>1430</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(93)90627-3</pub-id><pub-id pub-id-type="pmid">7916661</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Enomoto</surname><given-names>H</given-names></name><name><surname>Araki</surname><given-names>T</given-names></name><name><surname>Jackman</surname><given-names>A</given-names></name><name><surname>Heuckeroth</surname><given-names>RO</given-names></name><name><surname>Snider</surname><given-names>WD</given-names></name><name><surname>Johnson</surname><given-names>EM</given-names></name><name><surname>Milbrandt</surname><given-names>J</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>GFR alpha1-deficient mice have deficits in the enteric nervous system and kidneys</article-title><source>Neuron</source><volume>21</volume><fpage>317</fpage><lpage>324</lpage><pub-id pub-id-type="doi">10.1016/s0896-6273(00)80541-3</pub-id><pub-id pub-id-type="pmid">9728913</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Enomoto</surname><given-names>H</given-names></name><name><surname>Heuckeroth</surname><given-names>RO</given-names></name><name><surname>Golden</surname><given-names>JP</given-names></name><name><surname>Johnson</surname><given-names>EM</given-names></name><name><surname>Milbrandt</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Development of cranial parasympathetic ganglia requires sequential actions of GDNF and neurturin</article-title><source>Development</source><volume>127</volume><fpage>4877</fpage><lpage>4889</lpage><pub-id pub-id-type="doi">10.1242/dev.127.22.4877</pub-id><pub-id pub-id-type="pmid">11044402</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ernsberger</surname><given-names>U</given-names></name><name><surname>Deller</surname><given-names>T</given-names></name><name><surname>Rohrer</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The diversity of neuronal phenotypes in rodent and human autonomic ganglia</article-title><source>Cell and Tissue Research</source><volume>382</volume><fpage>201</fpage><lpage>231</lpage><pub-id pub-id-type="doi">10.1007/s00441-020-03279-6</pub-id><pub-id pub-id-type="pmid">32930881</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Escudero</surname><given-names>CA</given-names></name><name><surname>Cabeza</surname><given-names>C</given-names></name><name><surname>Moya-Alvarado</surname><given-names>G</given-names></name><name><surname>Maloney</surname><given-names>MT</given-names></name><name><surname>Flores</surname><given-names>CM</given-names></name><name><surname>Wu</surname><given-names>C</given-names></name><name><surname>Court</surname><given-names>FA</given-names></name><name><surname>Mobley</surname><given-names>WC</given-names></name><name><surname>Bronfman</surname><given-names>FC</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>c-Jun N-terminal kinase (JNK)-dependent internalization and Rab5-dependent endocytic sorting mediate long-distance retrograde neuronal death induced by axonal BDNF-p75 signaling</article-title><source>Scientific Reports</source><volume>9</volume><elocation-id>6070</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-019-42420-6</pub-id><pub-id pub-id-type="pmid">30988348</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Espinosa-Medina</surname><given-names>I</given-names></name><name><surname>Outin</surname><given-names>E</given-names></name><name><surname>Picard</surname><given-names>CA</given-names></name><name><surname>Chettouh</surname><given-names>Z</given-names></name><name><surname>Dymecki</surname><given-names>S</given-names></name><name><surname>Consalez</surname><given-names>GG</given-names></name><name><surname>Coppola</surname><given-names>E</given-names></name><name><surname>Brunet</surname><given-names>JF</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Neurodevelopment. Parasympathetic ganglia derive from Schwann cell precursors</article-title><source>Science</source><volume>345</volume><fpage>87</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1126/science.1253286</pub-id><pub-id pub-id-type="pmid">24925912</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Espinosa-Medina</surname><given-names>I</given-names></name><name><surname>Jevans</surname><given-names>B</given-names></name><name><surname>Boismoreau</surname><given-names>F</given-names></name><name><surname>Chettouh</surname><given-names>Z</given-names></name><name><surname>Enomoto</surname><given-names>H</given-names></name><name><surname>Müller</surname><given-names>T</given-names></name><name><surname>Birchmeier</surname><given-names>C</given-names></name><name><surname>Burns</surname><given-names>AJ</given-names></name><name><surname>Brunet</surname><given-names>JF</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Dual origin of enteric neurons in vagal Schwann cell precursors and the sympathetic neural crest</article-title><source>PNAS</source><volume>114</volume><fpage>11980</fpage><lpage>11985</lpage><pub-id pub-id-type="doi">10.1073/pnas.1710308114</pub-id><pub-id pub-id-type="pmid">29078343</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname><given-names>Y</given-names></name><name><surname>Huang</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>F</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Huang</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Zeng</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2024">2024a</year><article-title>Generation of functional and mature sympathetic neurons from human pluripotent stem cells via a neuroepithelial route</article-title><source>Journal of Molecular Neuroscience</source><volume>74</volume><elocation-id>19</elocation-id><pub-id pub-id-type="doi">10.1007/s12031-024-02196-5</pub-id><pub-id pub-id-type="pmid">38358571</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname><given-names>Y</given-names></name><name><surname>Huang</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Wu</surname><given-names>B</given-names></name><name><surname>Zhao</surname><given-names>Q</given-names></name><name><surname>Huang</surname><given-names>L</given-names></name><name><surname>Zheng</surname><given-names>Z</given-names></name><name><surname>Xie</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>W</given-names></name><name><surname>Sun</surname><given-names>J</given-names></name><name><surname>Zhu</surname><given-names>X</given-names></name><name><surname>Zhu</surname><given-names>J</given-names></name><name><surname>Xiang</surname><given-names>AP</given-names></name><name><surname>Li</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2024">2024b</year><article-title>The adipose-neural axis is involved in epicardial adipose tissue-related cardiac arrhythmias</article-title><source>Cell Reports. Medicine</source><volume>5</volume><elocation-id>101559</elocation-id><pub-id pub-id-type="doi">10.1016/j.xcrm.2024.101559</pub-id><pub-id pub-id-type="pmid">38744275</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fattahi</surname><given-names>F</given-names></name><name><surname>Steinbeck</surname><given-names>JA</given-names></name><name><surname>Kriks</surname><given-names>S</given-names></name><name><surname>Tchieu</surname><given-names>J</given-names></name><name><surname>Zimmer</surname><given-names>B</given-names></name><name><surname>Kishinevsky</surname><given-names>S</given-names></name><name><surname>Zeltner</surname><given-names>N</given-names></name><name><surname>Mica</surname><given-names>Y</given-names></name><name><surname>El-Nachef</surname><given-names>W</given-names></name><name><surname>Zhao</surname><given-names>H</given-names></name><name><surname>de Stanchina</surname><given-names>E</given-names></name><name><surname>Gershon</surname><given-names>MD</given-names></name><name><surname>Grikscheit</surname><given-names>TC</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Studer</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Deriving human ENS lineages for cell therapy and drug discovery in Hirschsprung disease</article-title><source>Nature</source><volume>531</volume><fpage>105</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.1038/nature16951</pub-id><pub-id pub-id-type="pmid">26863197</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faure</surname><given-names>S</given-names></name><name><surname>de Santa Barbara</surname><given-names>P</given-names></name><name><surname>Roberts</surname><given-names>DJ</given-names></name><name><surname>Whitman</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Endogenous patterns of BMP signaling during early chick development</article-title><source>Developmental Biology</source><volume>244</volume><fpage>44</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1006/dbio.2002.0579</pub-id><pub-id pub-id-type="pmid">11900458</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fedele</surname><given-names>L</given-names></name><name><surname>Brand</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The intrinsic cardiac nervous system and its role in cardiac pacemaking and conduction</article-title><source>Journal of Cardiovascular Development and Disease</source><volume>7</volume><elocation-id>54</elocation-id><pub-id pub-id-type="doi">10.3390/jcdd7040054</pub-id><pub-id pub-id-type="pmid">33255284</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Florea</surname><given-names>VG</given-names></name><name><surname>Cohn</surname><given-names>JN</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The autonomic nervous system and heart failure</article-title><source>Circulation Research</source><volume>114</volume><fpage>1815</fpage><lpage>1826</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.114.302589</pub-id><pub-id pub-id-type="pmid">24855204</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frith</surname><given-names>TJ</given-names></name><name><surname>Granata</surname><given-names>I</given-names></name><name><surname>Wind</surname><given-names>M</given-names></name><name><surname>Stout</surname><given-names>E</given-names></name><name><surname>Thompson</surname><given-names>O</given-names></name><name><surname>Neumann</surname><given-names>K</given-names></name><name><surname>Stavish</surname><given-names>D</given-names></name><name><surname>Heath</surname><given-names>PR</given-names></name><name><surname>Ortmann</surname><given-names>D</given-names></name><name><surname>Hackland</surname><given-names>JO</given-names></name><name><surname>Anastassiadis</surname><given-names>K</given-names></name><name><surname>Gouti</surname><given-names>M</given-names></name><name><surname>Briscoe</surname><given-names>J</given-names></name><name><surname>Wilson</surname><given-names>V</given-names></name><name><surname>Johnson</surname><given-names>SL</given-names></name><name><surname>Placzek</surname><given-names>M</given-names></name><name><surname>Guarracino</surname><given-names>MR</given-names></name><name><surname>Andrews</surname><given-names>PW</given-names></name><name><surname>Tsakiridis</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Human axial progenitors generate trunk neural crest cells in vitro</article-title><source>eLife</source><volume>7</volume><elocation-id>e35786</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.35786</pub-id><pub-id pub-id-type="pmid">30095409</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frith</surname><given-names>TJR</given-names></name><name><surname>Tsakiridis</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Efficient generation of trunk neural crest and sympathetic neurons from human pluripotent stem cells via a neuromesodermal axial progenitor intermediate</article-title><source>Current Protocols in Stem Cell Biology</source><volume>49</volume><elocation-id>e81</elocation-id><pub-id pub-id-type="doi">10.1002/cpsc.81</pub-id><pub-id pub-id-type="pmid">30688409</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>M</given-names></name><name><surname>Lui</surname><given-names>VCH</given-names></name><name><surname>Sham</surname><given-names>MH</given-names></name><name><surname>Pachnis</surname><given-names>V</given-names></name><name><surname>Tam</surname><given-names>PKH</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Sonic hedgehog regulates the proliferation, differentiation, and migration of enteric neural crest cells in gut</article-title><source>The Journal of Cell Biology</source><volume>166</volume><fpage>673</fpage><lpage>684</lpage><pub-id pub-id-type="doi">10.1083/jcb.200401077</pub-id><pub-id pub-id-type="pmid">15337776</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Furlan</surname><given-names>A</given-names></name><name><surname>La Manno</surname><given-names>G</given-names></name><name><surname>Lübke</surname><given-names>M</given-names></name><name><surname>Häring</surname><given-names>M</given-names></name><name><surname>Abdo</surname><given-names>H</given-names></name><name><surname>Hochgerner</surname><given-names>H</given-names></name><name><surname>Kupari</surname><given-names>J</given-names></name><name><surname>Usoskin</surname><given-names>D</given-names></name><name><surname>Airaksinen</surname><given-names>MS</given-names></name><name><surname>Oliver</surname><given-names>G</given-names></name><name><surname>Linnarsson</surname><given-names>S</given-names></name><name><surname>Ernfors</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Visceral motor neuron diversity delineates a cellular basis for nipple- and pilo-erection muscle control</article-title><source>Nature Neuroscience</source><volume>19</volume><fpage>1331</fpage><lpage>1340</lpage><pub-id pub-id-type="doi">10.1038/nn.4376</pub-id><pub-id pub-id-type="pmid">27571008</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ge</surname><given-names>Y</given-names></name><name><surname>Smits</surname><given-names>AM</given-names></name><name><surname>van Munsteren</surname><given-names>JC</given-names></name><name><surname>Gittenberger-de Groot</surname><given-names>AC</given-names></name><name><surname>Poelmann</surname><given-names>RE</given-names></name><name><surname>van Brakel</surname><given-names>TJ</given-names></name><name><surname>Schalij</surname><given-names>MJ</given-names></name><name><surname>Goumans</surname><given-names>M-J</given-names></name><name><surname>DeRuiter</surname><given-names>MC</given-names></name><name><surname>Jongbloed</surname><given-names>MRM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Human epicardium-derived cells reinforce cardiac sympathetic innervation</article-title><source>Journal of Molecular and Cellular Cardiology</source><volume>143</volume><fpage>26</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1016/j.yjmcc.2020.04.006</pub-id><pub-id pub-id-type="pmid">32277975</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ge</surname><given-names>Y</given-names></name><name><surname>Smits</surname><given-names>AM</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>van Brakel</surname><given-names>TJ</given-names></name><name><surname>Goumans</surname><given-names>M</given-names></name><name><surname>Jongbloed</surname><given-names>MRM</given-names></name><name><surname>de Vries</surname><given-names>AAF</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Generation, characterization, and application of inducible proliferative adult human epicardium-derived cells</article-title><source>Cells</source><volume>10</volume><elocation-id>2064</elocation-id><pub-id pub-id-type="doi">10.3390/cells10082064</pub-id><pub-id pub-id-type="pmid">34440833</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geling</surname><given-names>A</given-names></name><name><surname>Steiner</surname><given-names>H</given-names></name><name><surname>Willem</surname><given-names>M</given-names></name><name><surname>Bally-Cuif</surname><given-names>L</given-names></name><name><surname>Haass</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>A gamma-secretase inhibitor blocks Notch signaling in vivo and causes A severe neurogenic phenotype in zebrafish</article-title><source>EMBO Reports</source><volume>3</volume><fpage>688</fpage><lpage>694</lpage><pub-id pub-id-type="doi">10.1093/embo-reports/kvf124</pub-id><pub-id pub-id-type="pmid">12101103</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giacomelli</surname><given-names>E</given-names></name><name><surname>Meraviglia</surname><given-names>V</given-names></name><name><surname>Campostrini</surname><given-names>G</given-names></name><name><surname>Cochrane</surname><given-names>A</given-names></name><name><surname>Cao</surname><given-names>X</given-names></name><name><surname>van Helden</surname><given-names>RWJ</given-names></name><name><surname>Krotenberg Garcia</surname><given-names>A</given-names></name><name><surname>Mircea</surname><given-names>M</given-names></name><name><surname>Kostidis</surname><given-names>S</given-names></name><name><surname>Davis</surname><given-names>RP</given-names></name><name><surname>van Meer</surname><given-names>BJ</given-names></name><name><surname>Jost</surname><given-names>CR</given-names></name><name><surname>Koster</surname><given-names>AJ</given-names></name><name><surname>Mei</surname><given-names>H</given-names></name><name><surname>Míguez</surname><given-names>DG</given-names></name><name><surname>Mulder</surname><given-names>AA</given-names></name><name><surname>Ledesma-Terrón</surname><given-names>M</given-names></name><name><surname>Pompilio</surname><given-names>G</given-names></name><name><surname>Sala</surname><given-names>L</given-names></name><name><surname>Salvatori</surname><given-names>DCF</given-names></name><name><surname>Slieker</surname><given-names>RC</given-names></name><name><surname>Sommariva</surname><given-names>E</given-names></name><name><surname>de Vries</surname><given-names>AAF</given-names></name><name><surname>Giera</surname><given-names>M</given-names></name><name><surname>Semrau</surname><given-names>S</given-names></name><name><surname>Tertoolen</surname><given-names>LGJ</given-names></name><name><surname>Orlova</surname><given-names>VV</given-names></name><name><surname>Bellin</surname><given-names>M</given-names></name><name><surname>Mummery</surname><given-names>CL</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Human-iPSC-derived cardiac stromal cells enhance maturation in 3d cardiac microtissues and reveal non-cardiomyocyte contributions to heart disease</article-title><source>Cell Stem Cell</source><volume>26</volume><fpage>862</fpage><lpage>879</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2020.05.004</pub-id><pub-id pub-id-type="pmid">32459996</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldsteen</surname><given-names>PA</given-names></name><name><surname>Sabogal Guaqueta</surname><given-names>AM</given-names></name><name><surname>Mulder</surname><given-names>P</given-names></name><name><surname>Bos</surname><given-names>IST</given-names></name><name><surname>Eggens</surname><given-names>M</given-names></name><name><surname>Van der Koog</surname><given-names>L</given-names></name><name><surname>Soeiro</surname><given-names>JT</given-names></name><name><surname>Halayko</surname><given-names>AJ</given-names></name><name><surname>Mathwig</surname><given-names>K</given-names></name><name><surname>Kistemaker</surname><given-names>LEM</given-names></name><name><surname>Verpoorte</surname><given-names>EMJ</given-names></name><name><surname>Dolga</surname><given-names>AM</given-names></name><name><surname>Gosens</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Differentiation and on axon-guidance chip culture of human pluripotent stem cell-derived peripheral cholinergic neurons for airway neurobiology studies</article-title><source>Frontiers in Pharmacology</source><volume>13</volume><elocation-id>991072</elocation-id><pub-id pub-id-type="doi">10.3389/fphar.2022.991072</pub-id><pub-id pub-id-type="pmid">36386177</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomez</surname><given-names>GA</given-names></name><name><surname>Prasad</surname><given-names>MS</given-names></name><name><surname>Wong</surname><given-names>M</given-names></name><name><surname>Charney</surname><given-names>RM</given-names></name><name><surname>Shelar</surname><given-names>PB</given-names></name><name><surname>Sandhu</surname><given-names>N</given-names></name><name><surname>Hackland</surname><given-names>JOS</given-names></name><name><surname>Hernandez</surname><given-names>JC</given-names></name><name><surname>Leung</surname><given-names>AW</given-names></name><name><surname>García-Castro</surname><given-names>MI</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>WNT/β-catenin modulates the axial identity of embryonic stem cell-derived human neural crest</article-title><source>Development</source><volume>146</volume><elocation-id>dev175604</elocation-id><pub-id pub-id-type="doi">10.1242/dev.175604</pub-id><pub-id pub-id-type="pmid">31399472</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonsalvez</surname><given-names>DG</given-names></name><name><surname>Cane</surname><given-names>KN</given-names></name><name><surname>Landman</surname><given-names>KA</given-names></name><name><surname>Enomoto</surname><given-names>H</given-names></name><name><surname>Young</surname><given-names>HM</given-names></name><name><surname>Anderson</surname><given-names>CR</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Proliferation and cell cycle dynamics in the developing stellate ganglion</article-title><source>The Journal of Neuroscience</source><volume>33</volume><fpage>5969</fpage><lpage>5979</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4350-12.2013</pub-id><pub-id pub-id-type="pmid">23554478</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gouti</surname><given-names>M</given-names></name><name><surname>Delile</surname><given-names>J</given-names></name><name><surname>Stamataki</surname><given-names>D</given-names></name><name><surname>Wymeersch</surname><given-names>FJ</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Kleinjung</surname><given-names>J</given-names></name><name><surname>Wilson</surname><given-names>V</given-names></name><name><surname>Briscoe</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A gene regulatory network balances neural and mesoderm specification during vertebrate trunk development</article-title><source>Developmental Cell</source><volume>41</volume><fpage>243</fpage><lpage>261</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2017.04.002</pub-id><pub-id pub-id-type="pmid">28457792</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hackland</surname><given-names>JOS</given-names></name><name><surname>Frith</surname><given-names>TJR</given-names></name><name><surname>Thompson</surname><given-names>O</given-names></name><name><surname>Marin Navarro</surname><given-names>A</given-names></name><name><surname>Garcia-Castro</surname><given-names>MI</given-names></name><name><surname>Unger</surname><given-names>C</given-names></name><name><surname>Andrews</surname><given-names>PW</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Top-down inhibition of BMP signaling enables robust induction of hpscs into neural crest in fully defined, xeno-free conditions</article-title><source>Stem Cell Reports</source><volume>9</volume><fpage>1043</fpage><lpage>1052</lpage><pub-id pub-id-type="doi">10.1016/j.stemcr.2017.08.008</pub-id><pub-id pub-id-type="pmid">28919261</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hackland</surname><given-names>JOS</given-names></name><name><surname>Shelar</surname><given-names>PB</given-names></name><name><surname>Sandhu</surname><given-names>N</given-names></name><name><surname>Prasad</surname><given-names>MS</given-names></name><name><surname>Charney</surname><given-names>RM</given-names></name><name><surname>Gomez</surname><given-names>GA</given-names></name><name><surname>Frith</surname><given-names>TJR</given-names></name><name><surname>García-Castro</surname><given-names>MI</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>FGF modulates the axial identity of trunk hPSC-derived neural crest but not the cranial-trunk decision</article-title><source>Stem Cell Reports</source><volume>12</volume><fpage>920</fpage><lpage>933</lpage><pub-id pub-id-type="doi">10.1016/j.stemcr.2019.04.015</pub-id><pub-id pub-id-type="pmid">31091435</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanani</surname><given-names>M</given-names></name><name><surname>Spray</surname><given-names>DC</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Emerging importance of satellite glia in nervous system function and dysfunction</article-title><source>Nature Reviews. Neuroscience</source><volume>21</volume><fpage>485</fpage><lpage>498</lpage><pub-id pub-id-type="doi">10.1038/s41583-020-0333-z</pub-id><pub-id pub-id-type="pmid">32699292</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harlaar</surname><given-names>N</given-names></name><name><surname>Dekker</surname><given-names>SO</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Snabel</surname><given-names>RR</given-names></name><name><surname>Veldkamp</surname><given-names>MW</given-names></name><name><surname>Verkerk</surname><given-names>AO</given-names></name><name><surname>Fabres</surname><given-names>CC</given-names></name><name><surname>Schwach</surname><given-names>V</given-names></name><name><surname>Lerink</surname><given-names>LJS</given-names></name><name><surname>Rivaud</surname><given-names>MR</given-names></name><name><surname>Mulder</surname><given-names>AA</given-names></name><name><surname>Corver</surname><given-names>WE</given-names></name><name><surname>Goumans</surname><given-names>MJTH</given-names></name><name><surname>Dobrev</surname><given-names>D</given-names></name><name><surname>Klautz</surname><given-names>RJM</given-names></name><name><surname>Schalij</surname><given-names>MJ</given-names></name><name><surname>Veenstra</surname><given-names>GJC</given-names></name><name><surname>Passier</surname><given-names>R</given-names></name><name><surname>van Brakel</surname><given-names>TJ</given-names></name><name><surname>Pijnappels</surname><given-names>DA</given-names></name><name><surname>de Vries</surname><given-names>AAF</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Conditional immortalization of human atrial myocytes for the generation of in vitro models of atrial fibrillation</article-title><source>Nature Biomedical Engineering</source><volume>6</volume><fpage>389</fpage><lpage>402</lpage><pub-id pub-id-type="doi">10.1038/s41551-021-00827-5</pub-id><pub-id pub-id-type="pmid">34992271</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heanue</surname><given-names>TA</given-names></name><name><surname>Pachnis</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Expression profiling the developing mammalian enteric nervous system identifies marker and candidate Hirschsprung disease genes</article-title><source>PNAS</source><volume>103</volume><fpage>6919</fpage><lpage>6924</lpage><pub-id pub-id-type="doi">10.1073/pnas.0602152103</pub-id><pub-id pub-id-type="pmid">16632597</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heuckeroth</surname><given-names>RO</given-names></name><name><surname>Enomoto</surname><given-names>H</given-names></name><name><surname>Grider</surname><given-names>JR</given-names></name><name><surname>Golden</surname><given-names>JP</given-names></name><name><surname>Hanke</surname><given-names>JA</given-names></name><name><surname>Jackman</surname><given-names>A</given-names></name><name><surname>Molliver</surname><given-names>DC</given-names></name><name><surname>Bardgett</surname><given-names>ME</given-names></name><name><surname>Snider</surname><given-names>WD</given-names></name><name><surname>Johnson</surname><given-names>EM</given-names></name><name><surname>Milbrandt</surname><given-names>J</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Gene targeting reveals a critical role for neurturin in the development and maintenance of enteric, sensory, and parasympathetic neurons</article-title><source>Neuron</source><volume>22</volume><fpage>253</fpage><lpage>263</lpage><pub-id pub-id-type="doi">10.1016/s0896-6273(00)81087-9</pub-id><pub-id pub-id-type="pmid">10069332</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hildreth</surname><given-names>V</given-names></name><name><surname>Webb</surname><given-names>S</given-names></name><name><surname>Bradshaw</surname><given-names>L</given-names></name><name><surname>Brown</surname><given-names>NA</given-names></name><name><surname>Anderson</surname><given-names>RH</given-names></name><name><surname>Henderson</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Cells migrating from the neural crest contribute to the innervation of the venous pole of the heart</article-title><source>Journal of Anatomy</source><volume>212</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1111/j.1469-7580.2007.00833.x</pub-id><pub-id pub-id-type="pmid">18031480</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Home</surname><given-names>P</given-names></name><name><surname>Ray</surname><given-names>S</given-names></name><name><surname>Dutta</surname><given-names>D</given-names></name><name><surname>Bronshteyn</surname><given-names>I</given-names></name><name><surname>Larson</surname><given-names>M</given-names></name><name><surname>Paul</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>GATA3 is selectively expressed in the trophectoderm of peri-implantation embryo and directly regulates Cdx2 gene expression</article-title><source>The Journal of Biological Chemistry</source><volume>284</volume><fpage>28729</fpage><lpage>28737</lpage><pub-id pub-id-type="doi">10.1074/jbc.M109.016840</pub-id><pub-id pub-id-type="pmid">19700764</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Honma</surname><given-names>Y</given-names></name><name><surname>Araki</surname><given-names>T</given-names></name><name><surname>Gianino</surname><given-names>S</given-names></name><name><surname>Bruce</surname><given-names>A</given-names></name><name><surname>Heuckeroth</surname><given-names>R</given-names></name><name><surname>Johnson</surname><given-names>E</given-names></name><name><surname>Milbrandt</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Artemin is a vascular-derived neurotropic factor for developing sympathetic neurons</article-title><source>Neuron</source><volume>35</volume><fpage>267</fpage><lpage>282</lpage><pub-id pub-id-type="doi">10.1016/s0896-6273(02)00774-2</pub-id><pub-id pub-id-type="pmid">12160745</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>M</given-names></name><name><surname>Miller</surname><given-names>ML</given-names></name><name><surname>McHenry</surname><given-names>LK</given-names></name><name><surname>Zheng</surname><given-names>T</given-names></name><name><surname>Zhen</surname><given-names>Q</given-names></name><name><surname>Ilkhanizadeh</surname><given-names>S</given-names></name><name><surname>Conklin</surname><given-names>BR</given-names></name><name><surname>Bronner</surname><given-names>ME</given-names></name><name><surname>Weiss</surname><given-names>WA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Generating trunk neural crest from human pluripotent stem cells</article-title><source>Scientific Reports</source><volume>6</volume><elocation-id>19727</elocation-id><pub-id pub-id-type="doi">10.1038/srep19727</pub-id><pub-id pub-id-type="pmid">26812940</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hulme</surname><given-names>AJ</given-names></name><name><surname>Maksour</surname><given-names>S</given-names></name><name><surname>St-Clair Glover</surname><given-names>M</given-names></name><name><surname>Miellet</surname><given-names>S</given-names></name><name><surname>Dottori</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Making neurons, made easy: The use of Neurogenin-2 in neuronal differentiation</article-title><source>Stem Cell Reports</source><volume>17</volume><fpage>14</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1016/j.stemcr.2021.11.015</pub-id><pub-id pub-id-type="pmid">34971564</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ieda</surname><given-names>M</given-names></name><name><surname>Kanazawa</surname><given-names>H</given-names></name><name><surname>Kimura</surname><given-names>K</given-names></name><name><surname>Hattori</surname><given-names>F</given-names></name><name><surname>Ieda</surname><given-names>Y</given-names></name><name><surname>Taniguchi</surname><given-names>M</given-names></name><name><surname>Lee</surname><given-names>J-K</given-names></name><name><surname>Matsumura</surname><given-names>K</given-names></name><name><surname>Tomita</surname><given-names>Y</given-names></name><name><surname>Miyoshi</surname><given-names>S</given-names></name><name><surname>Shimoda</surname><given-names>K</given-names></name><name><surname>Makino</surname><given-names>S</given-names></name><name><surname>Sano</surname><given-names>M</given-names></name><name><surname>Kodama</surname><given-names>I</given-names></name><name><surname>Ogawa</surname><given-names>S</given-names></name><name><surname>Fukuda</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Sema3a maintains normal heart rhythm through sympathetic innervation patterning</article-title><source>Nature Medicine</source><volume>13</volume><fpage>604</fpage><lpage>612</lpage><pub-id pub-id-type="doi">10.1038/nm1570</pub-id><pub-id pub-id-type="pmid">17417650</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inman</surname><given-names>GJ</given-names></name><name><surname>Nicolás</surname><given-names>FJ</given-names></name><name><surname>Callahan</surname><given-names>JF</given-names></name><name><surname>Harling</surname><given-names>JD</given-names></name><name><surname>Gaster</surname><given-names>LM</given-names></name><name><surname>Reith</surname><given-names>AD</given-names></name><name><surname>Laping</surname><given-names>NJ</given-names></name><name><surname>Hill</surname><given-names>CS</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7</article-title><source>Molecular Pharmacology</source><volume>62</volume><fpage>65</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1124/mol.62.1.65</pub-id><pub-id pub-id-type="pmid">12065756</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Irioka</surname><given-names>T</given-names></name><name><surname>Watanabe</surname><given-names>K</given-names></name><name><surname>Mizusawa</surname><given-names>H</given-names></name><name><surname>Mizuseki</surname><given-names>K</given-names></name><name><surname>Sasai</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Distinct effects of caudalizing factors on regional specification of embryonic stem cell-derived neural precursors</article-title><source>Brain Research. Developmental Brain Research</source><volume>154</volume><fpage>63</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1016/j.devbrainres.2004.10.004</pub-id><pub-id pub-id-type="pmid">15617756</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Javali</surname><given-names>A</given-names></name><name><surname>Misra</surname><given-names>A</given-names></name><name><surname>Leonavicius</surname><given-names>K</given-names></name><name><surname>Acharyya</surname><given-names>D</given-names></name><name><surname>Vyas</surname><given-names>B</given-names></name><name><surname>Sambasivan</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Co-expression of Tbx6 and Sox2 identifies a novel transient neuromesoderm progenitor cell state</article-title><source>Development</source><volume>144</volume><fpage>4522</fpage><lpage>4529</lpage><pub-id pub-id-type="doi">10.1242/dev.153262</pub-id><pub-id pub-id-type="pmid">29084802</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karbassi</surname><given-names>E</given-names></name><name><surname>Fenix</surname><given-names>A</given-names></name><name><surname>Marchiano</surname><given-names>S</given-names></name><name><surname>Muraoka</surname><given-names>N</given-names></name><name><surname>Nakamura</surname><given-names>K</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Murry</surname><given-names>CE</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Cardiomyocyte maturation: advances in knowledge and implications for regenerative medicine</article-title><source>Nature Reviews. Cardiology</source><volume>17</volume><fpage>341</fpage><lpage>359</lpage><pub-id pub-id-type="doi">10.1038/s41569-019-0331-x</pub-id><pub-id pub-id-type="pmid">32015528</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kasemeier-Kulesa</surname><given-names>JC</given-names></name><name><surname>Bradley</surname><given-names>R</given-names></name><name><surname>Pasquale</surname><given-names>EB</given-names></name><name><surname>Lefcort</surname><given-names>F</given-names></name><name><surname>Kulesa</surname><given-names>PM</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Eph/ephrins and N-cadherin coordinate to control the pattern of sympathetic ganglia</article-title><source>Development</source><volume>133</volume><fpage>4839</fpage><lpage>4847</lpage><pub-id pub-id-type="doi">10.1242/dev.02662</pub-id><pub-id pub-id-type="pmid">17108003</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kasemeier-Kulesa</surname><given-names>JC</given-names></name><name><surname>Morrison</surname><given-names>JA</given-names></name><name><surname>Lefcort</surname><given-names>F</given-names></name><name><surname>Kulesa</surname><given-names>PM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>TrkB/BDNF signalling patterns the sympathetic nervous system</article-title><source>Nature Communications</source><volume>6</volume><elocation-id>8281</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms9281</pub-id><pub-id pub-id-type="pmid">26404565</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawasaki</surname><given-names>H</given-names></name><name><surname>Mizuseki</surname><given-names>K</given-names></name><name><surname>Nishikawa</surname><given-names>S</given-names></name><name><surname>Kaneko</surname><given-names>S</given-names></name><name><surname>Kuwana</surname><given-names>Y</given-names></name><name><surname>Nakanishi</surname><given-names>S</given-names></name><name><surname>Nishikawa</surname><given-names>SI</given-names></name><name><surname>Sasai</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity</article-title><source>Neuron</source><volume>28</volume><fpage>31</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1016/s0896-6273(00)00083-0</pub-id><pub-id pub-id-type="pmid">11086981</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawasaki</surname><given-names>T</given-names></name><name><surname>Bekku</surname><given-names>Y</given-names></name><name><surname>Suto</surname><given-names>F</given-names></name><name><surname>Kitsukawa</surname><given-names>T</given-names></name><name><surname>Taniguchi</surname><given-names>M</given-names></name><name><surname>Nagatsu</surname><given-names>I</given-names></name><name><surname>Nagatsu</surname><given-names>T</given-names></name><name><surname>Itoh</surname><given-names>K</given-names></name><name><surname>Yagi</surname><given-names>T</given-names></name><name><surname>Fujisawa</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Requirement of neuropilin 1-mediated Sema3A signals in patterning of the sympathetic nervous system</article-title><source>Development</source><volume>129</volume><fpage>671</fpage><lpage>680</lpage><pub-id pub-id-type="doi">10.1242/dev.129.3.671</pub-id><pub-id pub-id-type="pmid">11830568</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirino</surname><given-names>K</given-names></name><name><surname>Nakahata</surname><given-names>T</given-names></name><name><surname>Taguchi</surname><given-names>T</given-names></name><name><surname>Saito</surname><given-names>MK</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Efficient derivation of sympathetic neurons from human pluripotent stem cells with a defined condition</article-title><source>Scientific Reports</source><volume>8</volume><elocation-id>12865</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-018-31256-1</pub-id><pub-id pub-id-type="pmid">30150715</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knosp</surname><given-names>WM</given-names></name><name><surname>Knox</surname><given-names>SM</given-names></name><name><surname>Lombaert</surname><given-names>IMA</given-names></name><name><surname>Haddox</surname><given-names>CL</given-names></name><name><surname>Patel</surname><given-names>VN</given-names></name><name><surname>Hoffman</surname><given-names>MP</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Submandibular parasympathetic gangliogenesis requires sprouty-dependent Wnt signals from epithelial progenitors</article-title><source>Developmental Cell</source><volume>32</volume><fpage>667</fpage><lpage>677</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2015.01.023</pub-id><pub-id pub-id-type="pmid">25805134</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koszinowski</surname><given-names>S</given-names></name><name><surname>Boerries</surname><given-names>M</given-names></name><name><surname>Busch</surname><given-names>H</given-names></name><name><surname>Krieglstein</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>RARβ regulates neuronal cell death and differentiation in the avian ciliary ganglion</article-title><source>Developmental Neurobiology</source><volume>75</volume><fpage>1204</fpage><lpage>1218</lpage><pub-id pub-id-type="doi">10.1002/dneu.22278</pub-id><pub-id pub-id-type="pmid">25663354</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kruepunga</surname><given-names>N</given-names></name><name><surname>Hikspoors</surname><given-names>JPJM</given-names></name><name><surname>Hülsman</surname><given-names>CJM</given-names></name><name><surname>Mommen</surname><given-names>GMC</given-names></name><name><surname>Köhler</surname><given-names>SE</given-names></name><name><surname>Lamers</surname><given-names>WH</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Development of the sympathetic trunks in human embryos</article-title><source>Journal of Anatomy</source><volume>239</volume><fpage>32</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1111/joa.13415</pub-id><pub-id pub-id-type="pmid">33641166</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuruvilla</surname><given-names>R</given-names></name><name><surname>Zweifel</surname><given-names>LS</given-names></name><name><surname>Glebova</surname><given-names>NO</given-names></name><name><surname>Lonze</surname><given-names>BE</given-names></name><name><surname>Valdez</surname><given-names>G</given-names></name><name><surname>Ye</surname><given-names>H</given-names></name><name><surname>Ginty</surname><given-names>DD</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>A neurotrophin signaling cascade coordinates sympathetic neuron development through differential control of TrkA trafficking and retrograde signaling</article-title><source>Cell</source><volume>118</volume><fpage>243</fpage><lpage>255</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2004.06.021</pub-id><pub-id pub-id-type="pmid">15260993</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Landis</surname><given-names>SC</given-names></name><name><surname>Jackson</surname><given-names>PC</given-names></name><name><surname>Fredieu</surname><given-names>JR</given-names></name><name><surname>Thibault</surname><given-names>J</given-names></name></person-group><year iso-8601-date="1987">1987</year><article-title>Catecholaminergic properties of cholinergic neurons and synapses in adult rat ciliary ganglion</article-title><source>The Journal of Neuroscience</source><volume>7</volume><fpage>3574</fpage><lpage>3587</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.07-11-03574.1987</pub-id><pub-id pub-id-type="pmid">2890721</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langsdorf</surname><given-names>A</given-names></name><name><surname>Radzikinas</surname><given-names>K</given-names></name><name><surname>Kroten</surname><given-names>A</given-names></name><name><surname>Jain</surname><given-names>S</given-names></name><name><surname>Ai</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Neural crest cell origin and signals for intrinsic neurogenesis in the mammalian respiratory tract</article-title><source>American Journal of Respiratory Cell and Molecular Biology</source><volume>44</volume><fpage>293</fpage><lpage>301</lpage><pub-id pub-id-type="doi">10.1165/rcmb.2009-0462OC</pub-id><pub-id pub-id-type="pmid">20139349</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laurikainen</surname><given-names>A</given-names></name><name><surname>Hiltunen</surname><given-names>JO</given-names></name><name><surname>Thomas-Crusells</surname><given-names>J</given-names></name><name><surname>Vanhatalo</surname><given-names>S</given-names></name><name><surname>Arumäe</surname><given-names>U</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Neurturin is a neurotrophic factor for penile parasympathetic neurons in adult rat</article-title><source>Journal of Neurobiology</source><volume>43</volume><fpage>198</fpage><lpage>205</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1097-4695(200005)43:2&lt;198::AID-NEU9&gt;3.0.CO;2-D</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>HY</given-names></name><name><surname>Kléber</surname><given-names>M</given-names></name><name><surname>Hari</surname><given-names>L</given-names></name><name><surname>Brault</surname><given-names>V</given-names></name><name><surname>Suter</surname><given-names>U</given-names></name><name><surname>Taketo</surname><given-names>MM</given-names></name><name><surname>Kemler</surname><given-names>R</given-names></name><name><surname>Sommer</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Instructive role of Wnt/beta-catenin in sensory fate specification in neural crest stem cells</article-title><source>Science</source><volume>303</volume><fpage>1020</fpage><lpage>1023</lpage><pub-id pub-id-type="doi">10.1126/science.1091611</pub-id><pub-id pub-id-type="pmid">14716020</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Yao</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Shen</surname><given-names>L</given-names></name><name><surname>Rao</surname><given-names>Z</given-names></name><name><surname>Yuan</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>F</given-names></name><name><surname>Han</surname><given-names>S</given-names></name><name><surname>Geng</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Cheng</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Conversion of astrocytes and fibroblasts into functional noradrenergic neurons</article-title><source>Cell Reports</source><volume>28</volume><fpage>682</fpage><lpage>697</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2019.06.042</pub-id><pub-id pub-id-type="pmid">31315047</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>N</given-names></name><name><surname>Edel</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>K</given-names></name><name><surname>Denning</surname><given-names>C</given-names></name><name><surname>Betts</surname><given-names>J</given-names></name><name><surname>Neely</surname><given-names>OC</given-names></name><name><surname>Li</surname><given-names>D</given-names></name><name><surname>Paterson</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Human induced pluripotent stem cell-derived cardiac myocytes and sympathetic neurons in disease modelling</article-title><source>Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences</source><volume>378</volume><elocation-id>20220173</elocation-id><pub-id pub-id-type="doi">10.1098/rstb.2022.0173</pub-id><pub-id pub-id-type="pmid">37122212</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lippmann</surname><given-names>ES</given-names></name><name><surname>Williams</surname><given-names>CE</given-names></name><name><surname>Ruhl</surname><given-names>DA</given-names></name><name><surname>Estevez-Silva</surname><given-names>MC</given-names></name><name><surname>Chapman</surname><given-names>ER</given-names></name><name><surname>Coon</surname><given-names>JJ</given-names></name><name><surname>Ashton</surname><given-names>RS</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Deterministic HOX patterning in human pluripotent stem cell-derived neuroectoderm</article-title><source>Stem Cell Reports</source><volume>4</volume><fpage>632</fpage><lpage>644</lpage><pub-id pub-id-type="doi">10.1016/j.stemcr.2015.02.018</pub-id><pub-id pub-id-type="pmid">25843047</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Xiang</surname><given-names>K</given-names></name><name><surname>Yuan</surname><given-names>F</given-names></name><name><surname>Xiang</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Generation of self-organized autonomic ganglion organoids from fibroblasts</article-title><source>iScience</source><volume>26</volume><elocation-id>106241</elocation-id><pub-id pub-id-type="doi">10.1016/j.isci.2023.106241</pub-id><pub-id pub-id-type="pmid">36922996</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Makita</surname><given-names>T</given-names></name><name><surname>Sucov</surname><given-names>HM</given-names></name><name><surname>Gariepy</surname><given-names>CE</given-names></name><name><surname>Yanagisawa</surname><given-names>M</given-names></name><name><surname>Ginty</surname><given-names>DD</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Endothelins are vascular-derived axonal guidance cues for developing sympathetic neurons</article-title><source>Nature</source><volume>452</volume><fpage>759</fpage><lpage>763</lpage><pub-id pub-id-type="doi">10.1038/nature06859</pub-id><pub-id pub-id-type="pmid">18401410</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mallo</surname><given-names>M</given-names></name><name><surname>Wellik</surname><given-names>DM</given-names></name><name><surname>Deschamps</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Hox genes and regional patterning of the vertebrate body plan</article-title><source>Developmental Biology</source><volume>344</volume><fpage>7</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2010.04.024</pub-id><pub-id pub-id-type="pmid">20435029</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manousiouthakis</surname><given-names>E</given-names></name><name><surname>Mendez</surname><given-names>M</given-names></name><name><surname>Garner</surname><given-names>MC</given-names></name><name><surname>Exertier</surname><given-names>P</given-names></name><name><surname>Makita</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Venous endothelin guides sympathetic innervation of the developing mouse heart</article-title><source>Nature Communications</source><volume>5</volume><elocation-id>3918</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms4918</pub-id><pub-id pub-id-type="pmid">24875861</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mapps</surname><given-names>AA</given-names></name><name><surname>Thomsen</surname><given-names>MB</given-names></name><name><surname>Boehm</surname><given-names>E</given-names></name><name><surname>Zhao</surname><given-names>H</given-names></name><name><surname>Hattar</surname><given-names>S</given-names></name><name><surname>Kuruvilla</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Diversity of satellite glia in sympathetic and sensory ganglia</article-title><source>Cell Reports</source><volume>38</volume><elocation-id>110328</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2022.110328</pub-id><pub-id pub-id-type="pmid">35108545</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martik</surname><given-names>ML</given-names></name><name><surname>Bronner</surname><given-names>ME</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Regulatory logic underlying diversification of the neural crest</article-title><source>Trends in Genetics</source><volume>33</volume><fpage>715</fpage><lpage>727</lpage><pub-id pub-id-type="doi">10.1016/j.tig.2017.07.015</pub-id><pub-id pub-id-type="pmid">28851604</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mateos-Aparicio</surname><given-names>P</given-names></name><name><surname>Bello</surname><given-names>SA</given-names></name><name><surname>Rodríguez-Moreno</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Challenges in physiological phenotyping of hipsc-derived neurons: from 2d cultures to 3d brain organoids</article-title><source>Frontiers in Cell and Developmental Biology</source><volume>8</volume><elocation-id>797</elocation-id><pub-id pub-id-type="doi">10.3389/fcell.2020.00797</pub-id><pub-id pub-id-type="pmid">32984317</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McKinnon</surname><given-names>ML</given-names></name><name><surname>Tian</surname><given-names>K</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Sokoloff</surname><given-names>AJ</given-names></name><name><surname>Galvin</surname><given-names>ML</given-names></name><name><surname>Choi</surname><given-names>MH</given-names></name><name><surname>Prinz</surname><given-names>A</given-names></name><name><surname>Hochman</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Dramatically amplified thoracic sympathetic postganglionic excitability and integrative capacity revealed with whole-cell patch-clamp recordings</article-title><source>eNeuro</source><volume>6</volume><elocation-id>ENEURO.0433-18.2019</elocation-id><pub-id pub-id-type="doi">10.1523/ENEURO.0433-18.2019</pub-id><pub-id pub-id-type="pmid">31040159</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mica</surname><given-names>Y</given-names></name><name><surname>Lee</surname><given-names>G</given-names></name><name><surname>Chambers</surname><given-names>SM</given-names></name><name><surname>Tomishima</surname><given-names>MJ</given-names></name><name><surname>Studer</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Modeling neural crest induction, melanocyte specification, and disease-related pigmentation defects in hESCs and patient-specific iPSCs</article-title><source>Cell Reports</source><volume>3</volume><fpage>1140</fpage><lpage>1152</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2013.03.025</pub-id><pub-id pub-id-type="pmid">23583175</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohammadi</surname><given-names>M</given-names></name><name><surname>McMahon</surname><given-names>G</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name><name><surname>Tang</surname><given-names>C</given-names></name><name><surname>Hirth</surname><given-names>P</given-names></name><name><surname>Yeh</surname><given-names>BK</given-names></name><name><surname>Hubbard</surname><given-names>SR</given-names></name><name><surname>Schlessinger</surname><given-names>J</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors</article-title><source>Science</source><volume>276</volume><fpage>955</fpage><lpage>960</lpage><pub-id pub-id-type="doi">10.1126/science.276.5314.955</pub-id><pub-id pub-id-type="pmid">9139660</pub-id></element-citation></ref><ref id="bib102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname><given-names>MW</given-names></name><name><surname>Klein</surname><given-names>RD</given-names></name><name><surname>Fariñas</surname><given-names>I</given-names></name><name><surname>Sauer</surname><given-names>H</given-names></name><name><surname>Armanini</surname><given-names>M</given-names></name><name><surname>Phillips</surname><given-names>H</given-names></name><name><surname>Reichardt</surname><given-names>LF</given-names></name><name><surname>Ryan</surname><given-names>AM</given-names></name><name><surname>Carver-Moore</surname><given-names>K</given-names></name><name><surname>Rosenthal</surname><given-names>A</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Renal and neuronal abnormalities in mice lacking GDNF</article-title><source>Nature</source><volume>382</volume><fpage>76</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1038/382076a0</pub-id><pub-id pub-id-type="pmid">8657308</pub-id></element-citation></ref><ref id="bib103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morikawa</surname><given-names>Y</given-names></name><name><surname>Maska</surname><given-names>E</given-names></name><name><surname>Brody</surname><given-names>H</given-names></name><name><surname>Cserjesi</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Sonic hedgehog signaling is required for sympathetic nervous system development</article-title><source>Neuroreport</source><volume>20</volume><fpage>684</fpage><lpage>688</lpage><pub-id pub-id-type="doi">10.1097/WNR.0b013e32832a1e6d</pub-id><pub-id pub-id-type="pmid">19349918</pub-id></element-citation></ref><ref id="bib104"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moss</surname><given-names>A</given-names></name><name><surname>Robbins</surname><given-names>S</given-names></name><name><surname>Achanta</surname><given-names>S</given-names></name><name><surname>Kuttippurathu</surname><given-names>L</given-names></name><name><surname>Turick</surname><given-names>S</given-names></name><name><surname>Nieves</surname><given-names>S</given-names></name><name><surname>Hanna</surname><given-names>P</given-names></name><name><surname>Smith</surname><given-names>EH</given-names></name><name><surname>Hoover</surname><given-names>DB</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Cheng</surname><given-names>ZJ</given-names></name><name><surname>Ardell</surname><given-names>JL</given-names></name><name><surname>Shivkumar</surname><given-names>K</given-names></name><name><surname>Schwaber</surname><given-names>JS</given-names></name><name><surname>Vadigepalli</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>A single cell transcriptomics map of paracrine networks in the intrinsic cardiac nervous system</article-title><source>iScience</source><volume>24</volume><elocation-id>102713</elocation-id><pub-id pub-id-type="doi">10.1016/j.isci.2021.102713</pub-id><pub-id pub-id-type="pmid">34337356</pub-id></element-citation></ref><ref id="bib105"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Müller</surname><given-names>F</given-names></name><name><surname>Rohrer</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Molecular control of ciliary neuron development: BMPs and downstream transcriptional control in the parasympathetic lineage</article-title><source>Development</source><volume>129</volume><fpage>5707</fpage><lpage>5717</lpage><pub-id pub-id-type="doi">10.1242/dev.00165</pub-id><pub-id pub-id-type="pmid">12421710</pub-id></element-citation></ref><ref id="bib106"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muñoz-Bravo</surname><given-names>JL</given-names></name><name><surname>Hidalgo-Figueroa</surname><given-names>M</given-names></name><name><surname>Pascual</surname><given-names>A</given-names></name><name><surname>López-Barneo</surname><given-names>J</given-names></name><name><surname>Leal-Cerro</surname><given-names>A</given-names></name><name><surname>Cano</surname><given-names>DA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>GDNF is required for neural colonization of the pancreas</article-title><source>Development</source><volume>140</volume><fpage>3669</fpage><lpage>3679</lpage><pub-id pub-id-type="doi">10.1242/dev.091256</pub-id><pub-id pub-id-type="pmid">23903190</pub-id></element-citation></ref><ref id="bib107"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newbern</surname><given-names>J</given-names></name><name><surname>Birchmeier</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Nrg1/ErbB signaling networks in Schwann cell development and myelination</article-title><source>Seminars in Cell &amp; Developmental Biology</source><volume>21</volume><fpage>922</fpage><lpage>928</lpage><pub-id pub-id-type="doi">10.1016/j.semcdb.2010.08.008</pub-id><pub-id pub-id-type="pmid">20832498</pub-id></element-citation></ref><ref id="bib108"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oh</surname><given-names>Y</given-names></name><name><surname>Cho</surname><given-names>GS</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Hong</surname><given-names>I</given-names></name><name><surname>Zhu</surname><given-names>R</given-names></name><name><surname>Kim</surname><given-names>MJ</given-names></name><name><surname>Kim</surname><given-names>YJ</given-names></name><name><surname>Tampakakis</surname><given-names>E</given-names></name><name><surname>Tung</surname><given-names>L</given-names></name><name><surname>Huganir</surname><given-names>R</given-names></name><name><surname>Dong</surname><given-names>X</given-names></name><name><surname>Kwon</surname><given-names>C</given-names></name><name><surname>Lee</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Functional coupling with cardiac muscle promotes maturation of hPSC-derived sympathetic neurons</article-title><source>Cell Stem Cell</source><volume>19</volume><fpage>95</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2016.05.002</pub-id><pub-id pub-id-type="pmid">27320040</pub-id></element-citation></ref><ref id="bib109"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olivera-Martinez</surname><given-names>I</given-names></name><name><surname>Harada</surname><given-names>H</given-names></name><name><surname>Halley</surname><given-names>PA</given-names></name><name><surname>Storey</surname><given-names>KG</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Loss of FGF-dependent mesoderm identity and rise of endogenous retinoid signalling determine cessation of body axis elongation</article-title><source>PLOS Biology</source><volume>10</volume><elocation-id>e1001415</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.1001415</pub-id><pub-id pub-id-type="pmid">23118616</pub-id></element-citation></ref><ref id="bib110"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Rahilly</surname><given-names>R</given-names></name><name><surname>Müller</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>The development of the neural crest in the human</article-title><source>Journal of Anatomy</source><volume>211</volume><fpage>335</fpage><lpage>351</lpage><pub-id pub-id-type="doi">10.1111/j.1469-7580.2007.00773.x</pub-id><pub-id pub-id-type="pmid">17848161</pub-id></element-citation></ref><ref id="bib111"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ouzzani</surname><given-names>M</given-names></name><name><surname>Hammady</surname><given-names>H</given-names></name><name><surname>Fedorowicz</surname><given-names>Z</given-names></name><name><surname>Elmagarmid</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Rayyan-a web and mobile app for systematic reviews</article-title><source>Systematic Reviews</source><volume>5</volume><elocation-id>210</elocation-id><pub-id pub-id-type="doi">10.1186/s13643-016-0384-4</pub-id><pub-id pub-id-type="pmid">27919275</pub-id></element-citation></ref><ref id="bib112"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Page</surname><given-names>MJ</given-names></name><name><surname>McKenzie</surname><given-names>JE</given-names></name><name><surname>Bossuyt</surname><given-names>PM</given-names></name><name><surname>Boutron</surname><given-names>I</given-names></name><name><surname>Hoffmann</surname><given-names>TC</given-names></name><name><surname>Mulrow</surname><given-names>CD</given-names></name><name><surname>Shamseer</surname><given-names>L</given-names></name><name><surname>Tetzlaff</surname><given-names>JM</given-names></name><name><surname>Akl</surname><given-names>EA</given-names></name><name><surname>Brennan</surname><given-names>SE</given-names></name><name><surname>Chou</surname><given-names>R</given-names></name><name><surname>Glanville</surname><given-names>J</given-names></name><name><surname>Grimshaw</surname><given-names>JM</given-names></name><name><surname>Hróbjartsson</surname><given-names>A</given-names></name><name><surname>Lalu</surname><given-names>MM</given-names></name><name><surname>Li</surname><given-names>T</given-names></name><name><surname>Loder</surname><given-names>EW</given-names></name><name><surname>Mayo-Wilson</surname><given-names>E</given-names></name><name><surname>McDonald</surname><given-names>S</given-names></name><name><surname>McGuinness</surname><given-names>LA</given-names></name><name><surname>Stewart</surname><given-names>LA</given-names></name><name><surname>Thomas</surname><given-names>J</given-names></name><name><surname>Tricco</surname><given-names>AC</given-names></name><name><surname>Welch</surname><given-names>VA</given-names></name><name><surname>Whiting</surname><given-names>P</given-names></name><name><surname>Moher</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The PRISMA 2020 statement: an updated guideline for reporting systematic reviews</article-title><source>BMJ</source><volume>372</volume><elocation-id>n71</elocation-id><pub-id pub-id-type="doi">10.1136/bmj.n71</pub-id><pub-id pub-id-type="pmid">33782057</pub-id></element-citation></ref><ref id="bib113"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patthey</surname><given-names>C</given-names></name><name><surname>Edlund</surname><given-names>T</given-names></name><name><surname>Gunhaga</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Wnt-regulated temporal control of BMP exposure directs the choice between neural plate border and epidermal fate</article-title><source>Development</source><volume>136</volume><fpage>73</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1242/dev.025890</pub-id><pub-id pub-id-type="pmid">19060333</pub-id></element-citation></ref><ref id="bib114"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pera</surname><given-names>MF</given-names></name><name><surname>Andrade</surname><given-names>J</given-names></name><name><surname>Houssami</surname><given-names>S</given-names></name><name><surname>Reubinoff</surname><given-names>B</given-names></name><name><surname>Trounson</surname><given-names>A</given-names></name><name><surname>Stanley</surname><given-names>EG</given-names></name><name><surname>Ward-van Oostwaard</surname><given-names>D</given-names></name><name><surname>Mummery</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Regulation of human embryonic stem cell differentiation by BMP-2 and its antagonist noggin</article-title><source>Journal of Cell Science</source><volume>117</volume><fpage>1269</fpage><lpage>1280</lpage><pub-id pub-id-type="doi">10.1242/jcs.00970</pub-id><pub-id pub-id-type="pmid">14996946</pub-id></element-citation></ref><ref id="bib115"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Percie du Sert</surname><given-names>N</given-names></name><name><surname>Hurst</surname><given-names>V</given-names></name><name><surname>Ahluwalia</surname><given-names>A</given-names></name><name><surname>Alam</surname><given-names>S</given-names></name><name><surname>Avey</surname><given-names>MT</given-names></name><name><surname>Baker</surname><given-names>M</given-names></name><name><surname>Browne</surname><given-names>WJ</given-names></name><name><surname>Clark</surname><given-names>A</given-names></name><name><surname>Cuthill</surname><given-names>IC</given-names></name><name><surname>Dirnagl</surname><given-names>U</given-names></name><name><surname>Emerson</surname><given-names>M</given-names></name><name><surname>Garner</surname><given-names>P</given-names></name><name><surname>Holgate</surname><given-names>ST</given-names></name><name><surname>Howells</surname><given-names>DW</given-names></name><name><surname>Karp</surname><given-names>NA</given-names></name><name><surname>Lazic</surname><given-names>SE</given-names></name><name><surname>Lidster</surname><given-names>K</given-names></name><name><surname>MacCallum</surname><given-names>CJ</given-names></name><name><surname>Macleod</surname><given-names>M</given-names></name><name><surname>Pearl</surname><given-names>EJ</given-names></name><name><surname>Petersen</surname><given-names>OH</given-names></name><name><surname>Rawle</surname><given-names>F</given-names></name><name><surname>Reynolds</surname><given-names>P</given-names></name><name><surname>Rooney</surname><given-names>K</given-names></name><name><surname>Sena</surname><given-names>ES</given-names></name><name><surname>Silberberg</surname><given-names>SD</given-names></name><name><surname>Steckler</surname><given-names>T</given-names></name><name><surname>Würbel</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research</article-title><source>PLOS Biology</source><volume>18</volume><elocation-id>e3000410</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.3000410</pub-id><pub-id pub-id-type="pmid">32663219</pub-id></element-citation></ref><ref id="bib116"><element-citation publication-type="patent"><person-group person-group-type="inventor"><name><surname>Price</surname><given-names>P</given-names></name><name><surname>Tilkins</surname><given-names>ML</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Embryonic stem cell serum replacement</article-title><patent country="Switzerland">PCT/US98/00467</patent><source>International patent</source><ext-link ext-link-type="uri" xlink:href="https://patents.google.com/patent/WO1998030679A1/en">https://patents.google.com/patent/WO1998030679A1/en</ext-link></element-citation></ref><ref id="bib117"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Radzikinas</surname><given-names>K</given-names></name><name><surname>Aven</surname><given-names>L</given-names></name><name><surname>Jiang</surname><given-names>Z</given-names></name><name><surname>Tran</surname><given-names>T</given-names></name><name><surname>Paez-Cortez</surname><given-names>J</given-names></name><name><surname>Boppidi</surname><given-names>K</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Fine</surname><given-names>A</given-names></name><name><surname>Ai</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>A Shh/miR-206/BDNF cascade coordinates innervation and formation of airway smooth muscle</article-title><source>The Journal of Neuroscience</source><volume>31</volume><fpage>15407</fpage><lpage>15415</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2745-11.2011</pub-id><pub-id pub-id-type="pmid">22031887</pub-id></element-citation></ref><ref id="bib118"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reissmann</surname><given-names>E</given-names></name><name><surname>Ernsberger</surname><given-names>U</given-names></name><name><surname>Francis-West</surname><given-names>PH</given-names></name><name><surname>Rueger</surname><given-names>D</given-names></name><name><surname>Brickell</surname><given-names>PM</given-names></name><name><surname>Rohrer</surname><given-names>H</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Involvement of bone morphogenetic protein-4 and bone morphogenetic protein-7 in the differentiation of the adrenergic phenotype in developing sympathetic neurons</article-title><source>Development</source><volume>122</volume><fpage>2079</fpage><lpage>2088</lpage><pub-id pub-id-type="doi">10.1242/dev.122.7.2079</pub-id><pub-id pub-id-type="pmid">8681789</pub-id></element-citation></ref><ref id="bib119"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rickmann</surname><given-names>M</given-names></name><name><surname>Fawcett</surname><given-names>JW</given-names></name><name><surname>Keynes</surname><given-names>RJ</given-names></name></person-group><year iso-8601-date="1985">1985</year><article-title>The migration of neural crest cells and the growth of motor axons through the rostral half of the chick somite</article-title><source>Journal of Embryology and Experimental Morphology</source><volume>90</volume><fpage>437</fpage><lpage>455</lpage><pub-id pub-id-type="pmid">3834038</pub-id></element-citation></ref><ref id="bib120"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>NB</given-names></name><name><surname>Krieger</surname><given-names>K</given-names></name><name><surname>Khan</surname><given-names>FM</given-names></name><name><surname>Huffman</surname><given-names>W</given-names></name><name><surname>Chang</surname><given-names>M</given-names></name><name><surname>Naik</surname><given-names>A</given-names></name><name><surname>Yongle</surname><given-names>R</given-names></name><name><surname>Hameed</surname><given-names>I</given-names></name><name><surname>Krieger</surname><given-names>K</given-names></name><name><surname>Girardi</surname><given-names>LN</given-names></name><name><surname>Gaudino</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The current state of animal models in research: A review</article-title><source>International Journal of Surgery</source><volume>72</volume><fpage>9</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1016/j.ijsu.2019.10.015</pub-id><pub-id pub-id-type="pmid">31627013</pub-id></element-citation></ref><ref id="bib121"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodrigo Albors</surname><given-names>A</given-names></name><name><surname>Halley</surname><given-names>PA</given-names></name><name><surname>Storey</surname><given-names>KG</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Lineage tracing of axial progenitors using Nkx1-2CreER<sup>T2</sup> mice defines their trunk and tail contributions</article-title><source>Development</source><volume>145</volume><elocation-id>dev164319</elocation-id><pub-id pub-id-type="doi">10.1242/dev.164319</pub-id><pub-id pub-id-type="pmid">30201686</pub-id></element-citation></ref><ref id="bib122"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romano</surname><given-names>R</given-names></name><name><surname>Del Fiore</surname><given-names>VS</given-names></name><name><surname>Bucci</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Role of the intermediate filament protein peripherin in health and disease</article-title><source>International Journal of Molecular Sciences</source><volume>23</volume><elocation-id>15416</elocation-id><pub-id pub-id-type="doi">10.3390/ijms232315416</pub-id><pub-id pub-id-type="pmid">36499746</pub-id></element-citation></ref><ref id="bib123"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saito</surname><given-names>D</given-names></name><name><surname>Takase</surname><given-names>Y</given-names></name><name><surname>Murai</surname><given-names>H</given-names></name><name><surname>Takahashi</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The dorsal aorta initiates a molecular cascade that instructs sympatho-adrenal specification</article-title><source>Science</source><volume>336</volume><fpage>1578</fpage><lpage>1581</lpage><pub-id pub-id-type="doi">10.1126/science.1222369</pub-id><pub-id pub-id-type="pmid">22723422</pub-id></element-citation></ref><ref id="bib124"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saito-Diaz</surname><given-names>K</given-names></name><name><surname>Wu</surname><given-names>HF</given-names></name><name><surname>Zeltner</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Autonomic neurons with sympathetic character derived from human pluripotent stem cells</article-title><source>Current Protocols in Stem Cell Biology</source><volume>49</volume><elocation-id>e78</elocation-id><pub-id pub-id-type="doi">10.1002/cpsc.78</pub-id><pub-id pub-id-type="pmid">30702809</pub-id></element-citation></ref><ref id="bib125"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saldana-Guerrero</surname><given-names>IM</given-names></name><name><surname>Montano-Gutierrez</surname><given-names>LF</given-names></name><name><surname>Boswell</surname><given-names>K</given-names></name><name><surname>Hafemeister</surname><given-names>C</given-names></name><name><surname>Poon</surname><given-names>E</given-names></name><name><surname>Shaw</surname><given-names>LE</given-names></name><name><surname>Stavish</surname><given-names>D</given-names></name><name><surname>Lea</surname><given-names>RA</given-names></name><name><surname>Wernig-Zorc</surname><given-names>S</given-names></name><name><surname>Bozsaky</surname><given-names>E</given-names></name><name><surname>Fetahu</surname><given-names>IS</given-names></name><name><surname>Zoescher</surname><given-names>P</given-names></name><name><surname>Pötschger</surname><given-names>U</given-names></name><name><surname>Bernkopf</surname><given-names>M</given-names></name><name><surname>Wenninger-Weinzierl</surname><given-names>A</given-names></name><name><surname>Sturtzel</surname><given-names>C</given-names></name><name><surname>Souilhol</surname><given-names>C</given-names></name><name><surname>Tarelli</surname><given-names>S</given-names></name><name><surname>Shoeb</surname><given-names>MR</given-names></name><name><surname>Bozatzi</surname><given-names>P</given-names></name><name><surname>Rados</surname><given-names>M</given-names></name><name><surname>Guarini</surname><given-names>M</given-names></name><name><surname>Buri</surname><given-names>MC</given-names></name><name><surname>Weninger</surname><given-names>W</given-names></name><name><surname>Putz</surname><given-names>EM</given-names></name><name><surname>Huang</surname><given-names>M</given-names></name><name><surname>Ladenstein</surname><given-names>R</given-names></name><name><surname>Andrews</surname><given-names>PW</given-names></name><name><surname>Barbaric</surname><given-names>I</given-names></name><name><surname>Cresswell</surname><given-names>GD</given-names></name><name><surname>Bryant</surname><given-names>HE</given-names></name><name><surname>Distel</surname><given-names>M</given-names></name><name><surname>Chesler</surname><given-names>L</given-names></name><name><surname>Taschner-Mandl</surname><given-names>S</given-names></name><name><surname>Farlik</surname><given-names>M</given-names></name><name><surname>Tsakiridis</surname><given-names>A</given-names></name><name><surname>Halbritter</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>A human neural crest model reveals the developmental impact of neuroblastoma-associated chromosomal aberrations</article-title><source>Nature Communications</source><volume>15</volume><elocation-id>3745</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-024-47945-7</pub-id><pub-id pub-id-type="pmid">38702304</pub-id></element-citation></ref><ref id="bib126"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saleh</surname><given-names>MA</given-names></name><name><surname>Amer-Sarsour</surname><given-names>F</given-names></name><name><surname>Berant</surname><given-names>A</given-names></name><name><surname>Pasmanik-Chor</surname><given-names>M</given-names></name><name><surname>Kobo</surname><given-names>H</given-names></name><name><surname>Sharabi</surname><given-names>Y</given-names></name><name><surname>Vatine</surname><given-names>GD</given-names></name><name><surname>Ashkenazi</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Chronic and acute exposure to rotenone reveals distinct Parkinson’s disease-related phenotypes in human iPSC-derived peripheral neurons</article-title><source>Free Radical Biology &amp; Medicine</source><volume>213</volume><fpage>164</fpage><lpage>173</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2024.01.016</pub-id><pub-id pub-id-type="pmid">38246514</pub-id></element-citation></ref><ref id="bib127"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneider</surname><given-names>C</given-names></name><name><surname>Wicht</surname><given-names>H</given-names></name><name><surname>Enderich</surname><given-names>J</given-names></name><name><surname>Wegner</surname><given-names>M</given-names></name><name><surname>Rohrer</surname><given-names>H</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Bone morphogenetic proteins are required in vivo for the generation of sympathetic neurons</article-title><source>Neuron</source><volume>24</volume><fpage>861</fpage><lpage>870</lpage><pub-id pub-id-type="doi">10.1016/s0896-6273(00)81033-8</pub-id><pub-id pub-id-type="pmid">10624949</pub-id></element-citation></ref><ref id="bib128"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schulz</surname><given-names>KF</given-names></name><name><surname>Altman</surname><given-names>DG</given-names></name><name><surname>Moher</surname><given-names>D</given-names></name><collab>CONSORT Group</collab></person-group><year iso-8601-date="2010">2010</year><article-title>CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials</article-title><source>BMJ</source><volume>340</volume><elocation-id>c332</elocation-id><pub-id pub-id-type="doi">10.1136/bmj.c332</pub-id><pub-id pub-id-type="pmid">20332509</pub-id></element-citation></ref><ref id="bib129"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwartz</surname><given-names>CM</given-names></name><name><surname>Tavakoli</surname><given-names>T</given-names></name><name><surname>Jamias</surname><given-names>C</given-names></name><name><surname>Park</surname><given-names>S-S</given-names></name><name><surname>Maudsley</surname><given-names>S</given-names></name><name><surname>Martin</surname><given-names>B</given-names></name><name><surname>Phillips</surname><given-names>TM</given-names></name><name><surname>Yao</surname><given-names>PJ</given-names></name><name><surname>Itoh</surname><given-names>K</given-names></name><name><surname>Ma</surname><given-names>W</given-names></name><name><surname>Rao</surname><given-names>MS</given-names></name><name><surname>Arenas</surname><given-names>E</given-names></name><name><surname>Mattson</surname><given-names>MP</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Stromal factors SDF1α, sFRP1, and VEGFD induce dopaminergic neuron differentiation of human pluripotent stem cells</article-title><source>Journal of Neuroscience Research</source><volume>90</volume><fpage>1367</fpage><lpage>1381</lpage><pub-id pub-id-type="doi">10.1002/jnr.23064</pub-id><pub-id pub-id-type="pmid">22535492</pub-id></element-citation></ref><ref id="bib130"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scott-Solomon</surname><given-names>E</given-names></name><name><surname>Boehm</surname><given-names>E</given-names></name><name><surname>Kuruvilla</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The sympathetic nervous system in development and disease</article-title><source>Nature Reviews. Neuroscience</source><volume>22</volume><fpage>685</fpage><lpage>702</lpage><pub-id pub-id-type="doi">10.1038/s41583-021-00523-y</pub-id><pub-id pub-id-type="pmid">34599308</pub-id></element-citation></ref><ref id="bib131"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serbedzija</surname><given-names>GN</given-names></name><name><surname>Fraser</surname><given-names>SE</given-names></name><name><surname>Bronner-Fraser</surname><given-names>M</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>Pathways of trunk neural crest cell migration in the mouse embryo as revealed by vital dye labelling</article-title><source>Development</source><volume>108</volume><fpage>605</fpage><lpage>612</lpage><pub-id pub-id-type="doi">10.1242/dev.108.4.605</pub-id><pub-id pub-id-type="pmid">2387238</pub-id></element-citation></ref><ref id="bib132"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname><given-names>NM</given-names></name><name><surname>Groves</surname><given-names>AK</given-names></name><name><surname>Anderson</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Alternative neural crest cell fates are instructively promoted by TGFbeta superfamily members</article-title><source>Cell</source><volume>85</volume><fpage>331</fpage><lpage>343</lpage><pub-id pub-id-type="doi">10.1016/s0092-8674(00)81112-5</pub-id><pub-id pub-id-type="pmid">8616889</pub-id></element-citation></ref><ref id="bib133"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaker</surname><given-names>MR</given-names></name><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Kim</surname><given-names>KH</given-names></name><name><surname>Ban</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>VJ</given-names></name><name><surname>Kim</surname><given-names>JY</given-names></name><name><surname>Lee</surname><given-names>JY</given-names></name><name><surname>Sun</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Spatiotemporal contribution of neuromesodermal progenitor-derived neural cells in the elongation of developing mouse spinal cord</article-title><source>Life Sciences</source><volume>282</volume><elocation-id>119393</elocation-id><pub-id pub-id-type="doi">10.1016/j.lfs.2021.119393</pub-id><pub-id pub-id-type="pmid">34004249</pub-id></element-citation></ref><ref id="bib134"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shelton</surname><given-names>DL</given-names></name><name><surname>Reichardt</surname><given-names>LF</given-names></name></person-group><year iso-8601-date="1984">1984</year><article-title>Expression of the beta-nerve growth factor gene correlates with the density of sympathetic innervation in effector organs</article-title><source>PNAS</source><volume>81</volume><fpage>7951</fpage><lpage>7955</lpage><pub-id pub-id-type="doi">10.1073/pnas.81.24.7951</pub-id><pub-id pub-id-type="pmid">6595669</pub-id></element-citation></ref><ref id="bib135"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>MJ</given-names></name><name><surname>Zipes</surname><given-names>DP</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Role of the autonomic nervous system in modulating cardiac arrhythmias</article-title><source>Circulation Research</source><volume>114</volume><fpage>1004</fpage><lpage>1021</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.113.302549</pub-id><pub-id pub-id-type="pmid">24625726</pub-id></element-citation></ref><ref id="bib136"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheng</surname><given-names>G</given-names></name><name><surname>Stern</surname><given-names>CD</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Gata2 and Gata3: novel markers for early embryonic polarity and for non-neural ectoderm in the chick embryo</article-title><source>Mechanisms of Development</source><volume>87</volume><fpage>213</fpage><lpage>216</lpage><pub-id pub-id-type="doi">10.1016/s0925-4773(99)00150-1</pub-id><pub-id pub-id-type="pmid">10495290</pub-id></element-citation></ref><ref id="bib137"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shtukmaster</surname><given-names>S</given-names></name><name><surname>Huber</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>The role of the Notch signalling pathway in regulating the balance between neuronal and nonneuronal cells in sympathetic ganglia and the adrenal gland</article-title><source>PLOS ONE</source><volume>18</volume><elocation-id>e0281486</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0281486</pub-id><pub-id pub-id-type="pmid">36795650</pub-id></element-citation></ref><ref id="bib138"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>KK</given-names></name><name><surname>Park</surname><given-names>KJ</given-names></name><name><surname>Hong</surname><given-names>EJ</given-names></name><name><surname>Kramer</surname><given-names>BM</given-names></name><name><surname>Greenberg</surname><given-names>ME</given-names></name><name><surname>Kaplan</surname><given-names>DR</given-names></name><name><surname>Miller</surname><given-names>FD</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Developmental axon pruning mediated by BDNF-p75NTR-dependent axon degeneration</article-title><source>Nature Neuroscience</source><volume>11</volume><fpage>649</fpage><lpage>658</lpage><pub-id pub-id-type="doi">10.1038/nn.2114</pub-id><pub-id pub-id-type="pmid">18382462</pub-id></element-citation></ref><ref id="bib139"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Solovieva</surname><given-names>T</given-names></name><name><surname>Bronner</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Schwann cell precursors: Where they come from and where they go</article-title><source>Cells &amp; Development</source><volume>166</volume><elocation-id>203686</elocation-id><pub-id pub-id-type="doi">10.1016/j.cdev.2021.203686</pub-id><pub-id pub-id-type="pmid">33994354</pub-id></element-citation></ref><ref id="bib140"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stern</surname><given-names>CD</given-names></name><name><surname>Artinger</surname><given-names>KB</given-names></name><name><surname>Bronner-Fraser</surname><given-names>M</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Tissue interactions affecting the migration and differentiation of neural crest cells in the chick embryo</article-title><source>Development</source><volume>113</volume><fpage>207</fpage><lpage>216</lpage><pub-id pub-id-type="doi">10.1242/dev.113.1.207</pub-id><pub-id pub-id-type="pmid">1764996</pub-id></element-citation></ref><ref id="bib141"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stöckli</surname><given-names>KA</given-names></name><name><surname>Lottspeich</surname><given-names>F</given-names></name><name><surname>Sendtner</surname><given-names>M</given-names></name><name><surname>Masiakowski</surname><given-names>P</given-names></name><name><surname>Carroll</surname><given-names>P</given-names></name><name><surname>Götz</surname><given-names>R</given-names></name><name><surname>Lindholm</surname><given-names>D</given-names></name><name><surname>Thoenen</surname><given-names>H</given-names></name></person-group><year iso-8601-date="1989">1989</year><article-title>Molecular cloning, expression and regional distribution of rat ciliary neurotrophic factor</article-title><source>Nature</source><volume>342</volume><fpage>920</fpage><lpage>923</lpage><pub-id pub-id-type="doi">10.1038/342920a0</pub-id><pub-id pub-id-type="pmid">2594085</pub-id></element-citation></ref><ref id="bib142"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stuhlmiller</surname><given-names>TJ</given-names></name><name><surname>García-Castro</surname><given-names>MI</given-names></name></person-group><year iso-8601-date="2012">2012a</year><article-title>Current perspectives of the signaling pathways directing neural crest induction</article-title><source>Cellular and Molecular Life Sciences</source><volume>69</volume><fpage>3715</fpage><lpage>3737</lpage><pub-id pub-id-type="doi">10.1007/s00018-012-0991-8</pub-id><pub-id pub-id-type="pmid">22547091</pub-id></element-citation></ref><ref id="bib143"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stuhlmiller</surname><given-names>TJ</given-names></name><name><surname>García-Castro</surname><given-names>MI</given-names></name></person-group><year iso-8601-date="2012">2012b</year><article-title>FGF/MAPK signaling is required in the gastrula epiblast for avian neural crest induction</article-title><source>Development</source><volume>139</volume><fpage>289</fpage><lpage>300</lpage><pub-id pub-id-type="doi">10.1242/dev.070276</pub-id><pub-id pub-id-type="pmid">22129830</pub-id></element-citation></ref><ref id="bib144"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swoap</surname><given-names>SJ</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Wess</surname><given-names>J</given-names></name><name><surname>Parsons</surname><given-names>AD</given-names></name><name><surname>Williams</surname><given-names>TD</given-names></name><name><surname>Overton</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Vagal tone dominates autonomic control of mouse heart rate at thermoneutrality</article-title><source>American Journal of Physiology. Heart and Circulatory Physiology</source><volume>294</volume><fpage>H1581</fpage><lpage>H1588</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.01000.2007</pub-id><pub-id pub-id-type="pmid">18245567</pub-id></element-citation></ref><ref id="bib145"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>K</given-names></name><name><surname>Tanabe</surname><given-names>K</given-names></name><name><surname>Ohnuki</surname><given-names>M</given-names></name><name><surname>Narita</surname><given-names>M</given-names></name><name><surname>Ichisaka</surname><given-names>T</given-names></name><name><surname>Tomoda</surname><given-names>K</given-names></name><name><surname>Yamanaka</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Induction of pluripotent stem cells from adult human fibroblasts by defined factors</article-title><source>Cell</source><volume>131</volume><fpage>861</fpage><lpage>872</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2007.11.019</pub-id><pub-id pub-id-type="pmid">18035408</pub-id></element-citation></ref><ref id="bib146"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takaki</surname><given-names>F</given-names></name><name><surname>Nakamuta</surname><given-names>N</given-names></name><name><surname>Kusakabe</surname><given-names>T</given-names></name><name><surname>Yamamoto</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Sympathetic and sensory innervation of small intensely fluorescent (SIF) cells in rat superior cervical ganglion</article-title><source>Cell and Tissue Research</source><volume>359</volume><fpage>441</fpage><lpage>451</lpage><pub-id pub-id-type="doi">10.1007/s00441-014-2051-1</pub-id><pub-id pub-id-type="pmid">25416508</pub-id></element-citation></ref><ref id="bib147"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takayama</surname><given-names>Y</given-names></name><name><surname>Kushige</surname><given-names>H</given-names></name><name><surname>Akagi</surname><given-names>Y</given-names></name><name><surname>Suzuki</surname><given-names>Y</given-names></name><name><surname>Kumagai</surname><given-names>Y</given-names></name><name><surname>Kida</surname><given-names>YS</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Selective induction of human autonomic neurons enables precise control of cardiomyocyte beating</article-title><source>Scientific Reports</source><volume>10</volume><elocation-id>9464</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-020-66303-3</pub-id><pub-id pub-id-type="pmid">32528170</pub-id></element-citation></ref><ref id="bib148"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takayama</surname><given-names>Y</given-names></name><name><surname>Akagi</surname><given-names>Y</given-names></name><name><surname>Kida</surname><given-names>YS</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Deciphering the molecular mechanisms of autonomic nervous system neuron induction through integrative bioinformatics analysis</article-title><source>International Journal of Molecular Sciences</source><volume>24</volume><elocation-id>9053</elocation-id><pub-id pub-id-type="doi">10.3390/ijms24109053</pub-id><pub-id pub-id-type="pmid">37240399</pub-id></element-citation></ref><ref id="bib149"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teitelman</surname><given-names>G</given-names></name><name><surname>Baker</surname><given-names>H</given-names></name><name><surname>Joh</surname><given-names>TH</given-names></name><name><surname>Reis</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="1979">1979</year><article-title>Appearance of catecholamine-synthesizing enzymes during development of rat sympathetic nervous system: possible role of tissue environment</article-title><source>PNAS</source><volume>76</volume><fpage>509</fpage><lpage>513</lpage><pub-id pub-id-type="doi">10.1073/pnas.76.1.509</pub-id><pub-id pub-id-type="pmid">34153</pub-id></element-citation></ref><ref id="bib150"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thawani</surname><given-names>A</given-names></name><name><surname>Groves</surname><given-names>AK</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Building the border: development of the chordate neural plate border region and its derivatives</article-title><source>Frontiers in Physiology</source><volume>11</volume><elocation-id>608880</elocation-id><pub-id pub-id-type="doi">10.3389/fphys.2020.608880</pub-id><pub-id pub-id-type="pmid">33364980</pub-id></element-citation></ref><ref id="bib151"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomson</surname><given-names>JA</given-names></name><name><surname>Itskovitz-Eldor</surname><given-names>J</given-names></name><name><surname>Shapiro</surname><given-names>SS</given-names></name><name><surname>Waknitz</surname><given-names>MA</given-names></name><name><surname>Swiergiel</surname><given-names>JJ</given-names></name><name><surname>Marshall</surname><given-names>VS</given-names></name><name><surname>Jones</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Embryonic stem cell lines derived from human blastocysts</article-title><source>Science</source><volume>282</volume><fpage>1145</fpage><lpage>1147</lpage><pub-id pub-id-type="doi">10.1126/science.282.5391.1145</pub-id><pub-id pub-id-type="pmid">9804556</pub-id></element-citation></ref><ref id="bib152"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tiveron</surname><given-names>MC</given-names></name><name><surname>Hirsch</surname><given-names>MR</given-names></name><name><surname>Brunet</surname><given-names>JF</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>The expression pattern of the transcription factor Phox2 delineates synaptic pathways of the autonomic nervous system</article-title><source>The Journal of Neuroscience</source><volume>16</volume><fpage>7649</fpage><lpage>7660</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.16-23-07649.1996</pub-id><pub-id pub-id-type="pmid">8922421</pub-id></element-citation></ref><ref id="bib153"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tom</surname><given-names>FP</given-names></name><name><surname>Songte</surname><given-names>K</given-names></name><name><surname>Rae</surname><given-names>N</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Overexpression of ciliary neurotrophic factor in vivo rescues chick ciliary ganglion neurons from cell death</article-title><source>Journal of Neurobiology</source><volume>34</volume><fpage>283</fpage><lpage>293</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1097-4695(19980215)34:3&lt;283::AID-NEU7&gt;3.0.CO;2-Z</pub-id></element-citation></ref><ref id="bib154"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Troy</surname><given-names>CM</given-names></name><name><surname>Brown</surname><given-names>K</given-names></name><name><surname>Greene</surname><given-names>LA</given-names></name><name><surname>Shelanski</surname><given-names>ML</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>Ontogeny of the neuronal intermediate filament protein, peripherin, in the mouse embryo</article-title><source>Neuroscience</source><volume>36</volume><fpage>217</fpage><lpage>237</lpage><pub-id pub-id-type="doi">10.1016/0306-4522(90)90364-a</pub-id><pub-id pub-id-type="pmid">2215919</pub-id></element-citation></ref><ref id="bib155"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsarovina</surname><given-names>K</given-names></name><name><surname>Schellenberger</surname><given-names>J</given-names></name><name><surname>Schneider</surname><given-names>C</given-names></name><name><surname>Rohrer</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Progenitor cell maintenance and neurogenesis in sympathetic ganglia involves Notch signaling</article-title><source>Molecular and Cellular Neurosciences</source><volume>37</volume><fpage>20</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1016/j.mcn.2007.08.010</pub-id><pub-id pub-id-type="pmid">17920293</pub-id></element-citation></ref><ref id="bib156"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Haver</surname><given-names>S</given-names></name><name><surname>Fan</surname><given-names>Y</given-names></name><name><surname>Bekaert</surname><given-names>SL</given-names></name><name><surname>Everaert</surname><given-names>C</given-names></name><name><surname>Van Loocke</surname><given-names>W</given-names></name><name><surname>Zanzani</surname><given-names>V</given-names></name><name><surname>Deschildre</surname><given-names>J</given-names></name><name><surname>Maestre</surname><given-names>IF</given-names></name><name><surname>Amaro</surname><given-names>A</given-names></name><name><surname>Vermeirssen</surname><given-names>V</given-names></name><name><surname>De Preter</surname><given-names>K</given-names></name><name><surname>Zhou</surname><given-names>T</given-names></name><name><surname>Kentsis</surname><given-names>A</given-names></name><name><surname>Studer</surname><given-names>L</given-names></name><name><surname>Speleman</surname><given-names>F</given-names></name><name><surname>Roberts</surname><given-names>SS</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Human iPSC modeling recapitulates <italic>in vivo</italic> sympathoadrenal development and reveals an aberrant developmental subpopulation in familial neuroblastoma</article-title><source>iScience</source><volume>27</volume><elocation-id>108096</elocation-id><pub-id pub-id-type="doi">10.1016/j.isci.2023.108096</pub-id><pub-id pub-id-type="pmid">38222111</pub-id></element-citation></ref><ref id="bib157"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verberne</surname><given-names>ME</given-names></name><name><surname>Gittenberger-de Groot</surname><given-names>AC</given-names></name><name><surname>Poelmann</surname><given-names>RE</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Lineage and development of the parasympathetic nervous system of the embryonic chick heart</article-title><source>Anatomy and Embryology</source><volume>198</volume><fpage>171</fpage><lpage>184</lpage><pub-id pub-id-type="doi">10.1007/s004290050175</pub-id><pub-id pub-id-type="pmid">9764972</pub-id></element-citation></ref><ref id="bib158"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verdi</surname><given-names>JM</given-names></name><name><surname>Anderson</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Neurotrophins regulate sequential changes in neurotrophin receptor expression by sympathetic neuroblasts</article-title><source>Neuron</source><volume>13</volume><fpage>1359</fpage><lpage>1372</lpage><pub-id pub-id-type="doi">10.1016/0896-6273(94)90421-9</pub-id><pub-id pub-id-type="pmid">7993627</pub-id></element-citation></ref><ref id="bib159"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vinik</surname><given-names>AI</given-names></name><name><surname>Maser</surname><given-names>RE</given-names></name><name><surname>Mitchell</surname><given-names>BD</given-names></name><name><surname>Freeman</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Diabetic autonomic neuropathy</article-title><source>Diabetes Care</source><volume>26</volume><fpage>1553</fpage><lpage>1579</lpage><pub-id pub-id-type="doi">10.2337/diacare.26.5.1553</pub-id><pub-id pub-id-type="pmid">12716821</pub-id></element-citation></ref><ref id="bib160"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weeke-Klimp</surname><given-names>A</given-names></name><name><surname>Bax</surname><given-names>NAM</given-names></name><name><surname>Bellu</surname><given-names>AR</given-names></name><name><surname>Winter</surname><given-names>EM</given-names></name><name><surname>Vrolijk</surname><given-names>J</given-names></name><name><surname>Plantinga</surname><given-names>J</given-names></name><name><surname>Maas</surname><given-names>S</given-names></name><name><surname>Brinker</surname><given-names>M</given-names></name><name><surname>Mahtab</surname><given-names>EAF</given-names></name><name><surname>Gittenberger-de Groot</surname><given-names>AC</given-names></name><name><surname>van Luyn</surname><given-names>MJA</given-names></name><name><surname>Harmsen</surname><given-names>MC</given-names></name><name><surname>Lie-Venema</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Epicardium-derived cells enhance proliferation, cellular maturation and alignment of cardiomyocytes</article-title><source>Journal of Molecular and Cellular Cardiology</source><volume>49</volume><fpage>606</fpage><lpage>616</lpage><pub-id pub-id-type="doi">10.1016/j.yjmcc.2010.07.007</pub-id><pub-id pub-id-type="pmid">20655924</pub-id></element-citation></ref><ref id="bib161"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wehrwein</surname><given-names>EA</given-names></name><name><surname>Orer</surname><given-names>HS</given-names></name><name><surname>Barman</surname><given-names>SM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Overview of the anatomy, physiology, and pharmacology of the autonomic nervous system</article-title><source>Comprehensive Physiology</source><volume>6</volume><fpage>1239</fpage><lpage>1278</lpage><pub-id pub-id-type="doi">10.1002/cphy.c150037</pub-id><pub-id pub-id-type="pmid">27347892</pub-id></element-citation></ref><ref id="bib162"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wichterle</surname><given-names>H</given-names></name><name><surname>Lieberam</surname><given-names>I</given-names></name><name><surname>Porter</surname><given-names>JA</given-names></name><name><surname>Jessell</surname><given-names>TM</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Directed differentiation of embryonic stem cells into motor neurons</article-title><source>Cell</source><volume>110</volume><fpage>385</fpage><lpage>397</lpage><pub-id pub-id-type="doi">10.1016/s0092-8674(02)00835-8</pub-id><pub-id pub-id-type="pmid">12176325</pub-id></element-citation></ref><ref id="bib163"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>Z</given-names></name><name><surname>Tse</surname><given-names>V</given-names></name><name><surname>Hou</surname><given-names>L</given-names></name><name><surname>Xu</surname><given-names>L</given-names></name><name><surname>Silverberg</surname><given-names>GD</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Sonic hedgehog promotes proliferation and tyrosine hydroxylase induction of postnatal sympathetic cells in vitro</article-title><source>Neuroreport</source><volume>11</volume><fpage>3315</fpage><lpage>3319</lpage><pub-id pub-id-type="doi">10.1097/00001756-200010200-00011</pub-id><pub-id pub-id-type="pmid">11059894</pub-id></element-citation></ref><ref id="bib164"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winbo</surname><given-names>A</given-names></name><name><surname>Ramanan</surname><given-names>S</given-names></name><name><surname>Eugster</surname><given-names>E</given-names></name><name><surname>Jovinge</surname><given-names>S</given-names></name><name><surname>Skinner</surname><given-names>JR</given-names></name><name><surname>Montgomery</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Functional coculture of sympathetic neurons and cardiomyocytes derived from human-induced pluripotent stem cells</article-title><source>American Journal of Physiology. Heart and Circulatory Physiology</source><volume>319</volume><fpage>H927</fpage><lpage>H937</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.00546.2020</pub-id><pub-id pub-id-type="pmid">32822546</pub-id></element-citation></ref><ref id="bib165"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winbo</surname><given-names>A</given-names></name><name><surname>Ramanan</surname><given-names>S</given-names></name><name><surname>Eugster</surname><given-names>E</given-names></name><name><surname>Rydberg</surname><given-names>A</given-names></name><name><surname>Jovinge</surname><given-names>S</given-names></name><name><surname>Skinner</surname><given-names>JR</given-names></name><name><surname>Montgomery</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Functional hyperactivity in long QT syndrome type 1 pluripotent stem cell-derived sympathetic neurons</article-title><source>American Journal of Physiology. Heart and Circulatory Physiology</source><volume>321</volume><fpage>H217</fpage><lpage>H227</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.01002.2020</pub-id><pub-id pub-id-type="pmid">34142889</pub-id></element-citation></ref><ref id="bib166"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>HF</given-names></name><name><surname>Zeltner</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Overview of methods to differentiate sympathetic neurons from human pluripotent stem cells</article-title><source>Current Protocols in Stem Cell Biology</source><volume>50</volume><elocation-id>e92</elocation-id><pub-id pub-id-type="doi">10.1002/cpsc.92</pub-id><pub-id pub-id-type="pmid">31479594</pub-id></element-citation></ref><ref id="bib167"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>HF</given-names></name><name><surname>Zeltner</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Efficient differentiation of postganglionic sympathetic neurons using human pluripotent stem cells under feeder-free and chemically defined culture conditions</article-title><source>Journal of Visualized Experiments</source><volume>24</volume><elocation-id>60843</elocation-id><pub-id pub-id-type="doi">10.3791/60843</pub-id><pub-id pub-id-type="pmid">32510508</pub-id></element-citation></ref><ref id="bib168"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>HF</given-names></name><name><surname>Huang</surname><given-names>CW</given-names></name><name><surname>Daga</surname><given-names>KR</given-names></name><name><surname>Marklein</surname><given-names>RA</given-names></name><name><surname>Ivanova</surname><given-names>N</given-names></name><name><surname>Zeltner</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2022">2022a</year><article-title>Human pluripotent stem cell-derived functional sympathetic neurons express ACE2 and RAAS components: a framework for studying the effect of COVID-19 on sympathetic responsiveness</article-title><source>Clinical Autonomic Research</source><volume>32</volume><fpage>59</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1007/s10286-021-00850-1</pub-id><pub-id pub-id-type="pmid">35091835</pub-id></element-citation></ref><ref id="bib169"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>HF</given-names></name><name><surname>Yu</surname><given-names>W</given-names></name><name><surname>Saito-Diaz</surname><given-names>K</given-names></name><name><surname>Huang</surname><given-names>CW</given-names></name><name><surname>Carey</surname><given-names>J</given-names></name><name><surname>Lefcort</surname><given-names>F</given-names></name><name><surname>Hart</surname><given-names>GW</given-names></name><name><surname>Liu</surname><given-names>HX</given-names></name><name><surname>Zeltner</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2022">2022b</year><article-title>Norepinephrine transporter defects lead to sympathetic hyperactivity in Familial Dysautonomia models</article-title><source>Nature Communications</source><volume>13</volume><elocation-id>7032</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-022-34811-7</pub-id><pub-id pub-id-type="pmid">36396637</pub-id></element-citation></ref><ref id="bib170"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>HF</given-names></name><name><surname>Huang</surname><given-names>CW</given-names></name><name><surname>Art</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>HX</given-names></name><name><surname>Hart</surname><given-names>GW</given-names></name><name><surname>Zeltner</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>O-GlcNAcylation is crucial for sympathetic neuron development, maintenance, functionality and contributes to peripheral neuropathy</article-title><source>Frontiers in Neuroscience</source><volume>17</volume><elocation-id>1137847</elocation-id><pub-id pub-id-type="doi">10.3389/fnins.2023.1137847</pub-id><pub-id pub-id-type="pmid">37229433</pub-id></element-citation></ref><ref id="bib171"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>HF</given-names></name><name><surname>Art</surname><given-names>J</given-names></name><name><surname>Saini</surname><given-names>T</given-names></name><name><surname>Zeltner</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2024">2024a</year><article-title>Protocol for generating postganglionic sympathetic neurons using human pluripotent stem cells for electrophysiological and functional assessments</article-title><source>STAR Protocols</source><volume>5</volume><elocation-id>102970</elocation-id><pub-id pub-id-type="doi">10.1016/j.xpro.2024.102970</pub-id><pub-id pub-id-type="pmid">38517897</pub-id></element-citation></ref><ref id="bib172"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>HF</given-names></name><name><surname>Saito-Diaz</surname><given-names>K</given-names></name><name><surname>Huang</surname><given-names>C-W</given-names></name><name><surname>McAlpine</surname><given-names>JL</given-names></name><name><surname>Seo</surname><given-names>DE</given-names></name><name><surname>Magruder</surname><given-names>DS</given-names></name><name><surname>Ishan</surname><given-names>M</given-names></name><name><surname>Bergeron</surname><given-names>HC</given-names></name><name><surname>Delaney</surname><given-names>WH</given-names></name><name><surname>Santori</surname><given-names>FR</given-names></name><name><surname>Krishnaswamy</surname><given-names>S</given-names></name><name><surname>Hart</surname><given-names>GW</given-names></name><name><surname>Chen</surname><given-names>Y-W</given-names></name><name><surname>Hogan</surname><given-names>RJ</given-names></name><name><surname>Liu</surname><given-names>H-X</given-names></name><name><surname>Ivanova</surname><given-names>NB</given-names></name><name><surname>Zeltner</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2024">2024b</year><article-title>Parasympathetic neurons derived from human pluripotent stem cells model human diseases and development</article-title><source>Cell Stem Cell</source><volume>31</volume><fpage>734</fpage><lpage>753</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2024.03.011</pub-id><pub-id pub-id-type="pmid">38608707</pub-id></element-citation></ref><ref id="bib173"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wymeersch</surname><given-names>FJ</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Blin</surname><given-names>G</given-names></name><name><surname>Cambray</surname><given-names>N</given-names></name><name><surname>Wilkie</surname><given-names>R</given-names></name><name><surname>Wong</surname><given-names>FCK</given-names></name><name><surname>Wilson</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Position-dependent plasticity of distinct progenitor types in the primitive streak</article-title><source>eLife</source><volume>5</volume><elocation-id>e10042</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.10042</pub-id><pub-id pub-id-type="pmid">26780186</pub-id></element-citation></ref><ref id="bib174"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wymeersch</surname><given-names>FJ</given-names></name><name><surname>Skylaki</surname><given-names>S</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Watson</surname><given-names>JA</given-names></name><name><surname>Economou</surname><given-names>C</given-names></name><name><surname>Marek-Johnston</surname><given-names>C</given-names></name><name><surname>Tomlinson</surname><given-names>SR</given-names></name><name><surname>Wilson</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Transcriptionally dynamic progenitor populations organised around a stable niche drive axial patterning</article-title><source>Development</source><volume>146</volume><elocation-id>dev168161</elocation-id><pub-id pub-id-type="doi">10.1242/dev.168161</pub-id><pub-id pub-id-type="pmid">30559277</pub-id></element-citation></ref><ref id="bib175"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xicoy</surname><given-names>H</given-names></name><name><surname>Wieringa</surname><given-names>B</given-names></name><name><surname>Martens</surname><given-names>GJM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The SH-SY5Y cell line in Parkinson’s disease research: a systematic review</article-title><source>Molecular Neurodegeneration</source><volume>12</volume><elocation-id>10</elocation-id><pub-id pub-id-type="doi">10.1186/s13024-017-0149-0</pub-id><pub-id pub-id-type="pmid">28118852</pub-id></element-citation></ref><ref id="bib176"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zackenfels</surname><given-names>K</given-names></name><name><surname>Oppenheim</surname><given-names>RW</given-names></name><name><surname>Rohrer</surname><given-names>H</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Evidence for an important role of IGF-I and IGF-II for the early development of chick sympathetic neurons</article-title><source>Neuron</source><volume>14</volume><fpage>731</fpage><lpage>741</lpage><pub-id pub-id-type="doi">10.1016/0896-6273(95)90217-1</pub-id><pub-id pub-id-type="pmid">7718236</pub-id></element-citation></ref><ref id="bib177"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeltner</surname><given-names>N</given-names></name><name><surname>Fattahi</surname><given-names>F</given-names></name><name><surname>Dubois</surname><given-names>NC</given-names></name><name><surname>Saurat</surname><given-names>N</given-names></name><name><surname>Lafaille</surname><given-names>F</given-names></name><name><surname>Shang</surname><given-names>L</given-names></name><name><surname>Zimmer</surname><given-names>B</given-names></name><name><surname>Tchieu</surname><given-names>J</given-names></name><name><surname>Soliman</surname><given-names>MA</given-names></name><name><surname>Lee</surname><given-names>G</given-names></name><name><surname>Casanova</surname><given-names>JL</given-names></name><name><surname>Studer</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Capturing the biology of disease severity in a PSC-based model of familial dysautonomia</article-title><source>Nature Medicine</source><volume>22</volume><fpage>1421</fpage><lpage>1427</lpage><pub-id pub-id-type="doi">10.1038/nm.4220</pub-id><pub-id pub-id-type="pmid">27841875</pub-id></element-citation></ref><ref id="bib178"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>JT</given-names></name><name><surname>Weng</surname><given-names>ZH</given-names></name><name><surname>Tsang</surname><given-names>KS</given-names></name><name><surname>Tsang</surname><given-names>LL</given-names></name><name><surname>Chan</surname><given-names>HC</given-names></name><name><surname>Jiang</surname><given-names>XH</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>MycN is critical for the maintenance of human embryonic stem cell-derived neural crest stem cells</article-title><source>PLOS ONE</source><volume>11</volume><elocation-id>e0148062</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0148062</pub-id><pub-id pub-id-type="pmid">26815535</pub-id></element-citation></ref><ref id="bib179"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>T</given-names></name><name><surname>Zhou</surname><given-names>X</given-names></name><name><surname>Szabó</surname><given-names>N</given-names></name><name><surname>Leitges</surname><given-names>M</given-names></name><name><surname>Alvarez-Bolado</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Foxb1-driven Cre expression in somites and the neuroepithelium of diencephalon, brainstem, and spinal cord</article-title><source>Genesis</source><volume>45</volume><fpage>781</fpage><lpage>787</lpage><pub-id pub-id-type="doi">10.1002/dvg.20356</pub-id><pub-id pub-id-type="pmid">18064677</pub-id></element-citation></ref><ref id="bib180"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>S</given-names></name><name><surname>Wurdak</surname><given-names>H</given-names></name><name><surname>Schultz</surname><given-names>PG</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Directed embryonic stem cell differentiation with small molecules</article-title><source>Future Medicinal Chemistry</source><volume>2</volume><fpage>965</fpage><lpage>973</lpage><pub-id pub-id-type="doi">10.4155/fmc.10.190</pub-id><pub-id pub-id-type="pmid">21426114</pub-id></element-citation></ref><ref id="bib181"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zwanenburg</surname><given-names>F</given-names></name><name><surname>Bos</surname><given-names>TA</given-names></name><name><surname>Ten Harkel</surname><given-names>ADJ</given-names></name><name><surname>Haak</surname><given-names>MC</given-names></name><name><surname>Hahurij</surname><given-names>ND</given-names></name><name><surname>Poelmann</surname><given-names>RE</given-names></name><name><surname>van Munsteren</surname><given-names>CJ</given-names></name><name><surname>Wisse</surname><given-names>LJ</given-names></name><name><surname>Blom</surname><given-names>NA</given-names></name><name><surname>DeRuiter</surname><given-names>MC</given-names></name><name><surname>Jongbloed</surname><given-names>MRM</given-names></name></person-group><year iso-8601-date="2025">2025</year><article-title>Development of autonomic innervation at the venous pole of the heart: bridging the gap from mice to human</article-title><source>Journal of Translational Medicine</source><volume>23</volume><elocation-id>73</elocation-id><pub-id pub-id-type="doi">10.1186/s12967-024-06049-y</pub-id><pub-id pub-id-type="pmid">39815264</pub-id></element-citation></ref></ref-list><app-group><app id="appendix-1"><title>Appendix 1</title><sec sec-type="appendix" id="s8"><title>PubMed query</title><p>(&quot;pluripotent stem cells&quot;[mesh] OR &quot;pluripotent stem cell*&quot;[tw] OR &quot;PSC&quot;[tw] OR &quot;PSCs&quot;[tw] OR &quot;hPSC*&quot;[tw] OR &quot;iPSC*&quot;[tw] OR &quot;hiPSC*&quot;[tw] OR &quot;embryonic stem cell*&quot;[tw] OR &quot;hESC*&quot;[tw] OR &quot;ESC&quot;[tw] OR &quot;ESCs&quot;[tw] OR “immortal*”[tw] OR “inducible proliferati*”[tw] OR “conditional proliferati*”[tw]).</p><p>AND (&quot;ganglia, autonomic&quot;[mesh] OR &quot;autonomic nervous system&quot;[mesh] OR &quot;ANS&quot;[tw] OR &quot;autonomic neuron*&quot;[tw] OR “autonomic nerve cell*”[tw] OR &quot;autonomic-like neuron*&quot;[tw] OR &quot;autonomic-like nerve cell*&quot;[tw] OR &quot;sympathetic neuron*&quot;[tw] OR &quot;SNS &quot;[tw] OR “sympathetic-like neuron*”[tw] OR “sympathetic nerve cell*”[tw] OR &quot;sympathetic-like nerve cell*&quot;[tw]OR &quot;parasympathetic neuron*&quot;[tw] OR &quot;parasympathetic nerve cell*&quot;[tw] OR &quot;PNS&quot;[tw] OR &quot;para sympathetic neuron*&quot;[tw] OR &quot;para-sympathetic nerve cell*&quot;[tw] OR &quot;parasympathetic-like neuron*&quot;[tw] OR &quot;para-sympathetic-like neuron*&quot;[tw] OR &quot;parasympathetic-like nerve cell*&quot;[tw] OR &quot;para-sympathetic-like nerve cell*&quot;[tw] OR &quot;sympathoadrenal progenitor*&quot;[tw] OR &quot;sympathoadrenal precursor*&quot;[tw] OR &quot;schwann cell precursor*&quot;[tw] OR &quot;schwann cell progenitor*&quot;[tw]).</p><p>OR ((&quot;neural crest&quot;[mesh] OR &quot;neural crest cell*&quot;[tw] OR “neural crest stem cell*”[tw] OR “neural crest-like cell*”[tw] OR “neural crest progenitor cell*”[tw] OR “NC cell*”[tw] OR &quot;NCC&quot;[tw]) AND (“trunk”[tw] OR “posterior”[tw] OR “vagal”[tw] OR “cardiac”[tw])).</p><p>OR ((&quot;adrenergic neuron*&quot;[tw] OR &quot;adrenergic nerve cell*&quot;[tw] OR &quot;adrenergic-like neuron*&quot;[tw] OR &quot;adrenergic-like nerve cell*&quot;[tw] OR &quot;noradrenergic neuron*&quot;[tw] OR &quot;noradrenergic nerve cell*&quot;[tw] OR &quot;noradrenergic-like neuron*&quot;[tw] OR &quot;noradrenergic-like nerve cell*&quot;[tw] OR &quot;cholinergic-like nerve cell*&quot;[tw] OR &quot;cholinergic neuron*&quot;[tw] OR &quot;cholinergic-like neuron*&quot;[tw] OR &quot;cholinergic nerve cell*&quot;[tw]) AND (&quot;peripher*&quot;[tw] OR &quot;postganglion*&quot;[tw] OR &quot;post ganglion*&quot;[tw])).</p><p>AND (&quot;cell differentiation&quot;[Mesh] OR &quot;cells, cultured&quot;[Mesh] OR &quot;differentiat*&quot;[tw] OR &quot;deriv*&quot;[tw] OR &quot;induc*&quot;[tw]).</p><p>NOT (&quot;animals&quot;[mesh] NOT &quot;humans&quot;[mesh]).</p></sec><sec sec-type="appendix" id="s9"><title>Ovid query</title><p>(exp pluripotent stem cell/ OR &quot;pluripotent stem cell*&quot;.ti,ab. OR &quot;PSC&quot;.ti,ab. OR &quot;PSCs&quot;.ti,ab. OR &quot;hPSC*&quot;.ti,ab. OR &quot;iPSC*&quot;.ti,ab. OR &quot;hiPSC*&quot;.ti,ab. OR &quot;embryonic stem cell*&quot;.ti,ab. OR &quot;hESC*&quot;.ti,ab. OR &quot;ESC&quot;.ti,ab. OR &quot;ESCs&quot;.ti,ab. OR &quot;immortal*&quot;.ti,ab. OR &quot;inducible proliferati*&quot;.ti,ab. OR &quot;conditional proliferati*&quot;.ti,ab).</p><p>AND (exp autonomic ganglion/ OR exp autonomic nervous system/ OR &quot;ANS&quot;.ti,ab. OR &quot;autonomic neuron*&quot;.ti,ab. OR &quot;autonomic nerve cell*&quot;.ti,ab. OR &quot;autonomic-like neuron*&quot;.ti,ab. OR &quot;autonomic-like nerve cell*&quot;.ti,ab. OR &quot;sympathetic neuron*&quot;.ti,ab. OR &quot;SNS &quot;.ti,ab. OR &quot;sympathetic-like neuron*&quot;.ti,ab. OR exp sympathetic nerve cell/ OR &quot;sympathetic nerve cell*&quot;.ti,ab. OR &quot;sympathetic-like nerve cell*&quot;.ti,ab. OR &quot;parasympathetic neuron*&quot;.ti,ab. OR &quot;parasympathetic nerve cell*&quot;.ti,ab. OR &quot;PNS&quot;.ti,ab. OR &quot;para-sympathetic neuron*&quot;.ti,ab. OR &quot;para-sympathetic nerve cell*&quot;.ti,ab. OR &quot;parasympathetic-like neuron*&quot;.ti,ab. OR &quot;para-sympathetic-like neuron*&quot;.ti,ab. OR &quot;parasympathetic-like nerve cell*&quot;.ti,ab. OR &quot;para-sympathetic-like nerve cell*&quot;.ti,ab).</p><p>OR &quot;sympathoadrenal progenitor*&quot;.ti,ab. OR &quot;sympathoadrenal precursor*&quot;.ti,ab. OR &quot;schwann cell precursor*&quot;.ti,ab. OR &quot;schwann cell progenitor*&quot;.ti,ab.</p><p>OR ((exp neural crest/ OR &quot;neural crest cell*&quot;.ti,ab. OR &quot;neural crest stem cell*&quot;.ti,ab. OR &quot;neural crest-like cell*&quot;.ti,ab. OR &quot;neural crest progenitor cell*&quot;.ti,ab. OR &quot;NC cell*&quot;.ti,ab. OR &quot;NCC&quot;.ti,ab) AND (“trunk”.ti,ab. OR “posterior”.ti,ab. OR “vagal”.ti,ab. OR “cardiac”.ti,ab)).</p><p>OR ((&quot;adrenergic neuron*&quot;.ti,ab. OR &quot;adrenergic nerve cell*&quot;.ti,ab. OR &quot;adrenergic-like neuron*&quot;.ti,ab. OR &quot;adrenergic-like nerve cell*&quot;.ti,ab. OR &quot;noradrenergic neuron*&quot;.ti,ab. OR &quot;noradrenergic nerve cell*&quot;.ti,ab. OR &quot;noradrenergic-like neuron*&quot;.ti,ab. OR &quot;noradrenergic-like nerve cell*&quot;.ti,ab. OR &quot;cholinergic-like nerve cell*&quot;.ti,ab. OR &quot;cholinergic neuron*&quot;.ti,ab. OR &quot;cholinergic-like neuron*&quot;.ti,ab. OR &quot;cholinergic nerve cell*&quot;.ti,ab.) AND (&quot;peripher*&quot;.ti,ab. OR &quot;postganglion*&quot;.ti,ab. OR &quot;post-ganglion*&quot;.ti,ab)).</p><p>AND (exp cell differentiation/ OR exp cell culture/ OR &quot;differentiat*&quot;.ti,ab. OR &quot;deriv*&quot;.ti,ab. OR &quot;induc*&quot;.ti,ab).</p><p>NOT ((exp animal/ OR nonhuman/) NOT exp human/).</p><p>NOT (conference OR conference abstract OR conference review).pt.</p><p>NOT (&quot;Parkinson*&quot;.ti. OR (&quot;dopamin*&quot;.ti,ab. AND (&quot;Parkinson*&quot;.ti,ab. OR &quot;substantia nigra&quot;.ti,ab. OR &quot;striat*&quot;.ti,ab.))).</p></sec><sec sec-type="appendix" id="s10"><title>Web of Science query</title><p>TS=(&quot;pluripotent stem cell*&quot; OR &quot;PSC&quot; OR &quot;PSCs&quot; OR &quot;hPSC*&quot; OR &quot;iPSC*&quot; OR &quot;hiPSC*&quot; OR &quot;embryonic stem cell*&quot; OR &quot;hESC*&quot; OR &quot;ESC&quot; OR &quot;ESCs&quot; OR &quot;immortal*&quot; OR &quot;inducible proliferati*&quot; OR &quot;conditional proliferati*&quot;).</p><p>AND TS=(&quot;autonomic ganglion&quot; OR &quot;autonomic nervous system&quot; OR &quot;ANS&quot; OR &quot;autonomic neuron*&quot; OR &quot;autonomic nerve cell*&quot; OR &quot;autonomic-like neuron*&quot; OR &quot;autonomic-like nerve cell*&quot; OR &quot;sympathetic neuron*&quot; OR &quot;SNS &quot; OR &quot;sympathetic-like neuron*&quot; OR exp sympathetic nerve cell/ OR &quot;sympathetic nerve cell*&quot; OR &quot;sympathetic-like nerve cell*&quot; OR &quot;parasympathetic neuron*&quot; OR &quot;parasympathetic nerve cell*&quot; OR &quot;PNS&quot; OR &quot;para-sympathetic neuron*&quot; OR &quot;para-sympathetic nerve cell*&quot; OR &quot;parasympathetic-like neuron*&quot; OR &quot;para-sympathetic-like neuron*&quot; OR &quot;parasympathetic-like nerve cell*&quot; OR &quot;para-sympathetic-like nerve cell*&quot; OR &quot;sympathoadrenal progenitor*&quot; OR &quot;sympathoadrenal precursor*&quot; OR &quot;schwann cell precursor*&quot; OR &quot;schwann cell progenitor*&quot; OR).</p><p>((&quot;neural crest&quot; OR &quot;neural crest-like cell*&quot; OR &quot;NC cell*&quot; OR &quot;NCC&quot;) AND (“trunk” OR “posterior” OR “cardiac” OR “vagal”)) OR ((&quot;adrenergic neuron*&quot; OR &quot;adrenerg ic nerve cell*&quot; OR &quot;adrenergic-like neuron*&quot; OR &quot;adrenergic like nerve cell*&quot; OR &quot;noradrenergic neuron*&quot; OR &quot;noradrenergic nerve cell*&quot; OR &quot;noradrenergic-like neuron*&quot; OR &quot;noradrenergic-like nerve cell*&quot; OR &quot;cholinergic-like nerve cell*&quot; OR &quot;cholinergic neuron*&quot; OR &quot;cholinergic-like neuron*&quot; OR &quot;cholinergic nerve cell*&quot;) AND (&quot;peripher*&quot; OR &quot;postganglion*&quot; OR &quot;post-ganglion*&quot;)).</p><p>AND TS=(&quot;culture*&quot; OR &quot;differentiat*&quot; OR &quot;deriv*&quot; OR &quot;induc*&quot;).</p><p>NOT TI=((&quot;veterinar*&quot; OR &quot;animal*&quot; OR &quot;mouse&quot; OR “mammalian” OR &quot;mice&quot; OR &quot;rodent*&quot; OR &quot;murine&quot; OR &quot;rat&quot; OR “rats” OR &quot;pig&quot; OR “pigs” OR &quot;porcine&quot; OR &quot;chicken*&quot; OR &quot;avian&quot; OR &quot;zebrafish&quot; OR “piscine” OR &quot;rabbit*&quot; OR &quot;leporine&quot;) NOT “human*”).</p></sec></app></app-group></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.103728.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Scherschel</surname><given-names>Katharina</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/024z2rq82</institution-id><institution>Heinrich Heine University Düsseldorf</institution></institution-wrap><country>Germany</country></aff></contrib></contrib-group></front-stub><body><p>This valuable systematic review provides substantial insights into pluripotent stem cell-derived autonomic postganglionic neuron differentiation techniques. The methodology to collect the underlying evidence is solid. This work provides a helpful resource for researchers who want to establish differentiation pluripotent stem cell into autonomic postganglionic neurons for disease modeling.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.103728.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Scherschel</surname><given-names>Katharina</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/024z2rq82</institution-id><institution>Heinrich Heine University Düsseldorf</institution></institution-wrap><country>Germany</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Human autonomic postganglionic neurons for disease modelling: a systematic review in light of developmental cues&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by Olujimi Ajijola as the Senior Editor and by a Reviewing Editor.</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission. Please let us know when you plan to resubmit.</p><p>The manuscript entitled &quot;Human autonomic postganglionic neurons for disease modelling: a systematic review in light of developmental cues&quot; is a well-researched manuscript outlining the state of the field for the differentiation of human pluripotent stem cells. This is an important topic in the field, as accessible protocols for the creation of autonomic iPSCs that recapitulate the phenotypes of human neurons and allow modeling of disease are proving to be a powerful platform for scientific and medical research.</p><p>The authors compared in vitro autonomic neuron differentiation strategies to in vivo embryonic development of the autonomic nervous system, and highlighted unexplored in vitro signaling cues for autonomic neuronal differentiation.</p><p>As human autonomic neuronal cell models emerge as tools for disease modelling, this review will be very useful for the field of research.</p><p>Essential revisions:</p><p>The authors find that the review did assess the literature systematically and the manuscript is well written in general, but several major points came up in the review:</p><p>1. A more detailed record of how the largest number of records (969 records) were excluded would be helpful. In the same manner that the exclusion of 100 articles was detailed was informative – similar information for the 969 records (if possible) would increase confidence in the selected papers.</p><p>2. On many occasions, it seems like the authors only enumerate what has been done in the different publications without giving context. The authors should use their expertise and knowledge in this field to interpret the data and sum up the evidence for the reader. Based on their expertise, the authors should give clear recommendations on e.g. readouts for quality control (e.g. purity percentage?) and methods that should be used and reported when establishing and/or publishing new differentiation protocols.</p><p>3. The authors completely neglected to address the topic of 3D cell culture vs 2D cell culture. Were all protocols performed in 2D cell cullture? This might be a major limitation to the field, especially when considering the specific anatomy of autonomic neurons (assembled in ganglia with close intimacy of other cells types such as glia and fibroblasts). Please include this in the revised manuscript.</p><p>4. Most of the Figures are highly complex and not self-explanatory. While we appreciate the amount of work that went into them and are sure the authors have a well-thought-through colour scheme, please try to make them easier to understand for the general audience. We specifically suggest including (sub)titles, captions and legends for the different colours of bars, arrows and growth factors.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.103728.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>The authors find that the review did assess the literature systematically and the manuscript is well written in general, but several major points came up in the review:</p><p>1. A more detailed record of how the largest number of records (969 records) were excluded would be helpful. In the same manner that the exclusion of 100 articles was detailed was informative – similar information for the 969 records (if possible) would increase confidence in the selected papers.</p></disp-quote><p>Thank you for the suggestion, we agree this would increase confidence in the search process. During title abstract screening we documented exclusion reasons in Rayyan (https://www.rayyan.ai/) in case of conflicts between both reviewers. We have exported these from Rayyan and added the number of records per exclusion reason to figure 1. The dataset is available in Source Data File 1.</p><disp-quote content-type="editor-comment"><p>2. On many occasions, it seems like the authors only enumerate what has been done in the different publications without giving context. The authors should use their expertise and knowledge in this field to interpret the data and sum up the evidence for the reader. Based on their expertise, the authors should give clear recommendations on e.g. readouts for quality control (e.g. purity percentage?) and methods that should be used and reported when establishing and/or publishing new differentiation protocols.</p></disp-quote><p>We agree that in the first version of our manuscript, our results required the reader to make their own interpretations in many places. Below we have first described the general changes that were made per section, followed by specific quotes at the end of the response to this comment. In general, we have moved essential context and interpretations from the Discussion section to the Results section, or added new interpretations as needed.</p><p>First, in our comparison between in vitro protocols and embryology we have reorganized the neural crest section to make the rationale for the four different groups we identified more explicit. Here, we have also related the modulation of signaling pathways to the efficiency achieved in protocols modulating the pathway in question, to support several recommendations we have interweaved in this section.</p><p>Although there are too few parasympathetic articles to make meaningful groups to compare, the parasympathetic embryology text was restructured in a way that we believe better highlights the strengths and weaknesses of each protocol in comparison to embryonic development.</p><p>Next, following the overview of molecular identity markers, a separate paragraph was added to both the ‘sympathetic neuron definitions’ and ‘parasympathetic neuron definitions’ sections. Herein we have explicitly formulated recommendations supported by in vivo expression data.</p><p>Concerning recommendations for protocol efficiency, the acceptable minimal purity percentage is likely to vary based on the design and purpose of an experiment. Furthermore, there is little known about the effect of non-neuronal contamination on experimental outcomes. Therefore, we do not have any empirical data to base a minimal purity percentage recommendation on. Nonetheless, to provide the readers with a guideline, we have suggested the arbitrary proportion of two thirds. We believe this is a fair minimum proportion of the total cells to assume that most cellular interactions in the culture involve the neuronal population of interest. We have also adjusted our definition of a highly efficient protocol accordingly to two thirds throughout the text.</p><p>Finally, considering the similarities in functional readouts between sympathetic and parasympathetic neurons, we have combined both sympathetic and parasympathetic articles and discussed these per neuronal function tested. By doing so, we have avoided the necessarily enumerative description of the small number of parasympathetic protocols available. Moreover, we believe this structure provides the reader with more context on the value of each technique. We have also added a recommendation for the most optimal functional readouts for new protocols.</p><p>In summary, the following changes were made throughout the Results section:</p><p>In the results on lines 187-199 a conclusion about the similarity between embryonic development and SDIA was added:</p><p>“One of the earliest approaches, applied in two sympathetic protocols<sup>17,27</sup>, utilized the stromal cell-derived inducing activity (SDIA) of PA6 cells, a mouse preadipocyte cell line<sup>58.</sup> Although both protocols reported the expression of catecholaminergic markers, sympathetic neuron yields were low, despite the use of fluorescence-activated cell sorting (FACS) to select for NCC markers during differentiation. Moreover, the signaling cues involved in SDIA have not been fully defined, and can also induce dopaminergic neuron differentiation<sup>59</sup>. Together, this suggests SDIA does not specifically recapitulate the embryonic development of sympathetic neurons.”</p><p>The sections about dual SMAD inhibition and early Wnt activation have been rewritten to explain the rationale for the distinction between both groups. The current text reads as follows on lines 215-308. We have also added more context and interpretations:</p><p>“All other approaches applied activation of Wnt signaling via CHIR99021 (CHIR)-based glycogen synthesis kinase 3 inhibition to generate NCCs (Figure 3, for additional culture details see Figure 3 —figure supplement 1). The modes of action for all small molecules used in the included protocols are provided in Figure 3 —figure supplement 2. Activation of Wnt signaling via CHIR in these protocols is in line with avian NCC development, which also depends on Wnt signaling <sup>60</sup>(Figure 4A). Of protocols applying CHIR, two parasympathetic protocols<sup>42,46</sup> and four sympathetic protocols<sup>18,19,35,42</sup> applied a technique coined ‘dual SMAD inhibition’. These protocols combined SMAD2/3 inhibition and SMAD1/5/8 inhibition from the start of differentiation, and added CHIR from day two of differentiation. Transforming growth factor β (TGFβ)-, Activin- and Nodal-specific SMAD2/3 signaling was always inhibited via anaplastic lymphoma kinase (ALK)4/5/7 receptor inhibitor SB431542 (SB)<sup>61</sup>, and bone morphogenetic protein (BMP)-specific SMAD1/5/8 signaling was inhibited by small molecule inhibitors LDN193189 (LDN) or dorsomorphin (DMH)<sup>62,63</sup>. Although little seems to be known about SMAD2/3 signaling requirements for NCC induction in vivo, SMAD1/5/8 signaling is inhibited at the start of neural crest specification, followed by activation as neural crest development progresses<sup>60,64</sup>. This may parallel the use of LDN or DMH. Furthermore, in the absence of CHIR, dual SMAD inhibition instead results in high proportions of neural plate marker expression<sup>62</sup>. This resembles the way inhibition of Wnt induces neural plate expression in avian ectodermal explants which would otherwise express neural crest markers<sup>60</sup> (Figure 4A).</p><p>The addition of CHIR to dual SMAD inhibition results in ~70% of cells expressing neural crest marker SRY-box transcription factor 10 (SOX10) by day 12 of differentiation<sup>63</sup>. Addition of two other small molecules (DAPT, an indirect Notch signaling inhibitor<sup>65</sup>, and SU5402, an inhibitor of fibroblast growth factor receptor 1 (<italic>FGFR1</italic>) and vascular endothelial growth factor receptor 2 (VEGFR2)<sup>66</sup>) slightly increases the proportion of cells expressing SOX10 by day 12 of differentiation to ~80%<sup>63</sup>. Oh et al. later modified this approach (i.e. modified three inhibitor approach) by substituting SU5402 for PD173074<sup>18</sup>, another FGFR inhibitor. The mechanisms by which SU5402 or PD173074, and DAPT contribute to NCC induction are still unknown. Although Notch signaling influences fate decisions after NCC induction, any direct role of Notch in NCC induction is unclear in chicken and mice<sup>67</sup>. Furthermore, fibroblast growth factor (FGF) signaling inhibition by SU5402 or PD173074 seems to contradict the FGF requirement for NCC formation in vivo<sup>68</sup> (Figure 4A). On the other hand, the concentration of PD173074 used, 0.2 µM, may not entirely suppress endogenous cellular FGF signaling<sup>29</sup>.</p><p>CHIR-mediated Wnt signaling activation from day zero of differentiation under dual SMAD inhibition conditions dramatically reduces SOX10-positive NCC induction<sup>69</sup>. Therefore, we consider protocols employing CHIR from the start of differentiation (i.e. ‘early Wnt activation’) to be distinct from dual SMAD inhibition protocols. Protocols in the ‘early Wnt activation’ category often inhibited SMAD1/5/8 signaling via SB<sup>15,24,28,30,39,40,47</sup>, but did not inhibit BMP-specific SMAD2/3 signaling. The lack of BMP modulation in most early Wnt activation protocols seemingly contradicts evidence from embryonic development<sup>60,64</sup>. Similar to dual SMAD inhibition protocols, almost no early Wnt activation protocols actively stimulate FGF signaling simultaneously with Wnt stimulation, both of which are required for avian NCC development<sup>68</sup>. Nonetheless, three of the four protocols retrieved by our query which reported high sympathetic neuron differentiation purities (≥67% of cells expressing tyrosine hydroxylase (TH)), relied on a form of early Wnt activation without active FGF stimulation for NCC induction<sup>24,30,40</sup>. Information on endogenous cellular Wnt, BMP and FGF signaling in these protocols would help clarify this apparent discrepancy.”</p><p>Our interpretation of the embryonic evidence for NMP contributions to NCC induction on was also emphasized on lines 309-311: “A final induction strategy applied by Frith et al.<sup>21</sup>, is based on neuromesodermal progenitor (NMP) induction. Although the evidence is not conclusive, NMPs may contribute to posterior NCCs in vivo (Figure 4B), as suggested by various grafting and lineage tracing studies<sup>71-74</sup>.”</p><p>We have emphasized a relatively unexplored differentiation route on lines 331-334: “Strikingly, cells treated with 10 µM CHIR showed vastly higher HOXC9 expression than cells treated with 3 µM CHIR. Further investigation is warranted to explore whether this relatively simple approach to generate posterior NCCs can be used to efficiently generate mature sympathetic neurons.”</p><p>Following the section about axial identity of neural crest cells, a recommendation for future sympathetic protocols was added on lines 342-344: “Altogether, considering the instructive role HOX genes have during development<sup>85</sup>, we recommend demonstrating posterior HOX gene expression when establishing new sympathetic protocols.”</p><p>We have related the use of BMP to protocol efficiency on lines 356-359: “In any case, three of the four sympathetic protocols reporting high differentiation efficiencies (≥67% of cells expressing TH) actively stimulated BMP signaling<sup>24,35,40</sup>, suggesting this is also an important component of sympathetic neuron differentiation in vitro.”</p><p>We have related the use of SHH to protocol efficiency on lines 366-368: “However, direct stimulation of SHH signaling is only included in one of the four sympathetic protocols reporting high efficiencies (≥67% TH-positive)<sup>35</sup>. At most, this suggests that active stimulation of SHH signaling plays an accessory role in vitro.”</p><p>The investigation of glial cell generation in future protocols striving to recapitulate embryonic development has been recommended on lines 378-381: “In order to fully recapitulate sympathetic embryonic development, we believe a protocol should be capable of generating both glial cells and neurons from the same progenitor population, depending on Notch signaling. However, generally, the presence of glial cells was not investigated in current protocols.”</p><p>The comparison to parasympathetic embryonic development has been rewritten to follow the sequence of parasympathetic neurogenesis. In this way we believe it is clearer which protocols resemble embryonic development at each stage. The section now reads as follows on lines 429-516:</p><p>Lines 429-437: “After generating NCCs, each parasympathetic protocol employed divergent tactics to generate parasympathetic precursors (Figure 6A, full-length parasympathetic protocol overviews are shown in Figure 6 —figure supplement 1). in vivo, vagal NCCs migrate along preganglionic axons to the site of the prospective parasympathetic ganglia in the form of SCPs, which depend on axonal signals like NRG1 for survival<sup>122-124</sup> (Figure 6B). Goldsteen et al. and Wu et al. showed increased expression of axial markers of vagal NCCs<sup>46,47</sup>, homeobox B3 (HOXB3) and homeobox B5 (HOXB5). However, only Wu et al. explicitly targeted SCP generation via NRG1 in combination with CHIR and FGF2<sup>47</sup>. In strong support of the recapitulation of embryonic development in this protocol, Wu et al. showed that the resulting SOX10-positive SCPs were also capable of Schwann cell generation.”</p><p>Lines 438-459: “in vivo, the development of ciliary ganglion neurons, a parasympathetic neuron subtype, depends on local BMPs, possibly BMP4, BMP5, and/or BMP7<sup>125</sup>. The only parasympathetic protocol to actively stimulate BMP signaling after NCC induction was the protocol by Takayama et al.<sup>42</sup>. As mentioned before, sympathetic ganglia also rely on BMPs during development<sup>90,92-94</sup>. Instead of SCP generation, this protocol inhibited alternative NCC fates, to retain progenitor populations capable of both sympathetic and parasympathetic differentiation. SHH signaling stimulates enteric neuron-fated NCC proliferation<sup>126</sup>, and constitutively active Wnt signaling abolishes autonomic neuron differentiation in favor of sensory neuron differentiation<sup>127</sup>. Therefore, the inhibition of alternative NCC fates was implemented by SHH and Wnt inhibition, via SANT1 and IWR1, respectively<sup>42</sup>. This strategy contrasts strikingly with the majority of other autonomic protocols (9/12)<sup>15,18,19,21,28-30,35,46</sup> which apply activation of Wnt and/or SHH signaling. Nonetheless, neurons expressing either sympathetic or parasympathetic neuron markers were generated depending on BDNF and ciliary neurotrophic factor (CNTF) concentrations, as well as cell density. However, differentiation efficiencies of the optimized sympathetic- and parasympathetic-specific protocols were not reported and the efficiency of autonomic neuron induction in the combined autonomic protocol was &lt;10%. This suggests that this approach results in high proportions of contaminating cells.”</p><p>Lines 465-472: “Both Wu et al. and Takayama et al. used GDNF, among other factors, for neuronal maturation<sup>42,47</sup>. Once established near target tissues, parasympathetic precursors of several ganglia are initially dependent on Wnt and GDNF for proliferation<sup>128-130</sup> (Figure 6C). The only protocol not to apply GDNF was developed by Goldsteen et al. Instead, they relied on BDNF for development and maturation of parasympathetic neurons, based on its requirement for the innervation of distal airway smooth muscle<sup>131</sup>. However, postganglionic parasympathetic neurons barely innervate the distal airways<sup>132</sup>, and BDNF deletion therefore probably affects the extrinsic sympathetic, sensory and/or vagal innervation of the lungs.”</p><p>Lines 473-483: “Both Takayama et al. and Wu et al. applied CNTF for neuronal maturation<sup>42,47</sup>. Additionally, Takayama et al. applied NGF and NTF3<sup>42</sup>. Although CNTF and NGF promote parasympathetic neuron survival in vitro<sup>134-136</sup>, it is at best unknown if these factors are required during embryonic development<sup>137</sup>. Finally, Wu et al. developed the only protocol to date to apply late RA exposure<sup>47</sup>. Knockdown of RA receptor β in chicken ciliary ganglia delays mature neurotransmitter profiles and programmed cell death, characteristic of neuronal maturation<sup>57</sup>.”</p><p>Lines 512-516: <italic>“</italic>Upon maturation, parasympathetic neurons generally switch dependency from GDNF to NRTN<sup>128,133,138</sup>. Likewise, parasympathetic intrinsic airway neurons rely on GDNF family ligands for survival, one of which is likely NRTN<sup>139</sup>. Nonetheless, NRTN was not included in any parasympathetic protocol, and we believe this would be a promising candidate to improve parasympathetic neuron maturity.”</p><p>We have summed up the parasympathetic molecular definitions as follows on lines 568-578: “All six parasympathetic articles partly based their parasympathetic neuron definitions on the cholinergic enzyme (CHAT<sup>42-47</sup>). However, several other peripheral neurons also express CHAT, of which enteric neurons and cholinergic sympathetic neurons are derived from NCCs as well. This highlights the need for additional markers to support specific parasympathetic neuron identity. Other markers combined with CHAT in parasympathetic neuron articles included PHOX2B<sup>42,43,45</sup>, PRPH<sup>44,45,47</sup>, and the pan-neuronal marker, tubulin β3 (TUBB3)<sup>46</sup>.”</p><p>We have added an (arbitrary) recommendation about minimal purity percentage in the results on lines 608-610: “Generally, the acceptable minimal differentiation purity will differ per research goal. However, as an arbitrary rule of thumb, we recommend that at least two thirds of cells in culture express relevant autonomic neuron markers.”</p><p>Sympathetic and parasympathetic articles were combined for the functional section of our results to sum up the evidence across all articles. We have also divided the results by neuronal function to provide more context to the reader. The section now reads as follows, on lines 626-739:</p><p>Lines 626-631: “Many disease modelling applications of autonomic neurons require neurons that are capable of functional neuron firing and interactions with other cell types. To model in vivo neuronal functions, autonomic neurons should synthesize appropriate neurotransmitters, generate action potentials in response to nicotinic stimuli, and form synapses capable of functionally influencing target cell types. These neuronal functions have been demonstrated by a majority of autonomic protocols (11/17)<sup>18,19,21,24,30,35,40,42,46,47</sup> with varying degrees of success (Figure 2 —figure supplement 1).”</p><p>Lines 639-651: ”<italic>Neurotransmitter synthesis</italic></p><p>Neurotransmitter synthesis is essential to neuron function. Moreover, determining the presence of noradrenaline or acetylcholine provides specific information on neuronal identity. This was frequently measured (11/17)<sup>18,19,21,24,30,35,40,42,46,47</sup>, either via enzyme-linked immunosorbent assay (ELISA) or high-performance liquid chromatography. Eight protocols successfully demonstrated the presence of appropriate neurotransmitters in culture medium<sup>18,21,24,30,35,40,46,47</sup>. However, only three protocols measured neurotransmitter concentrations in culture medium following spontaneous release<sup>32,40,47</sup>. All others relied on non-physiological stimulatory cues like potassium chloride or optogenetic stimulation for neurotransmitter release. By instead using nicotine as a stimulatory cue, future protocols could simultaneously provide evidence for functional nicotinic acetylcholine receptors, a feature of all autonomic neurons<sup>1</sup>. Furthermore, determining the presence of additional neurotransmitters such as neuropeptide Y might further specify the identity of PSC-derived autonomic neurons<sup>148</sup>.”</p><p>Lines 657-684: “<italic>Electrophysiology</italic></p><p>Crucial to neuronal function, neurons integrate and pass on signals through action potential generation. Nine autonomic protocols provided evidence of action potential generation, via multi-electrode array (MEA) recordings, cytosolic [Ca<sup>2+</sup>] imaging, or whole-cell patch clamp recordings<sup>18,21,30,35,40,42,46,47</sup>. MEAs can record neuron firing rates of large areas of neurons over time or in response to stimuli, but provide limited information on the specific electrophysiological characteristics of individual neurons. In total, MEA recordings were reported for four protocols, revealing spontaneous firing in all cases<sup>31,43,46,47</sup>.</p><p>To measure electrophysiological characteristics and the associated action potential dynamics of individual neurons, cytosolic [Ca<sup>2+</sup>] imaging or patch clamp can be used. Cytosolic [Ca<sup>2+</sup>] imaging visualizes the calcium transients associated with electrical activity, but does not directly measure voltages and currents<sup>153</sup>. The most direct method to measure individual neuron electrophysiology is by whole-cell patch clamp recordings, reported for four protocols (Table 2): Oh et al., Frith et al., Winbo et al., and Fan et al.<sup>18,21,35,40</sup>. For lack of any primary human sympathetic neuron patch clamp data, whole-cell patch clamp data of adult murine thoracic sympathetic neurons have been added to Table 2 for reference<sup>154</sup>. All four protocols demonstrated in- and outward voltage-sensitive currents, and Winbo et al.<sup>35,36</sup> and Fan et al.<sup>41</sup> also demonstrated spontaneous firing. Although all adult murine sympathetic neurons fire repetitively (i.e. show tonic activation) following current injection, a substantial portion of the hPSC-derived sympathetic neurons produce only single action potentials (i.e. display phasic activation) after current injection.</p><p>Altogether, the electrophysiological characteristics measured by Winbo et al. most closely resemble those of adult murine sympathetic neurons. However, this may be due to the longer culture time of these neurons compared to the other protocols. When Winbo et al. measured sympathetic neurons after only 28-41 days of differentiation, resting membrane potentials were significantly less polarized and action potential kinetics significantly slower than at 48-76 days<sup>35</sup>. Wu et al. also showed increased spontaneous firing rates with extended culture times<sup>32</sup>. Together this emphasizes the importance of prolonged differentiation time for electrophysiological maturation.”</p><p>Lines 716-738: “<italic>Functional interactions with other cell types</italic></p><p>The ultimate result of autonomic neuronal function in vivo, is the establishment of functional changes in target cells. The rapid changes in cardiomyocyte beating rates following autonomic neuronal firing represent a practical way to demonstrate target cell coupling. In total, five sympathetic<sup>18,32,35,41,42</sup> and two parasympathetic protocols<sup>42,47</sup> showed altered beating rates of cardiomyocytes in co-culture with autonomic neurons following nicotinic stimulation. Although both parasympathetic studies adequately accounted for this, readers should note that nicotine administration can cause subtle decreases of hPSC-derived cardiomyocyte spontaneous beating rates, even in the absence of co-cultured autonomic neurons<sup>35,41,42</sup>. Therefore we recommend including a cardiomyocyte monoculture control for nicotine reactivity experiments.</p><p>Besides cardiomyocytes, other cell types have also successfully formed functional interactions with hPSC-derived autonomic neurons. Wu et al. also showed hPSC-derived parasympathetic neurons could increase calcium flux in salivary acinar cells upon nicotine administration<sup>47</sup>. Finally, autonomic neurons generated by Wu et al. and Fan et al. demonstrated specific interactions with adipocyte-like cells<sup>40,47</sup>. Co-culture with hPSC-derived sympathetic neurons caused human adipose-derived stem cells to increase lipid hydrolysis and adopt brown-like adipocyte identities<sup>40</sup>. Conversely, co-culture with hPSC-derived parasympathetic neurons caused 3T3-L1-derived mouse adipocytes to adopt mature morphology and increase adipogenesis<sup>47</sup>.”</p><p>To avoid repeating the same points as used to substantiate the above recommendations, the Discussion section was rewritten at several locations:</p><p>On lines 759-768: “However, factors like artemin, NRTN, endothelins, and netrin 1 may be required to recapitulate the target-specific phenotypical sympathetic neuron diversity observed in vivo<sup>111</sup>. For parasympathetic neurons, besides NRTN, TGFβ1, is another promising candidate to improve neuron maturation. in vivo, TGFβ1 regulates the expression of Ca<sup>2+</sup>-activated K<sup>+</sup>-channels together with NRG1<sup>156,157</sup>.”</p><p>On lines 786-821: “Besides markers expressed by the mature neurons,autonomic neuron identity was usually supported during differentiation by demonstrating the intermediate presence of NCC markers NGFR, HNK1 and/or SOX10 (or CD49d, which correlates with SOX10 expression<sup>158</sup>). Of these, SOX10 seems most robustly expressed in both human premigratory and migratory human NCCs<sup>87</sup>, but all markers are also expressed in parts of the neural tube, underscoring the need for multiple NCC markers in vitro.</p><p>After NCC induction, SCP formation is another specific feature of parasympathetic neuron development. However, only one article demonstrated the intermediate presence of SCPs by SOX10 expression and Schwann cell differentiation potential<sup>47</sup>. Considering that NCCs also express SOX10<sup>87</sup>, markers such as myelin protein 0 and cadherin 19 should be used to distinguish SCPs from NCCs<sup>122</sup>.</p><p>Even after establishing intermediate SCP identity, parasympathetic neurons and cholinergic enteric neurons cannot be distinguished from one another. The field currently lacks a comprehensive transcriptomic characterization of parasympathetic neurons<sup>148</sup>, as exists for sympathetic neurons<sup>111</sup>, to address this issue. A recent investigation of the right atrial ganglionic plexus, which contains parasympathetic neurons, may provide some clues<sup>160</sup>. However, the neurons of the intrinsic cardiac ganglia are diverse<sup>161</sup>. Ideally, single-cell RNA sequencing of peripheral cholinergic neurons would reveal specific molecular parasympathetic markers for future PSC-derived parasympathetic protocols.”</p><p>On lines 835-857: “From a functional point of view, a major challenge for hPSC-derived neurons is to develop from electrically passive hPSCs to mature neurons within a short time span. Besides prolonged time in culture, other strategies to improve autonomic neuronal maturity include the generation of microtissues containing multiple cell types. As an example, addition of hPSC-derived cardiac fibroblasts to three-dimensional (3D) microtissues consisting of hPSC-CMs and cardiac endothelial cells has been shown to improve hPSC-CM maturity<sup>165</sup>. Co-culture with epicardium-derived cells has also been shown to improve cardiomyocyte maturation and to stimulate sympathetic ganglion neurite outgrowth<sup>10,166</sup>. Satellite glial cells, which support neuronal survival and firing in vivo<sup>167</sup>, are another interesting candidate to assist autonomic neuronal maturation.”</p><disp-quote content-type="editor-comment"><p>3. The authors completely neglected to address the topic of 3D cell culture vs 2D cell culture. Were all protocols performed in 2D cell cullture? This might be a major limitation to the field, especially when considering the specific anatomy of autonomic neurons (assembled in ganglia with close intimacy of other cells types such as glia and fibroblasts). Please include this in the revised manuscript.</p></disp-quote><p>Thank you for this very relevant suggestion. All protocols were indeed developed for 2D culture. We have added a new paragraph to our discussion on lines 858-868:</p><p>“Three-dimensional autonomic neuronal models</p><p>In addition to glial cells, autonomic neurons neighbor several other cell types in vivo, such as pericytes and endoneurial fibroblasts<sup>168</sup>. Exposure to the signals and extracellular matrix deposited by these cells can influence culture stability, as well as gene and protein expression levels<sup>169</sup>. Ultimately, 3D cultures composed of multiple cell types could potentially model disease phenotypes that two-dimensional (2D) cultures consisting mainly of neurons may not be accurate or sensitive enough for. However, although several articles report the self-assembly of autonomic neurons into ganglia-like clusters<sup>21,30,42</sup>, all current protocols have been developed for 2D culture. Considering the variety of cells that is likely to impact autonomic neuron function, and the 3D anatomy of autonomic ganglia in vivo, the field would benefit from the availability of 3D models of autonomic ganglia with multiple cell types.”</p><disp-quote content-type="editor-comment"><p>4. Most of the Figures are highly complex and not self-explanatory. While we appreciate the amount of work that went into them and are sure the authors have a well-thought-through colour scheme, please try to make them easier to understand for the general audience. We specifically suggest including (sub)titles, captions and legends for the different colours of bars, arrows and growth factors.</p></disp-quote><p>Thank you for the suggestions to increase the impact of our figures. To improve interpretation, we have added titles to all figures, and internal figure legends where relevant. In addition, we have applied more neutral background colours for all figures explaining the in vivo functions of signaling cues. In doing so, we believe that the parallels between the colours used in the protocol overviews and the ‘in vivo<italic>’</italic> figures have become clearer.</p></body></sub-article></article>